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Pax6 encodes a highly conserved transcriptional regulator that is widely expressed 
during development of the eye, olfactory bulbs and central nervous system.  Pax6-/- 
mice exhibit severe brain defects, lack eyes and nasal structures, and die at birth.  
Included among the functions of Pax6 are cell adhesion, cell cycle progression, axon 
guidance and boundary formation.  The pallial-subpallial boundary (PSPB) is both a 
physical and gene expression boundary separating dorsal and ventral telencephalon.  
Pax6 is required for this boundary to develop.  In Pax6-/- embryos, genes which 
normally have a sharp border of expression at the PSPB become ectopically 
expressed and the radial glial fasicles that make up the physical component of the 
boundary fail to form.  There is also an increase in the number of interneurons 
migrating dorsally across the boundary to enter the cortex while corticofugal axons 
struggle to cross the PSPB and enter the ventral telencephalon.  Here a novel 
tauGFP-Pax6 reporter mouse, DTy54, is described in which cells capable of 
expressing Pax6 are tauGFP positive.  In general the expression pattern of tauGFP 
corresponds well with the known Pax6 expression pattern in the eye and forebrain 
and the gradient of cortical Pax6 expression from high rostro-laterally to low caudo-
medially is also recapitulated by tauGFP.  The cytoskeletal localisation of the 
tauGFP also labels cellular processes and the axons projecting from Pax6 positive 
cells such as those forming the optic nerve can be clearly seen.  At E10.5 the 
forebrain expression patterns of tauGFP and Pax6 correspond exactly, but at later 
stages tauGFP expression can be seen in areas negative for Pax6.  This can be seen at 
E12.5 in the ventral telencephalon and in both the dorsal and ventral telencephalon at 
E15.5.  Pax6 and tauGFP expression colocalise more closely in the diencephalon.  In 
situ hybridization analysis of Pax6 and tauGFP transcripts suggests that many of the 
discrepancies in expression seen at the protein level are due to a longer protein half-
life for tauGFP than for Pax6.  The expression of tauGFP allows the PSPB to be 
accurately dissected.  The cells from this region can then be sorted by FACS to 
isolate cells expressing high levels of tauGFP and enrich for the Pax6 positive 
population.  Microarray analysis of gene expression is this population of cells in 
Pax6+/+.DTy54+ and Pax6sey/sey.DTy54+ embryos is described here.  This analysis 
identified many genes that show a significant change in expression at the PSPB in 
the absence of Pax6 expression including Ngn2, Lhx6, Neurod6 and CyclinD1 and 2.  
The biological processes and molecular functions in which these genes are involved 
were examined to provide insight into the role of Pax6 in this population of cells.  
Several processes previously reported to be regulated by Pax6 were identified 
together with a number of novel processes with which Pax6 has not formerly been 
associated.  Some of these include cell cycle, neurogenesis, transcription and 
metabolic and signalling pathways.  This study has also identified many novel 
downstream targets of Pax6, such as Sema3G and PlexinA4, which will help to 
elucidate the genetic basis for the Pax6sey/sey phenotype at the PSPB.  The changes in 
expression levels of Ngn2, Lhx6 and Gsh2, identified by microarray, were validated 
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Chapter 1 – General Introduction
1.1 Early development of the brain 
The brain develops from the broad cranial end of the neural plate, which is composed 
of a thick layer of pesudostratified columnar neuroectoderm cells.  Indentations in 
this region mark out the three presumptive primary brain vesicles; the 
prosencephalon, mesencephalon and rhombencephalon.  Beginning on embryonic 
day 7.5 (E7.5) in mice, the neural plate undergoes a process called neurulation in 
which it folds along the craniocaudal axis so that its lateral edges meet in the dorsal 
midline, forming the hollow neural tube.  Neurulation is completed by the closing of 
the cranial and caudal neuropores (Rossant and Tam, 2002).    The space enclosed by 
the neural tube is the neural canal, which gives rise to the ventricles of the brain and 
persists as the central canal of the spinal cord.  Along its entire length the neural tube 
is divided into four longitudinal divisions; the floor, basal, alar and roof-plates.  The 
telencephalon develops at the most rostral end of the neural tube and from early 
stages can be seen to be divided into dorsal and ventral regions.  The doral part of the 
telencephalon is the pallium and gives rise to the cerebral cortex, while the ventral 
telencephalon is composed of the subpallium and this gives rise to the basal ganglia 
(Rossant and Tam, 2002; Fig. 1.1).   
 
At E9 swellings of the brain vesicles divide them into neuromeres, with neuromeric 
boundaries defined both by morphological structures and gene expression patterns 
(Puelles and Rubenstein, 1993; Rubenstein et al., 1994).  The prosomeric model uses 
these neuromeric divisions to describe the developing brain in terms of distinct 
segments.  According to this model the three primary brain vesicles are subdivided as 
follows:  The prosencephalon is divided into six prosomeres, numbered p1-6, with p6 
being the most rostral.  Within the rhombencephalon nine rhombomeres are formed; 
r1-8 and the rostral isthmus.  R8 is the most caudal of the rhombomeres.  The 
mesencephalon remains undivided.  These divisions are defined by morphological 
landmarks combined with gene expression patterns; with sharp borders of expression 
corresponding with the divisions of the model.  From E12 the five secondary brain 
vesicles can be distinguished.  The telencephalon and diencephalon are 
prosencephalic derivatives with p1-3 making up the diencephalon and p4-6 the 
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telencephalon (Bulfone et al., 1993).  The mesencephalon remains unchanged and 
the rhombencephalon gives rise to the metencephalon (r1) and myelencephalon (r2-
7).   
 
A number of problems have been encountered in applying the prosomeric model to 
the rostral forebrain.  In this region gene expression patterns do not clearly define the 
the boundaries between the putative prosomeres.  In order for a boundary to truly 
delimit one prosomere from another it must completely traverse the neural tube from 
roof- to floor-plate and this is not the case with the putative boundaries in the rostral 
forebrain (Puelles and Rubenstein, 2003).  There are also patterning effects seen 
here, which are not found elsewhere in the developing brain, and that result in the 
formation of oblique boundaries unique to the rostral forebrain.  To account for this, 
a simplified model has been suggested (Puelles and Rubenstein, 2003).  In this model 
p1-3 remain essentially unaltered with p1 comprising the pretectum, p2 the dorsal 
thalamus and epithalamus and p3 the ventral thalamus and eminentia thalami.  P4-6 
are no longer classified as 3 distinct prosomeres, instead the secondary 
prosencephalon is regarded as a single histogenetic field comprising the 
telencephalon and hypothalamus (Puelles and Rubenstein, 2003).  The longitudinal 
divisions of the neural tube, the floor, basal, alar and roof-plates, remain unchanged.  
The neuromeric divisions of the developing brain as defined by this modified model 
are outlined in Figure 1.2. 
 
1.2 Regulation of forebrain development by signalling molecules 
Patterning occurs along three axes of the developing brain; the anterior-posterior 
(AP) axis, medial-lateral axis and the dorso-ventral (DV) axis (Fig. 1.3).  The major 
signalling centres and the signalling molecules they produce are shown in Figure 1.3 
A.  Signalling centres for medial-lateral patterning most likely lie along the edges of 
the cortex.  The cortical hem, for example, which comprises the medial edge of the 
cortex, has been shown to express members of the Wnt and BMP gene families 
(Furuta et al., 1997; Grove et al., 1998).  Putative signalling centres for patterning 
along the AP axis include the anterior neural ridge (ANR) and anteromedial 
telencephalon (Shimamura and Rubenstein, 1997; McWhirter et al., 1997).  
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Figure 1.1: Dorso-ventral division of the telencephalon 
Schematic diagram of a coronal section through the left telencephalic vesical of the 
mouse forebrain at E12.5 showing the division into dorsal and ventral regions.  The 
dorsal pallium will give rise to the cerebral cortex while the ventrally lying 











Figure 1.2: Neuromeric divisions of the developing brain 
Schematic medial view of the embryonic mouse brain at E12.5 showing the 
prosomeric divisions.  Transverse and longitudinal boundaries are shown in blue.  
Acx, archicortex; cge, lge, mge, caudal, lateral and medial ganglionic eminences; dt, 
dorsal thalamus; et, epithalamus; emt, eminentia thalami; is, isthmus; m, 
mesencephalon; ncx, neocortex; ob, olfactory bulb; pt, pretectum; vt, ventral 
































Figure 1.3: Schematic representation of forebrain signalling centres and 
the dorso-ventral divisions of the telencephalon 
(A) Schematic diagram of the mouse forebrain at E11.5, viewed from the dorsal side, 
anterior is up.  Signalling centers, the signalling molecules they produce and their 
likely directions of diffusion are shown.  FGFs (black arrows) are expressed in the 
anterior neural ridge and then in the anteromedial telencephalon.  Wnts and BMPs 
(hatched arrows) are expressed in the cortical hem at the caudomedial edge of the 
cortex.  Dotted arrows indicated possible cortical patterning signals from lateral and 
posterior sources, which may include TGF-α and Shh.  The red arrow indicates the 
anterior-posterior axis of development.  (A was adapted from Ragsdale and Grove 
2001).  (B) shows a coronal section cut through the left telencephalic vesical at 
E11.5-E12.5.  The dorso-ventral divisions of the telencephalon are labelled and the 
locations of the cortical angle and pallial-subpallial boundary are indicated.  Red 























DV patterning occurs after the AP pattern has been laid down.  The DV axis is 
patterned by signalling molecules produced initially in the adjacent ectoderm and 
axial mesoderm and later in the roof and floor plates of the neural tube (Ericson et 
al., 1995; Furuta et al., 1997; Monuki et al., 2001).  Dorsal cell fates are induced by 
transforming growth factor-β (Tgfβ) family members, while ventral fates are induced 
by sonic hedgehog (Shh) (Ericson et al., 1995; Hébert et al., 2002; for review see 
Wilson and Rubenstein 2000; Ragsdale and Grove, 2001; Campbell, 2003).  
 
1.2.1 Medial-Lateral Patterning 
The cortical hem at the medial edge of the cortex expresses multiple Wnt genes as 
well as members of the BMP and Msx gene families (Furuta et al., 1997; Grove et 
al., 1998).  It is located between the developing hippocampus and choroid plexus, 
making it an ideal source of patterning signals for the development of both these 
structures.  The delineation of the cortical hem by the expression of Wnt genes can be 
seen from E12.5 (Grove et al., 1998).  Wnt signalling has been shown to be required 
for the specification of hippocampal cells and in Wnt3a mutant embryos the 
hippocampus fails to develop (Lee et al., 2000).  The signalling molecules of the 
cortical hem also have a role in establishing gene expression patterns along the 
medial-lateral axis of the dorsal telencephalon.  The transcription factor Emx2, which 
is expressed in a graded high posteromedial to low anterolateral pattern across the 
neocortex (Bishop et al., 2000, 2002; Muzio et al., 2002) has an enhancer that is a 
direct target of BMP and Wnt signalling and these signalling pathways act together 
to regulate the gradient of Emx2 expression (Theil et al., 2002).  At E8.5 canonical 
Wnt signalling occurs through much of the dorsal telencephalon but from E10.5 this 
activity retracts caudomedially so that by E12.5 it is only present in the cortical hem 
(Machon et al., 2007). The progression of neurogenesis in the dorsal telencephalon is 
complementary to this retraction of Wnt signalling (Machon et al., 2007).   
 
A further source of signalling molecules is the cortical antihem which lies along the 
lateral edge of the developing cortex at the junction between the dorsal and ventral 
telencephalon.  The curve of the antihem mirrors the curve of the cortical hem and 
together they demarcate the medial and lateral limits of the cortical ventricular zone 
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(Assimacopoulos et al., 2003).  The antihem expresses the epidermal growth factor 
(EGF) family members Tgfα, Neuregulin 1 (Nrg1), and Nrg3 along with Fgf7 and the 
Wnt antagonist secreted frizzled-related protein 2 (Sfrp2).  The expression of EGFs 
is not confined to the antihem; they are expressed in graded patterns, with the 
antihem showing the highest level of expression for each of the three genes.  The 
location of the antihem at the pallial-subpallial boundary (PSPB) allows it to 
influence medial-lateral patterning of the developing cortex as well as the DV 
patterning of telencephalon as a whole (Fig. 1.3 B).  The EGFs expressed in the 
antihem may also be involved in the regulation of migration of cortical interneurons 
from their source in the ventral telencephalon to the cortex (Assimacopoulos et al., 
2003).   
 
1.2.2 Dorso-Ventral Patterning 
Along the DV axis the telencephalon is divided into a ventral subpallial and dorsal 
pallial region.  These regions give rise to the basal ganglia and the cerebral cortex 
respectively.  The neuroepithelium of the pallium is the source of the cortical 
projection neurons while most interneurons migrate into the cortex from the 
subpallium (Porteus et al., 1994; DeCarlos et al., 1996; Tamamaki et al., 1997; Zhu 
et al., 1999).  As the DV pattern is established, different regions become 
characterised by distinct gene expression patterns.  For example dorsal telencephalic 
progenitor cells express members of the Emx gene family while ventral telencephalic 
progenitors express Nkx2.1 and Dlx family members (Wilson and Rubenstein, 2000).  
The PSPB, defined by gene expression patterns, does not lie at the cortical angle 
where the pallium and lateral ganglionic eminence (LGE) meet (Fig. 1.3 B).  Instead 
it is located in the dorsal-most part of the LGE and is marked by the restricted 
expression of transcription factors such as Pax6 and Dbx on the pallial side and Gsh2 
and Nkx2.1 on the subpallial side (Toresson et al., 2000; Yun et al., 2001).  These 
patterns of gene expression are established by members of the Tgfβ and hedgehog 
(HH) families of signalling molecules, which are critical in patterning the DV axis. 
 
The Tgfβ family members involved in DV patterning are BMPs.  BMPs are 
expressed in the roof plate of the developing neural tube and confer a dorsal identity 
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on cells (Furuta et al., 1997; Hébert et al., 2002).  They are required for the 
formation of the dorsal midline structures such as the choroid plexus and the 
hippocampus.  In the absence of BMP signalling these structures fail to form, 
although other aspects of dorsal patterning, such as the establishment of the cortical 
hem, still occur suggesting a role for other signalling molecules in the generation of 
dorsal cells (Hébert et al., 2002).  Further evidence of the importance of BMP 
signalling for the development of the dorsal midline is provided by the phenotype of 
mice lacking BMP receptors 1a and 1b.  These mice suffer from holoprosencephaly, 
with dorsal midline structures completely absent and impaired specification of 
ventral telencephalic cells (Fernandes et al., 2007).  Wnt family members are 
expressed in the dorsal midline and also in the VZ of the pallium and at the PSPB 
(Grove et al., 1998; Kim et al., 2001).  Together BMPs and Wnts act to regulate the 
expression of dorsal-specific transcription factors such as Emx1, Emx2 and Lhx2 
(Monuki et al., 2001; Theil et al., 2002).  Expression of Wnt7b and its inhibitor Sfrp2 
at the PSPB suggests that Wnt signalling may be involved in the formation of this 
boundary (Kim et al., 2001).   
 
Specification of ventral cell types at all AP levels of the neural tube occurs in 
response to Shh signalling (Fuccillo et al., 2004).  Shh, produced in the mesoderm 
beneath the neural tube and in the ventromedial cells of the forebrain, acts in a 
concentration dependent manner to induce specific cell types at different positions 
along the DV axis (Ericson et al., 1995).  This can be most clearly seen in the 
developing spinal cord where cells express floor plate marker genes in response to 
high levels of Shh, while at much lower levels Shh induces the differentiation of cells 
into motor neurons (Roelink et al., 1995).  The medial ganglionic eminences (MGEs) 
fail to form in the absence of Shh and Nkx2.1 expression is lost.  Development of the 
lateral ganglionic eminences (LGEs) still occurs however, suggesting that in the 
telencephalon Shh is essential for ventromedial patterning while more lateral fates 
can be produced in its absence (Rallu et al., 2002).   
 
In Shh null mutants the development of the telencephalon is extremely abnormal and 
by birth it cannot be recognised without the use of telencephalic-specific markers 
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(Rallu et al., 2002; Fuccillo et al., 2004).  In mammals the Gli transcription factors 
are the only known mediators of the HH signalling pathway, and of these the 
repressor form of Gli3 is the only one that has been shown to be involved in DV 
patterning (Rallu et al., 2002).  The interaction between Shh and Gli3 is mutually 
antagonistic with Shh repressing Gli3 in ventral regions of the neural tube and Gli3 
repressing Shh in dorsal regions.   
 
The importance of this interaction can be inferred by the phenotype of Shh/Gli3 
double mutants which is less severe than that of mutants for either gene on its own.  
Nkx2.1 expression (lost in the Shh mutant) is restored in the double mutant and a 
morphologically distinct MGE can be identified (Rallu et al., 2002).  Compared with 
the Gli3 single mutant the improved phenotype of the double mutant also suggests 
that the patterning defects seen in the Gli3 mutant are caused, in part at least, by 
increased Shh signalling.  The fact that DV patterning can be established in the 
absence of both Gli3 and Shh indicates that a second pathway, that is independent of 
Shh, must be involved in patterning the telencephalon along the DV axis. 
 
A potential signalling molecule for Shh-independent DV patterning is Fgf8.  Fgf8 
expression is lost in Shh mutants, but is upregulated in Gli3 mutants (Kuschel et al., 
2003).  Gli3 mutants show ventralisation of the dorsal telencephalon with the loss or 
reduction of Emx1 and Emx2 transcription.  In vitro, in the absence of Shh, Fgf8 has 
been shown to induce ventral marker genes such as Mash1 and Dlx2 in dorsal 
telencephalic explants and to suppress Emx1 expression (Kuschel et al., 2003).  The 
signalling centres that pattern the forebrain have been shown to interact and FGF 
signals are normally antagonised by BMP signalling (Shimogori et al., 2004; Storm 
et al., 2006).  The loss of BMP expression in Gli3 mutants allows Fgf8 to cause the 
development of rostroventral structures at the expense of the dorsomedial 
telencephalon (Kuschel et al., 2003). 
 
1.2.3 Anterior-Posterior Patterning 
AP patterning of the neural tube is largely established through the actions of FGFs.  
Fgf8 is expressed in the ANR and anteromedial telencephalon while the FGF 
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receptors Fgfr1, 2 and 3 are expressed in a graded pattern along the AP axis of the 
developing neocortex (Fukuchi-Shimogori and Grove, 2001).  Fgf8 induces the 
development of the rostral telencephalon and its overexpression in the ANR causes 
the anterior neocortical domain to increase in size by shifting boundaries, defined by 
cadherin expression, posteriorly along the AP axis.  This expansion occurs at the 
expense of the more posterior occipital domains, which contract so that the total AP 
length remains unchanged (Fukuchi-Shimogori and Grove, 2001).  Conversely if 
Fgf8 expression is reduced there is a decrease in the frontal domain with a 
corresponding increase in the size of more posterior regions, as their boundaries are 
shifted anteriorly. 
 
1.3 Regulation of forebrain development by transcription factors 
The signalling molecules that establish the pattern of the forebrain do so by 
regulating the expression of different transcription factors in specific areas of the 
forebrain.  These transcription factors in turn control the expression patterns of other 
genes, allowing distinct areas of the forebrain to express unique subsets of genes.  
This generates the genetic diversity seen in areas of the forebrain that are 
programmed to perform different functions.  Examples of some of the diverse roles 
of specific transcription factors are given below. 
 
Gli3 expression is essential for maintaining the molecular identity of the dorsal 
telencephalon.  Gli3 is a mediator of the Shh signalling pathway and has long been 
thought to prevent the ventralisation of dorsal regions of the telencephalon by Shh 
(Rallu et al., 2002).  More recent work by Rash and Grove (2007), however, suggests 
that the loss of dorsal fates seen in the absence of Gli3 is due to the effects of FGF 
signalling which is increased in Gli3 mutants.  There is also evidence to suggest that 
Gli3 expression is critical for the development of the boundary between 
diencephalon and telencephalon (Fotaki et al., 2006).  These two structures are 
joined abnormally in Gli3 mutants with diencephalic tissue present in a region that 
one might expect to be dorsal telencephalon.  This gives the appearance of 
ventralisation of this tissue as many ventral telencephalic marker genes are also 
expressed in the diencephalon (Fotaki et al., 2006).   
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The loss of the dorsomedial telencephalon in Gli3 mutants also results in the loss of 
the expression of BMPs and Wnts from the signalling centres in this tissue (Tole et 
al., 2000).  This results in a failure to correctly pattern the dorsal telencephalon with 
the early loss of Emx1 expression (Tole et al., 2000).  This in turn affects Pax6 
expression which by E14.5 is greatly reduced (Kuschel et al., 2003). 
 
As BMPs and Shh are confined to dorsomedial and ventromedial regions 
respectively, other factors must be involved in mediating the patterning of more 
lateral aspects of the DV axis.  Pax6 and Gsh2 have complementary expression 
patterns in the developing telencephalon, where they act to repress each other.  Pax6 
is expressed in the cortical VZ and in the lateralmost part of the LGE to the level of 
the PSPB.  On the subpallial side of this boundary Gsh2 is expressed in the VZ of 
both the LGE and MGE (Toresson et al., 2000; Yun et al., 2001).  Both genes are 
expressed in graded patterns with the highest levels of expression at the PSPB.  In 
the absence of Pax6 the PSPB doesn’t form correctly and a number of signalling 
molecules expressed at this boundary, including Wnt7b and Sfrp2, are lost (Kim et 
al., 2001; Assimacopoulos et al., 2003).  The antihem signalling centre is thereby 
completely lost in Pax6 mutants.  Pax6 mutants also show ectopic expression of 
ventral markers such as Mash1 and Dlx genes in the developing cortex, where they 
are normally repressed through the maintained expression of neurogenin 1 and 2 by 
Pax6 (Toresson et al., 2000). 
   
1.4 Pax6 and its role in eye and forebrain development 
1.4.1 The Pax6 gene 
Pax6 is a member of the paired-box family of transcription factors and therefore has 
two DNA binding domains – the paired-domain and the homeodomain.  These 
domains are separated by a glycine-rich linker sequence and can bind DNA both 
independently and cooperatively (Callaerts et al., 1997; Jun and Desplan, 1996; for 
reviews of Pax6 see Simpson and Price 2002; Manuel and Price 2005).  The paired 
box domain, which characterises the Pax gene family, was first discovered in the 
Drosophila gene paired and was found to be conserved in a number of functionally 
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related genes including gooseberry-proximal and -distal, Pox meso and Pox neuro 
(Bopp et al., 1986, 1989).  The paired box was subsequently found to be conserved 
across a wide variety of species from turtle and zebrafish to mammals.  The first 
murine Pax gene, Pax1, was identified in 1988 by Deutsch et al. using the paired box 
of gooseberry-distal to probe two mouse genomic libraries.  Nine members of the 
Pax gene family have since been identified in both mouse and human (for review see 
Lang et al., 2007). 
 
Pax6 expression is first seen as early as embryonic day 8.5 (E8.5) in the mouse.  It is 
widely expressed in the developing CNS including the forebrain, hindbrain, 
cerebellum and ventral neural tube (Grindley et al., 1995; Walther and Gruss, 1991).  
It is also expressed in pancreatic islet cells (Sander et al., 1997; St-Onge et al., 
1997), the developing olfactory system, and in the lens, cornea and retina of the 
developing eye (Grindley et al., 1995; Quinn et al., 1996).  Pax6 expression is 
critical for survival and Pax6 null mice die immediately after birth.  In these mice the 
eyes and nasal structures are absent and the diencephalon fails to innervate a severely 
malformed cerebral cortex (Hogan et al., 1986; Hill et al., 1991; Schmahl et al., 
1993; Pratt et al., 2000). 
 
1.4.2 Phenotypes of mutations in Pax6 
The human condition aniridia and its homologous mouse phenotype, small eye (Sey), 
were long believed to be caused by mutations in the same gene.  Analysis of a 
candidate gene for aniridia predicted that its protein product would have the 
characteristics of the paired box family of transcription factors (Ton et al., 1991) and 
a murine cDNA was subsequently found that was 92% homologous to the candidate 
aniridia gene at the nucleotide level and produced an almost identical amino acid 
sequence (Ton et al., 1992). Analysis of the Pax6 gene in mice with a variety of Sey 
alleles confirmed that Pax6 is the gene responsible for this phenotype (Hill et al, 
1991).  Identification of the Drosophila homolog of Pax6, eyeless, which is critical 
for eye formation in the fly, shows the high degree of functional conservation of this 
gene across species (Quiring et al., 1994). 
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The conservation of Pax6 function and the importance of its regulatory role during 
development are evident from the phenotypes caused by mutations in this gene.   In 
mice, heterozygosity results in a decrease in eye size and ocular abnormalities 
including iris hypoplasia, corneal opacification and cataracts (Hogan et al., 1988).  
Humans with heterozygous mutations in PAX6 suffer from aniridia, displaying a 
variable eye phenotype similar to that seen in heterozygous mice, and so Sey mice 
provide a good model in which to study aniridia (Glaser et al., 1990; van der Meer-
de Jong et al., 1990).  There is also a variety of structural brain abnormalities 
associated with PAX6 haploinsufficiency in humans.  The pineal gland is frequently 
absent or abnormal.  In a study of 24 subjects, only 4 had a pineal gland which was 
structurally normal (Mitchell et al., 2003).  The anterior commissure is often absent 
or hypoplastic and the corpus callosum may also be reduced in size (Sisodiya et al., 
2001).  This decrease in the callosal area is possibly due to a decrease in the number 
of interhemispheric projection fibres.  The anterior commissure also plays an 
important role in interhemispheric transfer, particularly of olfactory and auditory 
fibres.  Studies have shown that aniridia patients frequently have reduced olfaction 
(Sisodiya et al., 2001).  There is also evidence of deficient auditory interhemispheric 
transfer in aniridia patients often, but not always, associated with an 
absent/hypoplastic anterior commissure and/or a reduced corpus callosum (Bamiou 
et al., 2004). 
 
1.4.3 Pax6 and the dorso-ventral specification of the telencephalon 
The telencephalon is divided into a ventral subpallial and dorsal pallial region and 
these give rise to the basal ganglia and the cerebral cortex respectively (Fig. 1.1).  
Pax6 is expressed in dorsal regions of the telencephalon, throughout the population 
of cells dividing at the ventricular edge, and helps to delineate the PSPB, the earliest 
division to occur within this structure. Expression is much more limited to smaller 
groups of cells in the ventral telencephalon (Puelles et al., 1999).  Figure 1.4 shows 
the expression pattern of Pax6 in the developing mouse forebrain between E11.5 and 
E15.5.  As mentioned previously, the PSPB is located in the dorsal-most part of the 
LGE and is marked by higher/restricted expression of transcription factors such as  
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Figure 1.4: Schematic representation of the expression profile of Pax6 
in the wild-type developing forebrain from E11.5 to E15.5 
 (A and B) Coronal sections cut through the left telencephalic vesicle at E11.5–E12.5 
and E15.5, respectively. Low levels of Pax6 in the ventricular zone of the LGE are 
represented by the dotted area. (C and D) Parasagittal sections through the forebrain 
at E12.5 and E14.5 showing Pax6 expression in the telencephalon and diencephalon, 
but not in the mesencephalon. In the cortex, Pax6 is expressed in a rostro-lateralhigh 
to caudio-mediallow gradient.  Di, diencephalon; m, mesencephalon; t, telencephalon. 































Pax6 and Dbx on the pallial side and Gsh2 and Nkx2.1 on the subpallial side 
(Stoykova et al., 1996; 2000; Toresson et al., 2000; Yun et al., 2001).  This boundary 
is marked by gene expression patterns as early as E9.5 (Toresson et al., 2000; Yun et 
al., 2001).  A physical boundary also develops in this region in the form of radial 
glial fascicles which are most prominent at E16.5 in mice (Neyt et al., 1997; 
Stoykova et al., 1997).  In the absence of Pax6 protein, both the physical and the 
gene expression boundaries are lost. 
 
Cells from either side of the boundary have different adhesive properties due to the 
expression of different cadherins.  Cells of the LGE, ventral to the PSPB, express 
cadherin-6 while the cells of the developing cortex, dorsal to the boundary, express 
R-cadherin (Matsunami and Takeichi, 1995; Inoue et al., 2001).  The expression of 
R-cadherin is regulated in part by Pax6, with which its expression overlaps.  In 
Pax6Sey/Sey embryos, R-cadherin expression is reduced in areas where the two genes 
are normally co-expressed, although levels are unaltered in other areas (Stoykova et 
al., 1997).  These differences in cadherin expression are important in maintaining the 
PSPB by restricting the mixing of pallial and subpallial cells, as shown by 
aggregation experiments (Stoykova et al., 1997). Cortical and striatal cells, from 
mice aged between E12.5 and E14.5, tend to segregate if they are mixed in vitro.  By 
E15.5 this region-specific adhesion is lost.  In Pax6Sey/Sey mice the PSPB fails to form 
and cells from cortical and striatal regions in these animals fail to segregate if they 
are mixed between E12.5 and E14.5 (Stoykova et al., 1997).  This is due to an 
alteration in the adhesive properties of Pax6Sey/Sey cortical cells, as these cells 
segregate from wild-type cortical cells while striatal cells from wild-type and 
Pax6Sey/Sey mice still form mixed cell clusters. 
 
Pax6 is only one of a large number of genes, both pallial and subpallial, whose 
expression is delimited by the PSPB. Other dorsal markers whose expression patterns 
have a sharp border at the PSPB include Ngn2 and Tbr1, while ventral markers 
include Gsh2, Dlx1, Vax1, Mash1 and Six3 (Stoykova et al., 2000).  At E9.5, Gsh2, 
Dlx1 and Mash1 are expressed in progenitor cells of the LGE and MGE and by 
E10.5 they can be seen to be expressed most strongly adjacent to the PSPB (Toresson 
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et al., 2000; Yun et al., 2001).  Pax6 overlaps with Gsh2 expression in the dorsal-
most part of the LGE where it is expressed at low levels (Stenman et al., 2003; 
Toresson et al., 2000; Yun et al., 2001), but it is very strongly expressed in the 
ventral pallium, on the dorsal side of the boundary, where it coincides with the strong 
expression of Ngn2. 
 
Pax6 is critically important in establishing the PSPB.  The PSPB fails to form in 
Pax6-/- mutant mice and marker genes no longer have a sharp expression boundary in 
this region (Stoykova et al., 1996; Stoykova et al., 2000).  Several of these marker 
genes play complementary or cooperative roles to that of Pax6 in establishing the 
PSPB, as is demonstrated by the phenotype of animals with various combinations of 
mutations in these genes.  In the absence of Pax6 there is a dorsal expansion of 
subpallial markers which coincides with a downregulation of pallial marker genes.  
By E12.5 Gsh2, Dlx and Mash1 are all ectopically expressed in the progenitor cells 
of the ventrolateral cortex (Toresson et al., 2000; Yun et al., 2001).  This ectopic 
expression continues to expand dorsally so that by E14.5 it includes the ventricular 
zone (VZ) of the dorsolateral cortex (Toresson et al., 2000).  Ngn 2 expression is lost 
in the areas of ectopic Gsh2 expression and is downregulated in the remainder of the 
cortical VZ (Stoykova et al., 2000; Toresson et al., 2000; Kroll and O’Leary, 2005).   
 
Gsh2 protects the ventral telencephalon from becoming dorsalised by repressing 
Pax6 in the LGE (Toresson et al., 2000; Yun et al., 2001).  Gsh2-/- mice show a 
phenotype that is opposite to that of Pax6Sey/Sey embryos, with ectopic expression of 
the pallial markers Tbr2, Ngn1 and 2 and Pax6 in striatal progenitor cells at E10.5 
(Toresson et al., 2000; Yun et al., 2001).  This ventral expansion of dorsally-
expressed genes coincides with the loss of Dlx and Mash1 from much of the LGE, 
where they are expressed at high levels in the wildtype.  The misspecification of 
these cells is less pronounced at E12.5 and by E14.5 pallial genes are no longer 
ectopically expressed, possibly due to the effect of ectopic Gsh1 expression (Yun et 
al., 2001).  Gsh1 is normally only expressed in ventral parts of the LGE, but it is 
expressed more strongly in the Gsh2 mutant and at later stages it expands into the 
dorsal LGE where it is thought to compensate for Gsh2, thereby reducing the 
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molecular abnormalities in the LGE.  These mutants also have abnormalities in the 
differentiation of striatal cells and the developing olfactory bulb is reduced in size 
(Yun et al., 2001). 
 
In Pax6-/-/Gsh2-/- double mutants, striatal development is improved compared with 
the Gsh2-/- single mutants.  Cortical progenitors remain misspecified and continue to 
express ventral marker genes, as in Pax6-/- mice, although the double mutants do 
show an improvement in cortical plate formation.  Neuronal migration, from the VZ 
to the cortical plate, is guided by the processes of radial glial cells (Anton et al., 
1996).  Ectopic expression of Gsh2 in more dorsal regions of the telencephalon may 
be involved in the alteration of radial glial cell morphology seen in Pax6 mutants, 
thereby having a direct effect on the manifestation of migration defects seen in these 
embryos (Carić et al., 1997; Toresson et al., 2000).  This may also account for the 
failure of the radial glial fascicles to form at the PSPB in the Pax6 mutant.   
 
Tlx is another gene that cooperates with Pax6 in the formation of the PSPB.  
Although Tlx is expressed in VZ cells on both sides of the PSPB, Tlx loss-of-function 
mutants show a misspecification of the ventral pallium that is similar to, but less 
severe than, that seen in the Pax6-/- mutant (Stenman et al., 2003).  Gsh2 expression 
is expanded dorsally so that its region of overlap with Pax6 expression is wider than 
in wildtypes (Stenman et al., 2003). A stream of migrating Pax6-positive cells, 
which appear to originate from the region of overlapping Pax6 and Gsh2 expression, 
extends out along the PSPB from the subventricular zone (SVZ) towards the pial 
surface as part of the lateral cortical stream (LCS).  In the Tlx mutant, where this 
overlapping region is increased, a much wider stream of cells can be seen (Stenman 
et al., 2003), while there is a marked decrease in these cells in the Gsh2 mutant 
(Toresson et al., 2000).  Ngn2 expression retracts dorsally, corresponding to the 
dorsal expansion of Mash1, while both Dbx1 and Sfrp2 expression are lost from the 
VZ of the ventral pallium.  Heterozygous mutations in either Pax6 or Tlx do not 
appear to have any effect on the development of the PSPB; however, compound 
heterozygotes display a mild phenotype with some ectopic Gsh2 and Mash1 positive 
cells present in the ventral pallium.  The loss of one copy of Pax6 on the Tlx-/- 
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background results in a phenotype that, while worse than Tlx-/- on its own, is less 
severe than that of Pax6-/- mice (Stenman et al., 2003).  However, the loss of one or 
both copies of Tlx on the Pax6-/- background does not affect the patterning defects 
seen in Pax6 mutants.  This is probably due to a much broader requirement for Pax6 
than for Tlx in patterning the dorsal telencephalon.  
 
1.4.4 Pax6 in cortical development and neurogenesis 
The neocortex develops from the prosencephalon at the rostral end of the neural tube.  
Its six-layered structure is formed by the migration of differentiated cells from the 
proliferative ventricular and subventricular zones.  It develops from the inside out, 
with later born neurons migrating past earlier born neurons to form the outer layers 
(Angevine and Sidman, 1961; Rakic, 1974).  When the earliest neurons are produced 
they become organised as the preplate, within which the cortical plate proper is laid 
down.  As more and more cortical neurons migrate towards the pial surface, the 
preplate becomes divided into the superficial marginal zone and the deep subplate, 
with the developing cortical plate lying between these two layers (Marin-Padilla, 
1978).  As soon as they are generated, postmitotic neurons migrate away from the 
ventricular zone towards the developing cortical plate where they bypass older 
cortical plate neurons to take up more superficial positions, just deep to the marginal 
zone (Angevine and Sidman, 1961; Rakic, 1974).  The neurons then associate into 
layers, with each layer containing neurons of a similar birth date (Rakic, 1974).  In 
this way the six-layered structure of the neocortex is established with layer 2 
composed of the latest born neurons.  By birth the VZ has been lost, along with most 
of the cells of the subplate and marginal zone (Estivill-Torrus et al., 2002). 
 
In mice cortical neurogenesis begins around E11 (Levers et al., 2001).  The 
progenitor cells that produce the majority of the different cell types found in the 
cortex are located in the ventricular and subventricular zones.  There are two main 
types of progenitor cells – radial glia and intermediate progenitor cells.  Intermediate 
progenitor cells are also called basal progenitors as they divide away from the 
ventricular surface (Miyata et al., 2004; Noctor et al., 2004).  They are derived from 
radial glial cells and can only give rise to neurons.  Radial glia, on the other hand, are 
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multipotent precursors that divide at the ventricular surface and can give rise to both 
neurons and glia (Götz et al., 1998; Heins et al., 2002; Noctor et al., 2001; 2002).  
Along with their role as progenitor cells, radial glial cells have other important 
functions in the developing brain.  They are involved in neuronal migration and also 
in boundary formation and patterning of the cortex. 
 
In the absence of functional Pax6 a number of defects occur during cortical 
neurogenesis.  These result in the formation of a thin and disorganised cortical plate 
and the accumulation of neurons in the SVZ and IZ, where they from dense clusters 
(Schmahl et al., 1993; Carić et al., 1997).  This phenotype results in part from 
migrational defects in late-born neurons (from E15).  Early born neurons can migrate 
normally to the cortical plate (Schmahl et al., 1993) and it is during the late stages of 
neurogenesis that cells can be seen to accumulate in the SVZ and IZ (Schmahl et al., 
1993; Carić et al., 1997).  These migrational problems are caused by a defect in the 
mutant environment rather than by a cell autonomous requirement for Pax6 in late-
born neurons and can be rescued by transplantation into a wildtype cortex (Carić et 
al., 1997).  The underlying defect is likely to be the changes in the morphology of 
radial glial cells that occur in the absence of Pax6 (Götz et al., 1998).  During normal 
corticogenesis the radial migration of neurons is guided by radial glial cells with 
which they form cell junctions and this method of migration becomes more 
important at later stages of cortical development (Anton et al., 1996). 
 
Pax6 is important not only for the correct migration of neurons to the cortical plate 
but also for the regulation of cell cycle parameters in the progenitor cell population 
(Götz et al., 1998; Estivill-Torrus et al., 2002; Manuel et al., 2007; Quinn et al., 
2007).  A shortening of the cell cycle at E12.5, early in corticogenesis, has been 
reported (Estivill-Torrus et al., 2002), but a more recent study by Quinn et al. (2007) 
found no significant difference between wildtype and mutant progenitors at this age, 
probably due to the use of a different method to measure cell cycle length.  Between 
E12.5 and E15.5 there is a more rapid increase in the proportion of cells dividing 
asymmetrically (to produce neurons) as opposed to symmetrically (to self-renew) in 
the Pax6 mutant compared to wildtype (Estivill-Torrus et al., 2002).  This 
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observation corresponds well with the decrease in the number of cells re-entering S-
phase at this age in Pax6-/-, seen by Quinn et al. (2007).  Concurrent with the 
decrease in S-phase re-entry is an increase in the proportion of differentiating 
neurons, suggesting that in the absence of functional Pax6 cortical progenitor cells 
exit the cell cycle early (Quinn et al., 2007).  Early cell cycle exit would also explain 
the decrease in neurogenic potential observed in cortical radial glial cells isolated 
from E14 Pax6 mutant embryos (Heins et al., 2002). 
 
There is not only a requirement for Pax6 expression in the proliferative cells of the 
developing cortex, the correct level of expression is also important, with changes in 
cell cycle kinetics observed both in the absence of Pax6 and when is expressed at 
higher than normal levels (Talamillo et al., 2003; Manuel et al., 2007; Quinn et al., 
2007).  Analysis of Pax6-/-↔Pax6+/+ chimeric embryos shows that Pax6-/- cells 
segregate from wildtype cells by E10.5 (Talamillo et al., 2003).  In addition to this 
there is an under-representation of these cells in the hippocampus, cortex and dorsal 
LGE in chimeras at E12.5 (Quinn et al., 2007).  Over-expression of Pax6 also affects 
corticogenesis causing a decrease in the thickness of the superficial cortical layers 
(Manuel et al., 2007).  Pax77+ mice carry 5-7 copies of the human PAX6 gene in 
YAC Y593 and show an increase in Pax6 protein levels specifically in the normal 
Pax6 expression pattern.  At E15.5 Pax77+ embryos show a reduction in the 
proportion of S-phase cells and in the density of cells undergoing mitosis specifically 
in rostral and central parts of the cortex but not in caudal areas (Manuel et al., 2007).  
In Pax77+↔Pax6+/+ chimeras there is an under-representation of Pax77+ cells at all 
rostro-caudal levels of the cortical VZ and in the rostral IZ.  This emphasises the 
importance of maintaining the correct level of Pax6 expression if normal 
corticogenesis is to occur.  
 
1.4.5 Pax6 in the regulation of cortical arealisation 
Pax6 and Emx2 are expressed in opposing patterns along the medial-lateral axis of 
the developing cortex, with high levels of Pax6 in rostro-lateral regions and of Emx2 
in caudo-medial areas (Bishop et al., 2000; 2002).  Emx2 and Pax6 proteins are 
required to establish this graded expression pattern and they also act to down-
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regulate each other’s activity (Muzio et al., 2002).  In this way Emx2 and Pax6 help 
to regulate the early regionalisation of the neocortex, although the importance of 
Pax6 in this process is disputed by Manuel et al. (2007).   
 
Emx2 and Pax6 preferentially impart caudo-medial and rostro-lateral identities 
respectively.  The expression patterns of the areal markers Cadherin6 (Cad6) and 
Cadherin8 (Cad8) show complementary changes in Emx2 and Pax6 mutants.  Cad6 
marks the somatosensory and auditory areas while Cad8 labels the more rostrally 
located motor area (Bishop et al., 2000).  In the Emx2 mutant the expression pattern 
of these marker genes is shifted caudo-medially resulting in an expansion of rostro-
lateral areas at the expense of caudo-medial regions which, while present, are greatly 
reduced in size.  An opposite shift in cadherin expression patterns occurs in the Pax6 
mutant (Bishop et al., 2000).  If Pax6 and Emx2 were equally important in this 
process one might expect to see a caudo-medial shift in cortical patterning in Pax6 
over-expressing animals. Contrary to expectations however the position of the 
somatosensory area was unaltered in these animals compared to wildtype (Manuel et 
al., 2007). 
 
Emx2 and Pax6 are also involved in establishing the expression patterns of Wnt 
genes in the cortical hem and this signalling centre is distorted in both Emx2 and 
Pax6 mutants (Muzio et al., 2002).  Emx2 mutants also show down-regulation of 
Wnt3a and restriction of Wnt8b expression to a small region at the medial boundary 
of the cortex (Muzio et al., 2002).  In contrast Wnt8b expression is expanded along 
the medial-lateral axis of Pax6 mutants, although the expression of Wnt3a remains 
unaltered.  
 
A cortex specific knockout of Pax6 allowed the effect of loss of Pax6 on cortical 
arealisation to be analysed at postnatal stages as these animals survive to adulthood, 
unlike Pax6sey/sey animals which die a birth.  Expression analysis of regional markers 
in Pax6 cortical knockout animals showed a rostral shift in the boundary between 
visual and somatosensory areas (Piñon et al., 2008).  The boundary between the 
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somatosensory and motor areas was also shifted rostrally and there was a severe 
decrease in the size of the frontoorbital/motor area (Piñon et al., 2008). 
 
1.4.6 The involvement of Pax6 in the development of forebrain axonal 
connections 
Pax6 is important for the correct development of a number of the axonal tracts that 
connect different areas of the brain.  The posterior commissure (PC) and the tract of 
the postoptic commissure (TPOC) are among the earliest tracts to develop and can be 
identified from E10.5.  Pax6 expression is required for the correct development of 
both these tracts (Grindley et al., 1997; Mastick et al., 1997; Andrews and Mastick 
2003; Nural and Mastick 2004).  The PC crosses the dorsal midline at the 
p1/mesencephalic boundary and is severely reduced in size in Pax6 mutant embryos 
(Grindley et al., 1997; Mastick et al., 1997).  In wildtype embryos at E10.5 a number 
of axon bundles can be seen crossing the midline in this region.  These bundles are 
completely absent in Pax6 mutants, although by E11.5 some axons can be seen 
crossing the midline in this area (Mastick et al., 1997).  The cells which do project to 
the PC in Pax6 mutants are located in the ventral part of p1, suggesting that Pax6 is 
only required for the projection of a subset of PC cells, those located in dorsal p1 
(Mastick et al., 1997). 
 
At E9.5 cells at the base of the optic stalk begin to send out axons that will form the 
TPOC (Easter et al., 1993).  The course of the TPOC at E10.5 correlates well with 
the pattern of Pax6 expression.  Initially a tight axon bundle, the tract widens in p3 as 
axons fan out over an area defined by strong Pax6 expression before narrowing again 
to cross the p2/p3 boundary (Mastick et al., 1997).  Axons of the TPOC display 
pathfinding errors in Pax6 mutant embryos, specifically when navigating through p3 
where they would normally encounter strong Pax6 expression.  Many axons wrongly 
enter the cerebral vesicle while others form loops or project ventral to the tract.  Of 
the axons that reach the p2/p3 boundary, very few manage to cross it with the 
majority turning to run dorsally along the boundary (Mastick et al., 1997).  It seems 
likely that the role of Pax6 in guiding the navigation of TPOC axons is mediated 
through R-cadherin.  In Pax6 mutants R-cadherin expression is lost from regions 
 29
where its expression overlaps with Pax6, including p3 where TPOC pathfinding 
errors occur.  Electroporation of an R-cadherin expression construct into the Pax6 
mutant forebrain at E10.5 is sufficient to rescue the defects in TPOC navigation 
(Andrews and Mastick, 2003). 
 
Two other major tracts disrupted in Pax6 mutants are the thalamocortical and 
corticothalamic tracts.  The axons of the thalamocortical tract begin to emerge from 
the dorsal thalamus at E13.  The tract passes through the ventral thalamus then turns 
sharply to avoid the hypothalamus and enter the ventral telencephalon.  In the ventral 
telencephalon axons pass through the internal capsule and arrive at the cortex around 
E15 (Braisted et al., 1999).  Formation of the thalamocortical tract is disrupted in 
Pax6 mutants.  Although the dorsal thalamus is present, and the tract does begin to 
project, it doesn’t extend far into the ventral telencephalon and so never reaches its 
target cells in the cortex (Kawano et al., 1999; Pratt et al., 2000; Hevner et al., 2002; 
Jones et al., 2002).  Co-culture experiments combined with analysis of Pax6-/-
↔Pax6+/+ chimeras suggests that there is a cell autonomous requirement for Pax6 in 
the dorsal thalamic cells whose axons form the thalamocortical tract (Pratt et al., 
2002).  Cortical expression of Pax6 is not required for the correct navigation of these 
axons as the thalamocortical tract forms normally in cortex specific Pax6 knockout 
mice (Piñon et al., 2008). 
 
Corticothalamic axons navigate along the same pathway as thalamocortical axons, 
but in the opposite direction.  In the absence of Pax6 these axons also fail to reach 
their targets (Hevner et al., 2002; Jones et al., 2002).  Corticothalamic axons have 
difficulties crossing the PSPB with most axons becoming displaced laterally when 
they encounter this boundary.  In caudal regions some axons are able to cross the 
PSPB but they do so in abnormal fasciculations (Jones et al., 2002).  At E18.5 
cortical axons can be seen forming an abnormal bundle in the basal forebrain, but 
these axons do not enter the thalamus (Hevner et al., 2002).  Difficulties crossing the 
PSPB may be due to changes in the cellular arrangement at this boundary.   In the 
absence of Pax6 the neuroepithelium of the PSPB is broad and irregular with cells 
more tightly packed than in wildtype (Jones et al., 2002). 
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The expression of a number of axon guidance molecules is altered in the dorsal 
telencephalon in the absence of Pax6 and this may contribute to the navigation 
difficulties of the thalamocortical and corticothalamic axons.  The semaphorins 
Sema3c and Sema5a are both expressed in the pallium with highest expression seen 
adjacent to the PSPB.  In Pax6-/- embryos pallial expression of Sema3c is abolished 
while Sema5a expression is lost at the PSPB, although it is still expressed at lower 
levels in more dorsal parts of the pallium (Jones et al., 2002). 
 
1.4.7 The role of Pax6 in the regulation of migration 
The correct migration of neurons from the area in which they are produced to their 
final location in the cortex is a critical part of normal brain development with some 
neurons travelling significant distances from the area in which they are produced.  
Migration takes place along migratory pathways which are generally either radially 
or tangentially oriented.  The projection neurons that populate the cortex of the 
telencephalon migrate radially from the ventricular and subventricular zones in 
which they are produced to the developing cortical plate where they come to rest in 
layers formed by cells of similar birthdates (Rakic, 1974).  The majority of cortical 
interneurons are produced not in the cortical VZ but in the VZ of the ganglionic 
eminences (Anderson et al., 1997; deCarlos et al., 1996).  These interneurons 
migrate tangentially across the PSPB, with cells originating in the MGE travelling in 
the intermediate zone before moving radially into the cortical plate while cells from 
the LGE pass initially into the cortical proliferative zone (Anderson et al., 2001).  
Interneurons also migrate tangentially to the striatum and along the rostral migratory 
stream to populate the olfactory bulb. 
 
Radial migration occurs either by somal translocation or by locomotion.  Early born 
neurons that will go on to form the marginal zone, subplate and early cortical plate 
migrate mainly by somal translocation.  These cells have their cell body located in 
the VZ and a leading process that extends to the pial surface, spanning more that half 
the depth of the cerebral wall.  They migrate by shortening the leading process, 
causing the continuous advancement of the cell body (Nadarajah et al., 2001).  
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During later developmental stages however, locomotion becomes more common 
perhaps due to the increase in the distance that must be travelled.  The migration of 
locomotive cells is guided by radial glia with which they make specialised junctions 
(Anton et al., 1996).  Radial glial cells are bipolar cells whose cell bodies lie in the 
VZ with a short process extending to the ventricular surface and a much longer 
process spanning the depth of the cortex to reach the pial surface.  This morphology 
allows them to guide the radial migration of newborn neurons away from the VZ to 
the correct layer of the developing cortical plate (Naradjah et al., 2001).  Locomotion 
is slower than translocation as movement is discontinuous with rapid forward 
movement alternated with periods of relatively slow progress (Nadarajah et al., 
2001).  Many locomotive neurons complete their migrations by somal translocation.  
Once their leading process makes contact with the marginal zone their cell body 
moves to its correct location within the cortical plate by the shortening and 
thickening of this process (Nadarajah et al., 2001).   
 
Radial glia express different transcription factors depending on the region of brain in 
which they are located.  Cortical radial glia, for example, express Pax6 which is 
critical for the correct patterning of the telencephalon.  Ectopic expression of Gsh2 in 
more dorsal regions of the telencephalon may be involved in the alteration of radial 
glial cell morphology seen in Pax6 mutants; thereby having a direct effect on the 
manifestation of the migration defects seen in these embryos (Carić et al., 1997; 
Toresson et al., 2000).  Their processes become wavy with small branches, making 
them appear more like the radial glia of the ganglionic eminences where Pax6 is not 
normally expressed (Götz et al., 1998). 
 
Tangentially migrating neurons in the proliferative zones on either side of the PSPB 
slow down as they approach the boundary region, probably in response to a short-
range inhibitory signal (Neyt et al., 1997).  This role in limiting migration is not 
restricted to proliferative regions.  The number of MGE/LGE derived GABAergic 
interneurons that enter the cortex is controlled by the PSPB and there is a significant 
increase in the number of dorsally migrating cells when the PSPB is lost in Pax6 
mutant mice (Chapouton et al., 1999).   
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Sfrp2 is a Wnt antagonist which, in the region of the PSPB, appears to have a 
complementary expression pattern to Wnt-7b (Kim et al., 2001).  Sfrp2 expression is 
confined to the cortical neuroepithelium where it overlaps with Pax6 while Wnt7b is 
expressed in the LGE, closely apposed to the PSPB.  In the Pax6 mutant Sfrp2 and 
Wnt7b expression at the PSPB is lost (Kim et al., 2001).  Given these expression 
patterns, and their change in response to a loss of Pax6, it is possible that Wnt 
signalling may play a role in the migration of interneurons across the PSPB.  Indeed, 
Sfrp2 has been shown to inhibit migration of malignant glioma cells in vitro (Roth et 
al., 2000) and so may have a role in limiting dorsal migration at the PSPB. 
 
Much of the increase in the number of cortical interneurons in Pax6sey/sey embryos 
may be due not to increased migration across the PSPB, but rather to dorsal cells 
acquiring a ventral fate.  In the absence of Pax6 there is a gradual expansion of 
expression of ventral marker genes into the dorsal telencephalic VZ.  By E14.5 
Mash1 is expressed throughout the VZ of the dorsal telencephalon, while there is 
Dlx1/2 expression superficial to Mash1 expression (Kroll and O’Leary, 2005; Quinn 
et al., 2007).  As well as aberrantly expressing ventral markers, these dorsal cells 
show a change in fate, producing GABAergic interneurons that would normally be 
produced by progenitor cells of the LGE.  Within the Pax6Sey/Sey cortex numerous 
ectopias can be seen which are composed mainly of interneurons.  These ectopias are 
linked by streams of cells that connect them to misspecified dorsal progenitor cells.  
Lineage tracing confirms that the cells forming these streams and ectopias are of an 
Emx1 lineage that would normally produce the Emx1-positive cortical plate neurons 
(Kroll and O’Leary, 2005). 
 
Another population of migratory cells to show defects in the absence of Pax6 is the 
lateral cortical stream (LCS).  These cells are produced from progenitor cells at the 
PSPB and then migrate ventrally towards the amygdaloid region of the ventral 
telencephalon where they contribute to specific nuclei in this structure.  The LCS is 
composed of a mixture of Pax6- and Dlx2-positive cells along with a significant 
number of cells that express both Pax6 and Dlx2.  The Pax6-positive cells start to 
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migrate before the Dlx2-positive cells with large numbers of both cell types 
contributing to the migratory stream by mid-neurogenesis (Carney et al., 2006).  
Although the LCS still forms in the absence of Pax6, the cells that form this 
migratory stream do not stop migrating when they reach the amygdaloid area but 
instead continue towards the pial surface where they form an aberrant accumulation 
(Brunjes et al., 1998).   
 
It is clear that Pax6 has a wide range of activities during forebrain development from 
regulating the cell cycle to influencing migration and axon guidance.  As these 
activities have been well characterised in the literature the time is now ripe to 
identify the molecular targets of this important transcription factor in order to fully 
understand how Pax6 exerts its effect. 
 
1.5 Identifying transcription factor targets 
The controlled expression of genes in specific spatio-temporal patterns is critical 
during development.  Transcription factors play an important role in regulating gene 
expression patterns so there is much interest in identifying their downstream targets.  
Where information is available on potential candidate genes these can be investigated 
by reverse transcriptase-coupled polymerase chain reaction (RT-PCR) and in situ 
hybridization to see if expression of the target gene changes when the transcription 
factor is mutated.  A variety of techniques have been developed to identify potential 
transcription factor targets and a number of these are described below. 
 
Chromatin immunoprecipitation (ChIP) and DNA adenine methyltransferase 
identification (DamID) allow the identification of the genomic binding sites of 
transcription factors.  ChIP involves the in vivo cross-linking of proteins to chromatin 
with formaldehyde followed by the isolation of protein-DNA complexes by 
immunoprecipitation using an antibody to the protein of interest.  Reversal of the 
cross-linking step allows the immunoprecipitated DNA to be analysed (for review 
see Orlando, 2000).  The DamID technique involves fusing the bacterial protein 
DNA adenine methylase (Dam) to the protein of interest, causing methylation of 
adenine residues in the region of the protein binding site.  The restriction enzyme 
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DpnI can then be used to isolate methylated DNA fragments for investigation (for 
review see Orian, 2006). Both ChIP and DamID can be combined with genomic 
DNA microarray techniques to allow the rapid analysis of many binding sites at once 
(for examples see Ren et al., 2000; van Steensel et al., 2001). 
 
Subtractive hybridization allows the comparison of two conditions, such as mutant 
and wildtype, to identify transcripts present in one but not the other.  Labelled cDNA 
derived from mutant mRNA is hybridized repeatedly to plasmid DNA from a cDNA 
library of wildtype transcripts.  This removes cDNA from transcripts present in both 
populations, thereby enriching for transcripts unique to, or at higher levels in, the 
mutant situation.  These enriched transcripts can then be cloned and sequenced or 
used as probes to screen a cDNA library of mutant transcripts.  This technique was 
first used by Scott et al (1983) to identify genes differentially expressed in a mouse 
cell line transformed with the tumour virus SV40. 
 
Another way of generating clones of transcripts present/up-regulated in one mRNA 
population compared with another is by differential display, a method described by 
Liang and Pardee in 1992.  This technique uses a combination of reverse 
transcription and PCR to amplify a subset of cDNA fragments from the pools of 
mRNA to be compared.  The cDNA fragments are then resolved side by side on a 
polyacrilamide gel and fragments showing differential expression can be excised and 
investigated.  Not only is this method quicker than subtractive hybridization, it has 
the added advantage of allowing more than two conditions to be compared at the 
same time. 
 
A further method for the identification of transcription factor targets is serial analysis 
of gene expression (SAGE; Velculescu et al., 1995).  This involves the generation of 
short nucleotide tags that can uniquely identify a transcript.  cDNA is synthesised 
from mRNA using a biotinylated oligo (dT) primer and then cut with a restriction 
enzyme.  The 3' ends of the cDNAs are then isolated by binding to streptavidin beads 
and a linker sequence containing a type IIS restriction site is ligated to the 5' end.  
Type IIS enzymes will cleave DNA a short but defined distance away from their 
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recognition site (Szybalski, 1985).  Cleavage with a type IIS enzyme therefore 
produces short nucleotide tags with a known sequence at its 5' end corresponding to 
the recognition site of the restriction enzyme used to cut the cDNA.  Pairs of tags, or 
ditags, can be generated by blunt end ligation.  Concatenation of these ditags 
followed by cloning allows sequencing of multiple tags within a single clone.  The 
known restriction enzyme recognition site, located at either end of a ditag, acts as 
punctuation to identify sequences that belong to different transcripts.  In this manner 
transcripts for different populations can be compared (Velculescu et al., 1995; for 
review see Taverner et al., 2004). 
 
These techniques are very labour intensive and require a substantial amount of time 
spent generating clones of transcripts before potential targets can be identified.  
Differential display in particular also suffers from a poor signal to noise ratio, which 
makes the identification of target genes difficult.  As a result, the use of these 
techniques has been largely superseded by the microarray approach to identifying 
transcription factor targets which allows efficient screening of the entire 
transcriptome. 
 
1.5.1 Microarray approach to identifying transcription factor targets 
The first DNA array studies were performed using macroarrays consisting of up to 
several hundred cDNA probes bound to a nylon membrane.  Target RNA was 
labelled with a radioisotope, hybridized to the membrane and the signal intensity for 
each probe measured.  The first data generated from such a study was published by 
Schena et al. (1995).  Technical advances led to the design of microarrays with 
numbers of probes in the tens of thousands.  A microarray, or DNA chip, consists of 
a glass slide to which arrays of probes have been attached in an ordered grid so that 
each probe can be identified by its location (Luo and Geschwind, 2001).  The probes 
are either short oligonucleotides or cDNAs.  Early microarrays contained, at most, 
several hundred probes, but technological advances mean that probes can now be 
arrayed at high densities (Lipshutz et al., 1999).  This coupled with the completion of 
the sequencing of many genomes means that microarrays with probes covering the 
entire transcriptome are available for many organisms (Slonim, 2002; Elvidge, 
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2006).  In most microarray experiments 2 samples to be compared are labelled with 
different fluorescent dyes, either Cy3 or Cy5, and then the samples are mixed and 
hybridized to the same DNA chip (Simon et al., 2003).  Affymetrix microarrays are 
an exception to this with each sample hybridized to separate DNA chip (Luo and 
Geschwind, 2001).  After hybridization the microarray is scanned and the fluorescent 
intensity of bound target from each sample is measured for each probe.  This gives a 
measure of the abundance of any given transcript in a sample. 
 
The development of efficient methods of linear mRNA amplification has also meant 
that gene expression in small populations of cells, or even in single cells, can be 
investigated (for examples see Kamme et al., 2003; Torres-Munoz et al., 2004; 
Marsh et al., 2008).  This is particularly useful for the study of complex tissues such 
as the brain where the heterogeneous cell composition may mask changes in gene 
expression, occurring only in a specific cell type, when measurements are made from 
whole tissue samples.  Isolation of the cells of interest prior to RNA extraction 
allows a more accurate picture of gene expression levels to be produced (Morris and 
Wilson, 2004).  One recent study, for example, used fluorescence activated cell 
sorting (FACS) to isolate GFP labelled cortical interneurons from E14.5 mouse 
cortices, where they are present in relatively low abundance, to determine the genes 
involved in the development of this cell type (Marsh et al., 2008). 
 
1.6 Aims of this thesis 
• To characterise a novel Pax6 reporter mouse line, DTy54, in which cells 
expressing Pax6 also express tau.GFP and are neomycin resistant 
• To examine gene expression in Pax6 positive cells at the PSPB, as identified 
by tauGFP expression, in Pax6+/+.DTy54 and Pax6sey/sey.DTy54 embryos at 
E12.5 using a microarray experiment 
• To analyse the microarray data and compare it with known alterations in gene 
expression in this area and with published microarray data on dorsal and 
ventral telencephalon 
• To validate by in situ hybridization some of the changes in gene expression 
identified by microarray 
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Chapter 2 – Materials and Methods 
2.1 Animals 
The DTy54 mouse line (Tyas et al., 2006) was hemizygous for the tauGFP-Pax6 
reporter transgene and was maintained on a CD1 background.  The Sey line was 
maintained on a Swiss background.  Sey mice are heterozygous for the Pax6SeyEd 
allele.  This allele has a premature stop codon caused by a point mutation, which 
prevents the production of functional Pax6 protein (Hill et al., 1991).  DTy54 and 
Swiss Sey lines were intercrossed to produce a DTy54-Sey line of compound 
heterozygotes.  The DTy54-Sey line was used to generate embryos carrying the 
DTy54 transgene on all Pax6 backgrounds.  Sey animals and embryos older than 
E14.5 were identified by eye phenotype. Embryos younger than E14.5 were 
identified by polymerase chain reaction (PCR) for Pax6 followed by DdeI digestion 
of the PCR product to allow differentiation between the Pax6 wildtype and Sey 
alleles.  DTy54 animals were identified by PCR for the reporter transgene and 
embryos were identified by GFP fluorescence.  Where embryos were being collected, 
the day of vaginal plug following mating was designated E0.5 and pregnant females 
were killed at various ages by cervical dislocation.   
 
2.2 Genomic DNA Extraction and Polymerase Chain Reaction 
Genomic DNA was extracted from ear clips or from embryonic limb tissue.  Tissue 
was lysed in 50µl hotshot lysis buffer (25mM NaOH; 0.2mM EDTA) at 95ºC for 30 
minutes and then cooled to 4ºC.  50µl of neutralizing buffer (40mM Tris-HCl) was 
then added to stop the reaction.  1µl of this solution was added to 19µl of PCR 
reaction mix: 
10x Reaction buffer   2.0µl 
Forward Primer (10μM)  1.0µl 
Reverse Primer (10μM)  1.0µl 
dNTPs (10mM each)   0.4µl 
H2O    13.8µl 
MgCl2 (50mM)   0.6µl 
Taq polymerase   0.2µl 
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Table 2.1: Primers for Genotyping by PCR 
Allele Primer Sequence Product Size (bp) 
DTy54 
construct 
Forward: 5’ CCGTGTGCCTCAACCGTA 3’ 
Reverse: 5’ CACGGTTTACTGGGTCTGG 3’ 
283 
Pax6 
Forward: 5’ TTAGGAAGGCTTTGTGGAGGC 3’ 
Reverse: 5’ CTTTCTCCAGAGCCTCAATCTG 3’ 
282 
 
For DTy54 primers, cycle conditions were as follows: 
96ºC for 2 minutes 
[96ºC for 30 seconds, 57.5ºC for 30 seconds and 72ºC for 45 seconds] for 30 cycles 
 
For Pax6 primers, cycle conditions were as follows: 
95˚C for 2 minutes 
[95˚C for 1 minute, 56.5˚C for 1 minute and 72˚Cfor 1 minute] for 43 cycles 
5μl of the PCR product was then incubated with DdeI enzyme for 3 hours at 37˚C.  
DdeI cleaves the wildtype allele of Pax6 once to give products of 199 and 83 base 
pairs.  The Sey allele of Pax6 is cleaved a second time at its point mutation giving 
products of 180, 83 and 19 base pairs.  This allows wildtype, heterozygous and 
homozygous mutant samples to be distinguished.  
 
2.3 Histology 
Embryos were collected in ice cold phosphate buffered saline (PBS), decapitated and 
the heads fixed overnight in ice cold 4% paraformaldehyde (PFA). After fixation 
tissue was rinsed in PBS before processing for vibratome or wax sectioning. 
 
2.3.1 Vibratome sectioning 
Heads were embedded in 4% low melting point agarose.  Vibratome sections were 
cut at 100 or 200μm and collected in 1:1 glycerol:PBS containing TOPRO3 (1:5000; 
Molecular Probes).  After 24 hours sections were transferred to 9:1 glycerol:PBS, 




2.3.2 Wax Sectioning 
Tissue was dehydrated through graded alcohols and embedded in paraffin wax.  
Microtome sections (10µm) were cut and mounted on superfrost positively charged 
glass slides (VWR).  Sections were allowed to air dry and were then incubated 
overnight at 37ºC prior to use. 
 
2.3.3 Cryostat Sectioning 
Embryos for cryostat sectioning were collected in ice cold PBS, decapitated and 
frozen on dry ice.  OCT embedding medium (RA Lamb) was used to attach the tissue 
to the chuck at -20˚C.  Cryostat sections (15μm) were cut at between -20˚C and -
25˚C and mounted on superfrost positively charged glass slides.  Tissue was 
sectioned and reacted on the day of collection. 
 
2.3.4 Immunofluorescence 
Cryostat sections were dried at room temperature and fixed for 10 minutes in 1:1 
methanol/acetone at -20ºC.  Sections were then dried for 15 minutes at room 
temperature, rehydrated in PBS for 5 minutes and incubated for 15 minutes in 
blocking solution containing 2% bovine serum albumin, 2% sheep serum, 7% 
glycerol and 0.2% Tween 20 in PBS.  Sections were then incubated overnight at 
room temperature with primary antibodies.  Sections were washed three times in 
PBS/Tween 200.2% and incubated with secondary antibodies for 1 hour at room 
temperature. 
 
Table 2.2: Details of Antibodies 
 
1ºAntibody Raised Dilution 2ºAntibody Dilution 
Pax6 AD1.5.6 and AD2.35 




Goat anti-mouse Alexa fluor 568 
(Molecular Probes) 
1:150 
GFP (Abcam) Rabbit 1:8000 
Goat anti-mouse Alexa fluor 488 
(Molecular Probes) 
1:150 
2.3.5 In situ Hybridization 
In situ hybridization was performed on 10µm wax sections.  Sections were dewaxed 
and rehydrated through xylene and graded alcohols, washed in PBS and digested in 
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20µg/ml Proteinase K in PBS at 37ºC for 5 minutes.  Sections were then washed first 
in 0.2% Glycine/PBS and then in PBS, followed by post-fixing in 4% PFA/0.2% 
glutaraldehyde for 20 minutes.  Sections were washed again in PBS before 
incubation with prehyb solution for 2 hours and were then hybridized overnight with 
1ng/µl probe in prehyb solution.  Following hybridization sections were rinsed in 
2xSSC, pH4.5 and then washed at 5˚C below the hybridization temperature in 50% 
Formamide/2xSSC.  Sections were then washed in PBS/Tween0.1%, incubated for 1 
hour at room temperature in Boehringer blocking solution containing 10% sheep 
serum followed by incubation at 37ºC with anti-DIG for 2 hours.  Sections were 
washed overnight in PBS/Tween0.1%, and finally washed in NTM and stained with 
NBT/BCIP.  
Prehyb Solution
Formamide   5.0ml 
20xSSC, pH4.5  2.5ml 
Boehringer Block 100mg 
ddH2O    2.0ml 
Dissolve in waterbath at 65˚C 
0.5M EDTA   100μl 
10% Tween-20  100μl 
10% CHAPS   100μl 
Heparin (50mg/ml)      4μl 
tRNA (50mg/ml)  200μl 
 
20xSSC 
NaCl   87.66g 
Tri-soduim Citrate 44.12g 
In 500ml ddH20; pH4.5 
 
NTM 
1M Tris-HCl, pH9.5 25.0ml 
5M NaCl    5.0ml 
1M MgCl2  12.5ml 
Make up to 250ml with distilled water. 
 
2.4 Generation of RNA probes for in situ hybridization 
Five probes were used for in situ hybridization.  Plasmid templates for 3 of these 
were available in the lab.  The GFP and Gsh2 probes were synthesised from plasmid 
DNA containing the full length coding region for mGFP and Gsh2 respectively.  The 
Pax6 probe contained a 1.2kb segment of the Pax6 coding region, including exon 5a. 
 
DNA templates for the generation of RNA probes for Ngn2 and Lhx6 were amplified 
by PCR from the 3' end of the gene of interest in genomic DNA, ligated into a 
plasmid vector and transfected into competent cells. 
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PCR Reaction Mix
10x Reaction buffer   5.0µl 
Forward Primer (10μM)  2.5µl 
Reverse Primer (10μM)  2.5µl 
dNTPs (10mM each)   1.0µl 
H2O    35.5µl 
Pfu polymerase    0.2µl 
DNA      3.0µl 
 
Table 2.3: Primers to amplify sequences for cloning 
Probe Primer Sequences Product size 
Lhx6 
Forward: 5' AGGTACCCATGGCTTCAGTG 3' 
Reverse: 5' GGAGACGTCTGACTGCAACA 3' 
829bp 
Ngn2 
Forward: 5' CCCTCTCTCGTCCTCTACCC 3' 
Reverse: 5' ATGAAGCAATCCTCCCTCCT 3' 
822bp 
 
Cycle conditions for Lhx6 primers: 
95ºC for 2 minutes 
[95ºC for 30 seconds, 57ºC for 30 seconds and 72ºC for 2 minutes] for 30 cycles 
72ºC for 5 minutes 
4ºC holding step 
 
Cycle conditions for Ngn2 primers: 
95ºC for 2 minutes 
[95ºC for 30 seconds, 55ºC for 30 seconds and 72ºC for 2 minutes] for 30 cycles 
72ºC for 5 minutes 
4ºC holding step 
 
2.4.1 Purification of PCR products 
PCR products were purified using a QIAquick gel extraction kit (Qiagen) for column 
purification of DNA from enzymatic reactions.  The protocol was followed 
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according to manufacturer’s instructions using a bench top microcentrifuge.  DNA 
was eluted in 30µl ddH2O. 
 
2.4.2 A-tailing modification of blunt-ended PCR fragments and ligation 
into vectors 
A-tails were added to the blunt-ended PCR fragments generated using Pfu 
polymerase by incubation for 30 minutes at 70ºC in the following solution: 
Purified PCR fragment  1µl 
10x Taq reaction buffer with MgCl2 1µl 
1mM ATP (final conc. 0.2mM) 2µl 
Taq DNA polymerase (5units/µl) 1µl 
H2O     5µl 
 
A-tailed PCR fragments were then ligated into pGEM®-T Easy vectors (Promega).  
Ligation reactions were set up as follows: 
      Standard         Positive         Background
      Reaction Control Control
2x rapid ligation buffer, T4 DNA ligase     5μl      5μl      5μl 
pGEM®-T Easy vector (50ng)      1μl      1μl      1μl 
PCR product         2μl      ---      ---  
Control Insert DNA        ---      2μl      ---  
T4 DNA Ligase (3units/μl)       1μl      1μl      1μl 
H2O          1μl      1μl      3μl 
 
Ligation reactions were incubated either for 1 hour at room temperature or overnight 
at 4˚C before transfection into JM109 competent cells (Promega).  JM109 cells were 
thawed on ice for 5 minutes.  50μl of cells was then added to 2μl ligation reaction in 
a 10ml serile tube on ice, mixed by flicking and left on ice for 20 minutes.  Cells 
were heat-shocked in a water bath at exactly 42˚C for 45 seconds and then returned 
to ice for 2 minutes.  950μl SOC medium (Invitrogen) was added to the cells which 
were then incubated for 1.5 hours at 37˚C in a shaking incubator.  100μl and 900μl of 
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these cultures were plated onto LB/ampicillin agar plates and incubated overnight at 




Yeast extract 2.5g 
NaCl  2.5g 
In 500ml ddH2O, pH7.0; autoclave 
For LB/ampicillin for agar plates 7.5g agar was added before autoclaving and 
allowed to cool to 50ºC.  Ampicillin was then added to a final concentration of 
100µg/ml.  Agar was poured into 85mm petri dishes and allowed to set.  Plates were 
stored upside down at 4ºC. 
 
10 colonies from each ligation reaction were grown overnight in 1.5ml LB medium 
at 37˚C with shaking.  Plasmid DNA was recovered by miniprep using a QIAprep kit 
(Qiagen) according to manufacturer’s protocol and eluted in 50µl ddH2O.  Plasmid 
DNA was digested with EcoRI to liberate the PCR product.  Colonies identified as 
having been successfully transfected with the PCR product were grown overnight in 
150ml LB medium at 37˚C with shaking.  Plasmid DNA was recovered using a 
HiSpeed Plasmid Midi Kit (Qiagen) and protocol provided by the manufacturer.  
Plasmid DNA was eluted in 1ml ddH2O. 
 
2.4.3 Synthesis of RNA probes 
Plasmid DNA was linearised using the appropriate enzyme and the linearised DNA 
purified and used as template for the synthesis of RNA probes. 
Table 2.4: Details of probes 







GFP pBluescript II KS+ KpnI T7 745bp 70ºC 
Pax6 pCR-Blunt II-TOPO BamHI T7 1.2kb 70 ºC 
Gsh2 pBluescript II KS- NotI T3 951bp 65 ºC 
Lhx6 pGEM®-T Easy SacII SP6 829bp 70 ºC 
Ngn2 pGEM®-T Easy SacII SP6 822bp 65 ºC 
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Reaction Mix using T7/T3 Reaction Mix using SP6
DNA    1.0μg DNA    1.0μg 
10x Reaction buffer  2.0μl 5x Reaction buffer  4.0μl 
DIG-labelled dNTPs  2.0μl DIG-labelled dNTPs  2.0μl 
RNase Inhibitor  0.5μl DDT    2.0μl 
T7/T3 RNA polymerase 2.0μl RNase Inhibitor  0.5μl 
ddH2O to 20μl                       _Xμl_  SP6 RNA polymerase  2.0μl 
ddH2O to 20μl                        _Xμl_ Total    20μl 
Total    20μl  
 
Reactions were incubated in a water bath at 37ºC for 2 hours.  2µl DNaseI, RNase 
free (10 units/µl) was then added and incubated for a further 15 minutes at 37ºC.  2µl 
0.2M EDTA was added to stop the reaction.  2.5µl 4M LiCl and 75µl chilled EtOH 
were then added and the probe was precipitated overnight at -20ºC.  The probe was 
pelleted by centrifugation at 13,000rpm for 15 minutes and the supernatant removed.  
The probe was rinsed in 70% EtOH, centrifuged again and the supernatant removed.  
Tubes were covered with pierced parafilm and probes left to dry for 1 hour at room 
temperature before being re-suspended in 100µl RNase free ddH2O. 
 
2.5 Dissection of Telencephalic Tissue 
E12.5 embryos were collected in ice-cold, oxygenated Earle’s balanced salt solution 
(EBSS).  Pax6+/+.DTy54+ embryos were identified by GFP fluorescence, 
Pax6sey/sey.DTy54+ embryos were identified by the absence of eyes and GFP 
fluorescence.  The telencephalic lobes were isolated and flattened to show the 
ventricular surface.  The strong expression of GFP at the pallial-subpallial boundary 
(PSPB) was then used as a guide to dissect each lobe into dorsal, lateral and ventral 
regions, with the lateral portion including the PSPB.  A more detailed description of 
the dissection technique is given in Chapter 4. 
 
2.6 Cell Dissociation and FACS 
Dissected telencephalic tissue was dissociated using the papain dissociation system 
(Worthington Biochem).  Briefly, tissue was triturated with 1ml papain solution, 
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containing DNase (20 units of papain; 100 units of DNase), and incubated at 37ºC 
for 10 minutes, followed by centrifugation at 300g for 7 minutes.  The cell pellet was 
resuspended in 1ml low concentration albumin-ovomucoid inhibitor and gently 
pipetted onto 1.5ml high concentration albumin-ovomuciod inhibitor to create a 
density gradient.  This was centrifuged at 70g for 7 minutes and cells were 
resuspended in 1% goat serum in PBS.  Cells were sorted for GFP by fluorescence 
activated cell sorting (FACS) using a DakoCytomation MoFlo MLS high speed 
sorter.  If cells were to be analysed but not sorted, the analysis was carried out on a 
Beckman-Coulter XL flow cytometer (10,000-20,000 cells were analysed per 
sample).   Telencephalic cells dissociated from non-transgenic littermates were used 
as negative controls to position the gates for both sorting and analysis. 
 
2.7 Immunocytochemistry on sorted cells 
After sorting cells were fixed in 500µl of 70% ethanol and stored at -70ºC.  5% goat 
serum in PBS (PBSG) was added to 1.5ml in an eppendorf tube.  Cells were 
centrifuged for 6 minutes at 6500rpm in a bench top microcentrifuge and the 
supernatant removed by pipetting.  Mouse anti-Pax6 primary antibody (1:200; 
DSHB) was added in 200µl PBSG, mixed by pipetting and incubated for 1 hour at 
room temperature.  PBSG was added to 1.5ml, inverted to mix and left for 2-3 
minutes to rinse.  Cells were centrifuged for 6 minutes at 6500rpm and the 
supernatant removed by pipetting.  Secondary antibody, goat anti-mouse alexa fluor 
647 (1:150; Molecular Probes), was added in 150µl PBSG, mixed by pipetting and 
incubated for 45 minutes in the dark at room temperature.  Cells were rinsed as 
before and resuspended in 500µl PBSG.  Cells were analysed using a BD 
Biosciences FACSCalibur® flow cytometer.  Telencephalic cells from a non-
transgenic littermate and incubated without primary antibody were used as a negative 
control.  Data was analysed and images generated using WinMDI 2.8 software 






2.8 RNA extraction 
RNA was extracted from either dissected telencephalic tissue or FACS sorted cells 
using a Qiagen RNeasy kit.  Membranes were disrupted and the lysate homogenized 
on a QIAshredder spin column.  70% ethanol was added to facilitate binding of RNA 
to the silica-gel membrane of the RNeasy spin column.  Any traces of genomic DNA 
were removed by on-column DNase digestion.  Contaminants were removed by 
washing and then the RNA was eluted in RNase-free water.  RNA was stored at -
80ºC. 
 
2.9 Real time RT-PCR 
RNA from dorsal, lateral and ventral telencephalic tissue was reverse transcribed to 
cDNA as follows: ~0.5µg RNA was made up to a final volume of 20.1µl in RNase-
free H2O, incubated at 75ºC for 5 minutes and then held on ice for 2 minutes.  7.9µl 
of RT reaction mix was added to each sample and samples were then incubated at 
42ºC for 1 hour, with 2µl of RT added after the first 5 minutes, and then at 95ºC for 5 
minutes.  If the cDNA was not to be used immediately it was stored at -20ºC. 
1µl of cDNA was added to 24µl of real time RT-PCR reaction mix. 
RT Reaction Mix 
Random hexamers  1.0µl 
10x reaction buffer  3.0µl 
MgCl2 (50mM)  1.8µl 
dNTPs (10mM each)  1.5µl 
RNase inhibitor (50u/µl) 0.6µl  
Real time RT-PCR Reaction Mix
Primer mix (12.5µM each)   1.0µl 
H2O    10.5µl 
SYBR® PCR Master Mix 12.5µl 
 
 
Cycle conditions for real time RT-PCR for all primers were as follows: 
96ºC for 3minutes 
[96ºC for 30 seconds, 55ºC for 1 minute and 72ºC for 1 minute] for 30 cycles 






Table 2.5: PCR primers for real time RT-PCR 
Gene Primer Sequence Product Size (bp) 
Dbx1 
Forward: 5’ CAACAGACCCACCACCTTCT 3’ 
Reverse: 5’ TGGCTCACAGTAAGCACTGG 3’ 
226 
Dlx2 
Forward: 5’ CCAAAAGCAGCTACGACCT 3’ 
Reverse: 5’ GGCCAGATACTGGGTCTTCT 3’ 
224 
Mash1 
Forward: 5’ GGGATCCTACGACCCTCTTA 3’ 
Reverse: 5’ TAGTGAAGGTGCCCCTGTAG 3’ 
238 
Ngn2 
Forward: 5’ CAAACTTTCCCTTCTTGATG 3’ 
Reverse: 5’ CATTCAACCCTTACAAAAGC 3’ 
250 
Sfrp2 
Forward: 5’ AAGTTCCTGTGCTCGCTCTT 3’ 
Reverse: 5’ TGTCGTTGTCGTCCTCATTC 3’ 
309 
 
2.10 Statistical Analysis 
Statistical analysis of any data, other than the microarray data, was carried out using 
Microsoft Excel.  Statistical analysis of the microarray data is described below and in 
chapter 4. 
 
2.11 Microarray Experiment 
As microarrays are a highly specialised technique help and advice on the design and 
implementation of the microarray experiment was sought from Prof. Peter Ghazal at 
the Scottish Centre for Genomic Technology and Informatics (CGTI; now the 
Division of Pathway Medicine), University of Edinburgh Medical School. The 
amplification, labelling and hybridization of the RNA samples to the microarrays 
were carried out by Alan Ross at the CGTI.  Thorsten Forster, also at the CGTI, 
carried out the initial quality control checks, normalisation and statistical analysis of 
the array data. 
 
2.11.1 RNA Amplification and Labelling 
RNA extracted from FACS sorted lateral telencephalic cells was amplified and 
labelled with cyanine dyes.  Before amplification, RNA quality was assessed using 
the Agilent bioanalyser which measures the degree of RNA degradation and assigns 
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each sample with an RNA integrity number (RIN) between 1 and 10, where 10 is 
high quality, intact RNA.  The Agilent low RNA input linear amplification kit was 
then used to amplify the RNA samples and to produce cRNA, labelled with either 
Cyanine 3 (Cy3) or Cyanine 5 (Cy5) fluorescent labels.  Briefly; a poly dT primer 
with a T7 polymerase promoter was annealed to the poly A+ RNA.  Reverse 
transcriptase was then added to the reaction and double stranded cDNA was 
synthesised.  Using T7 RNA polymerase, cRNA, incorporating either cyanine 3- or 
cyanine 5-labelled CTP, was synthesised from the cDNA.  Using this protocol 
approximately 1μg cRNA is produced from 50ng of starting material. 
 
2.11.2 Microarray Hybridization 
Fluorescently labelled cRNA samples were hybridized to Agilent dual-dye whole 
mouse genome arrays (G4122A) in accordance with Agilent protocols.  750ng of 
cyanine 3- and 750ng of cyanine 5-labelled cRNA were hybridized at 60ºC for 17 
hours in a rotating oven. 
 
2.11.3 Imaging Software 
After hybridization arrays were scanned in an Agilent scanner for Cy3 and Cy5 and 
images analysed using Agilent’s feature extraction software (version 7.1). 
 
2.11.4 Normalisation and Statistical Analysis 
Normalisation and statistical analysis of the microarray data was performed using R-
based software (www.R-project.org) and is described in detail in Chapter 4. 
 
2.11.5 Gene Ontology Analysis 
Gene ontology analysis of genes found to be significantly up- or down-regulated in 
Pax6sey/sey.DTy54+ compared to Pax6+/+.DTy54+ was carried out using two free, web-
based packages.  These were WebGestalt (WEB-based GEne SeT AnaLysis Toolkit; 
http://bioinfo.vanderbilt.edu/webgestalt/) and FunNet, Transcriptional Networks 
Analysis (www.funnet.info).  Both of these packages analyse sets of genes on the 
basis of how the individual genes in the set are annotated in the Gene Ontology (GO; 
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Chapter 3 – Validation of DTy54 Reporter Mouse 
3.1 Introduction 
Neurogenesis in normal development of the mouse forebrain takes place from 
embryonic day 11 (E11) to E17 (Levers et al., 2001).  Pax6 is one of the first 
members of the Pax family to be expressed, with expression in the dividing cells of 
the neuroepithelium of the forebrain and hindbrain seen as early as E8.0 (Walther 
and Gruss, 1991).  Pax6 plays a wide variety of roles in brain development.  These 
roles include regulation of cell adhesion, regulation of cell cycle progression in 
progenitor cells, arealisation, and neuron specification and axon guidance (for review 
see Simpson and Price, 2002; Manuel and Price, 2005).  Pax6 is also involved in cell 
migration; however this is most likely a secondary function as the migrational 
defects of Pax6Sey/Sey cells can be rescued by transplantation into a wild-type 
environment (Carić et al., 1997).  Another role for Pax6 can be seen in the formation 
of boundaries in the developing CNS, where it is involved in establishing the di-
mesencephalic boundary and boundaries along the dorso-ventral axis (Matsunaga et 
al., 2000).   
 
The diverse functions of Pax6 in the development of the mammalian brain mean that 
a reliable tool for the investigation of this gene would be extremely useful.  Here, a 
recently derived Pax6 reporter mouse, DTy54, is described (Tyas et al., 2006).  The 
reporter cassette of the Pax6 transgene consists of tauGFP-IRESKozak-NeoR-pA-
C2MAZ.  It has been inserted in exon 4 of the PAX6 gene in yeast artificial 
chromosome (YAC) Y593 and its expression is therefore under the control of PAX6 
regulatory elements.  Y593 contains the entire human PAX6 locus and sufficient 
surrounding genomic material to recapitulate the normal Pax6 expression pattern in 
mice (Schedl et al., 1996), emphasising the high degree of conservation between 
mouse and human not only in the coding region of Pax6 but also in its regulatory 
sequences.  It has also been shown to be capable of rescuing the small eye (Sey) 
phenotype in mice.  The IRESKozak component of the construct contains an internal 
ribosome entry site (IRES).  These sites allow the 40S ribosome subunit to bind 
internally to the mRNA enabling the translation of two genes, in this case tauGFP 
and the neomycin resistance gene, from a single mRNA transcript (for review see 
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Vagner et al., 2001). This means that every cell capable of expressing Pax6 should 
also express GFP and be neomycin resistant, thereby allowing cell dissociation and 
subsequent isolation of Pax6 positive cells to be carried out, either by fluorescence 
activated cell sorting (FACS) or by selection for G418 antibiotic resistance.  The pA 
(polyadenylation) site is necessary for the production of fully functional mRNA in 
eukaryotic cells.  C2MAZ is a binding site for the transcription factor MAZ, located 
downstream of the human C2 gene and it has been shown to pause transcription by 
RNA polymerase II (Ashfield et al., 1991, 1994; Yonaha and Proudfoot, 2000).  It is 
used here as a strong stop site to prevent loss of the construct by the splicing of exon 
3 to downstream exons by slowing down RNA polymerase II and pausing 
transcription.  The generation of the DTy54 mouse line is described in detail in Tyas 
et al., 2006.   
 
3.2 Results 
In order for mice carrying the DTy54 reporter transgene to act as a useful tool for 
studying Pax6, the tauGFP expression pattern must be clearly defined in relation to 
the known pattern of Pax6 expression.  Any differences between the two expression 
patterns must be highlighted in order to prevent the erroneous interpretation of future 
results generated using these mice.  To investigate if tauGFP expression in DTy54 
mice was consistent with the known expression pattern of Pax6, embryos were 
collected at E10.5, 12.5, 14.5 and 15.5.  Pax6 is normally expressed in the forebrain, 
hindbrain, cerebellum and the developing eye.  Here the focus is on the expression 
pattern of the tauGFP reporter in the forebrain and eye; however this reporter has 
also been shown to recapitulate the Pax6 expression pattern in the hindbrain and the 
cerebellum (Tyas et al., 2006).   
 
3.2.1 Expression of tauGFP in the developing eye 
Pax6 is critical for the development of the eye where it is expressed in the cornea, 
lens epithelium, and retina (Grindley et al., 1995; Davis et al., 2003).  At all ages 
examined tauGFP expression was seen in those parts of the eye where Pax6 is 
normally found.  Examples are shown at E12.5 (Fig. 3.1 A and B) and E14.5 (Fig. 
3.1 C and D).   
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Figure 3.1: Coronal sections showing tauGFP expression in the 
developing eye  
A)-D) show tauGFP expression in the retina, lens and cornea of the eye at E12.5.  (A 
and B) and at E14.5 (C and D).  TauGFP can also be seen in retinal ganglion cell 
axons as they leave the eye (B and C), in the optic nerves (E) and at the optic chiasm 
(F).  Images were converted to greyscale to allow the GFP labelling to be seen more 
clearly.  Co, cornea; le, lens; oc, optic chiasm; on, optic nerve and re, retina.  Scale 















3.2.2 Expression of tauGFP in cellular processes 
The cytoplasmic localisation of tauGFP allows cellular processes to be visualised.  
This is most strikingly demonstrated in the axons of retinal ganglion cells.  These 
axons are labelled along their length with tauGFP and can be seen leaving the eye to 
form the optic nerve and at the optic chiasm (Fig. 3.1 E and F).  Other axon tracts are 
also labelled including the posterior commissure, shown here at E12.5 (Fig. 3.2 A).  
The processes of radial glial cells are labelled along their length by tauGFP and can 
be seen extending out towards the pial surface of the cortex (Fig. 3.2 F).   
 
3.2.3 Expression of tauGFP in the developing forebrain 
Within the developing cortex Pax6 is expressed in a high rostro-lateral to low caudo-
medial gradient (Walther and Gruss, 1991; Stoykova et al., 1997; Puelles et al., 
1999) and this gradient is mirrored in the expression levels of tauGFP.  The medio-
lateral component of this gradient is shown here in coronal sections at both E12.5 
and E14.5 where expression of tauGFP can be seen to increase from medial to lateral 
regions of the developing cortex with highest expression at the pallial-subpallial 
boundary (PSPB) (Fig. 3.2 A, B and D).  The rostro-caudal component of the 
gradient is demonstrated in Tyas et al., 2006.  A population of GFP positive cells can 
be seen ventral to this region of strong expression (arrows in Fig. 3.2 C).  These are 
most likely part of the population of Pax6 positive cells that are known to migrate 
from the PSPB to contribute to the amygdala (Carney et al., 2006).  In the 
diencephalon at E12.5 tauGFP can be seen in the ventral thalamus in a pattern 
characteristic of Pax6 expression in this region (Fig. 3.2 A) (Stoykova et al., 1996; 
Jones et al., 2002).  Pax6 has been shown to be expressed in the pineal gland, and is 
required for the formation of this structure (Estivill-Torrús et al., 2001).  In caudal 
regions at E14.5 the pineal gland is clearly labelled by tauGFP expression (Fig. 3.2 
E). 
 
3.2.4 Co-localisation of Pax6 and tauGFP protein 
Immunofluorescence was carried out to determine whether Pax6 and tauGFP 
proteins co-localise.  At E10.5 their expression patterns can be seen to overlap 
exactly (Fig. 3.3).  In the telencephalon the boundary of expression between pallium 
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Figure 3.2: Coronal sections showing tauGFP expression in the 
developing forebrain 
A) and B) show tauGFP expression in the developing cortex at E12.5, with strongest 
expression seen at the pallial-subpallial boundary (indicated by the dashed red line in 
B).  In A) expression can also be seen in the ventral thalamus and eye and in the 
axons of the developing optic chiasm and the posterior commissure.  C) is a high 
magnification of the boxed area in B), showing GFP positive cells (arrows) in the 
ventral telencephalon; these are most likely part of the population of Pax6 positive 
cells known to migrate to the ventral telencephalon from the pallial-subpallial 
boundary.  The graded expression of tauGFP in the cortex, with highest expression at 
the pallial-subpallial boundary (dashed red line), is still evident at E14.5 (D).  
Expression in the pineal gland is shown in E).  Labelling of radial glial processes 
extending towards the pial surface of the cortex can be seen in F).  Images were 
converted to greyscale to allow the GFP labelling to be seen more clearly. Cge, 
caudal ganglionic eminence; ctx, cortex; lge, lateral ganglionic eminence; mge, 
medial ganglionic eminence; oc, optic chiasm; pc, posterior commissure; pi, pineal 
gland and vt, ventral thalamus.  Scale bars: 200µm in A, B, D and E; 50µm in C and 



















Figure 3.3: Immunofluorescence to show co-localisation of Pax6 and 
GFP at E10.5 
Immunofluorescence for Pax6 and GFP on 15μm coronal sections at E10.5.  A) and 
D) show Pax6 expression, GFP expression is shown in B) and E) and overlays of  
both genes are shown in C) and F).  At E10.5 there is an exact correspondence 
between Pax6 and GFP expression, with a clear decrease in expression of both 
proteins moving from pallium to subpallium.  The E10.5 thalamus is shown in D)-F), 
demonstrating the much wider expression of Pax6/GFP at this age compared with 
later stages when expression becomes more restricted in this tissue.  Dt, dorsal 
thalamus; p, pallium; sp, subpallium; vt, ventral thalamus.  Scale bars: 50µm. 
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and subpallium can be clearly seen (Fig. 3.3 A-C).  Pax6 is expressed throughout 
both the dorsal and ventral thalamus at E10.5.  TauGFP can also be seen throughout 
this structure at this age, showing a close correspondence to the Pax6 expression 
pattern (Fig. 3.3 D-F).   
 
At later stages however, there is an increasing discrepancy between the expression 
patterns of the two genes at the protein level.  At E12.5 the expression patterns of 
Pax6 and tauGFP can be seen to diverge increasingly moving from dorsal to ventral 
telencephalon (Fig. 3.4).  In the dorsal pallium Pax6 and tauGFP expression patterns 
are identical (Fig. 3.4 B-B'') but, approaching the PSPB, tauGFP positive/Pax6 
negative cells can be seen in the area between the ventricular zone (VZ) and the pial 
surface (Fig. 3.4 C-C''; area to the left of broken line in C'').  Cells double labelled for 
Pax6 and tauGFP can be seen adjacent to the PSPB, but these are surrounded by a 
large area of tissue that is tauGFP positive/Pax6 negative (Fig. 3.4 D-E''; arrows in 
D'' and E'').  Further ventrally in the amygdaloid area a discrete population of tauGFP 
negative/Pax6 positive cells can be seen (Fig. 3.4 F-F'').  By E15.5 the differences 
between Pax6 and tauGFP expression have become more marked (Fig. 3.5).  This is 
especially noticeable in the developing cortex where a band of tauGFP expression 
can be seen surrounding the double labelled VZ (Fig. 3.5 B-C''; area to the right of 
broken line in B'').  In the ventral telencephalon tauGFP positive/Pax6 positive cells 
can again be seen in a much wider area that is tauGFP positive/Pax6 negative (Fig. 
3.5 D-D''; arrows in D'').  There is also strong tauGFP labelling of the internal 
capsule where only a few Pax6 positive cells can be seen (Fig. 3.5 E-E''; arrows in 
E). 
 
In the thalamus at E15.5 the expression patterns of both Pax6 and tauGFP have 
become more restricted.  Pax6 expression, which was throughout the diencephalon at 
E10.5, is now confined to a highly distinctive pattern of expression in the ventral 
thalamus (Stoykova et al., 1996; Jones et al., 2002).  The expression of tauGFP more 
closely recapitulates the changes in diencephalic Pax6 expression over time.  By 
E15.5 the domain of tauGFP expression has become greatly restricted and has also 
acquired the butterfly shape characteristic of Pax6 expression at this age.  There are,  
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Figure 3.4: Co-localisation of Pax6 and GFP in the telencephalon at 
E12.5 
Immunofluorescence for Pax6 and GFP on 15μm coronal sections at E12.5.  a) is a 
schematic showing the outline of the tissue in A)-A'').  The arrow indicates the 
cortical angle and the dashed line shows the position of the pallial-subpallial 
boundary.  A)-F) show Pax6 expression.  GFP expression is shown in A')-F') and 
overlays of both genes are shown in A'')-F'').  Low power images are shown in A)-
A'').  The boxed areas labelled B-F in A'') indicate the areas shown at high power in 
B)-F'').  B)-B'') shows a very tight correspondence between Pax6 and GFP expression 
in the dorsal pallium.  Moving ventrally towards the cortical angle GFP positive cells 
start to appear outside the ventricular zone (dashed white line in C''), where Pax6 is 
not being expressed C)-C'').  An increasing discrepancy can be seen between the 
expression of Pax6 and GFP as you move from dorsal to ventral telencephalon.  D)-
E'') show Pax6 positive/GFP positive cells (some of which are indicated by arrows) 
in the ventral telencephalon surrounded by a wider area of Pax6 negative/GFP 
positive tissue.  A discrete population of Pax6 positive/GFP negative cells in the 
most ventral part of the telencephalon is shown in F)-F'').  Lge, lateral ganglionic 
eminence; mge, medial ganglionic eminence; p, pallium; vz, ventricular zone.  Scale 

























Figure 3.5: Immunofluorescence to show co-localisation of Pax6 and 
GFP at E15.5 
Immunofluorescence for Pax6 and GFP on 15μm coronal sections at E15.5.  a) is a 
schematic showing the outline of the tissue in A)-A'').  The position of the pallial-
subpallial boundary is indicated by the dashed line and the blue lines show the 
location of the internal capsule.  A)-F) show Pax6 expression.  GFP expression is 
shown in A')-F') and overlays of both genes are shown in A'')-F'').  Low power 
images are shown in A)-A'').  The boxed areas labelled B-F in A'') indicate the areas 
shown at high power in B)-F'').  B)-B'') shows expression in the cortical ventricular 
zone where Pax6 and GFP co-localise.  GFP expression can also be seen in the 
subventricular zone where Pax6 in not expressed.  The expression pattern moving 
away from the ventricular zone, towards the pial surface, is shown in C)-C'').  Pax6 
expression is absent from this region and the area adjacent to the pia can be seen to 
be negative for both proteins.  Pax6 positive/GFP positive cells (examples marked 
with arrows) in the ventral telencephalon can be seen to be surrounded by a wider are 
of Pax6 negative/GFP positive tissue in D)-D'').  The internal capsule is shown in E)-
E'').  Strong GFP label can be seen in this area (E'), but Pax6 expression is limited to 
just a few cells (arrows in E).  Thalamic expression of Pax6 and GFP is shown in F)-
F'').  The two proteins co-localise well in the ventral thalamus, although there are 
areas which are Pax6 negative/GFP positive (see boxed area in F'').  Ctx, cortex; dt, 
dorsal thalamus; ic, internal capsule; svz, subventricular zone; vt, ventral thalamus; 






























however, regions that are tauGFP positive/Pax6 negative (Fig. 3.5 F-F'') although in 
these areas tauGFP staining appears more diffuse and may be present in cellular 
processes rather than in cell bodies.  
 
3.2.5 Co-localisation of Pax6 and tauGFP transcripts 
As there were some discrepancies between the expression of Pax6 and tauGFP 
proteins it was decided to use in situ hybridization to determine if there was a greater 
degree of co-localisation at the RNA level.  In order to carry out an accurate 
comparison, adjacent sections were hybridized with either a Pax6 or a GFP probe.  
At E12.5 the transcription pattern in the dorsal pallium is identical for both genes 
(Fig. 3.6 A, B, E and F).  Moving ventrally towards the PSPB, to where the 
differences in protein expression begin to appear, transcription of the two genes 
continues to be confined to the VZ (Fig. 3.6 C and G).  In the ventral telencephalon, 
however, there is a much larger population of Pax6 positive cells than GFP positive 
cells (compare Fig3.6 D and H) which corresponds with the tauGFP negative/Pax6 
positive population seen in the amygdaloid region by immunofluorescence. 
 
At E15.5, the patterns of expression of Pax6 and GFP are highly similar (Fig. 3.7 A 
and E), particularly in the cortex where there is a dramatic difference in protein 
expression at this stage.  In the cortex both Pax6 and GFP expression are clearly 
confined to the VZ (Fig. 3.7 B and F).  In the thalamus, although the general pattern 
of GFP transcription is the same as for Pax6, GFP is not as strongly expressed as 
Pax6 in this region (Fig. 3.7 C and G).  GFP may also be less widely expressed than 
Pax6 in the thalamus but due to the high levels of background staining it is difficult 
to be certain if this is the case.  The internal capsule which was strongly labelled for 
GFP by immunofluorescence can be seen to be surrounded by GFP positive cells, 






Figure 3.6: In situ hybridization for Pax6 and GFP on coronal sections 
at E12.5 
Adjacent 10μm coronal sections hybridized with a probe for Pax6 (A-D) or GFP (E-
H).  Background levels of staining are indicated in I)-K) which show non-transgenic 
tissue hybridized with the GFP probe.  Boxed areas in A), E) and I) indicate the 
areas shown at high power in B)-D), F)-H) and J) and K) respectively.  B) and F) 
show Pax6 and GFP expression throughout the cortical depth in the dorsal pallium.  
At the cortical angle expression of both genes can be seen to be restricted to the 
ventricular zone (C and G; dashed red line indicates the limit of the VZ).  In the 
ventral telencephalon a population of Pax6 positive cells can be seen (D).  There is a 
similar, but smaller, population of cells positive for GFP (H); it is likely that these 
cells are also positive for Pax6.  The most ventral cells of the Pax6 positive group 
(boxed area in D) are in a region that is GFP negative.  Vz, ventricular zone.  Scale 

























Figure 3.7: In situ hybridization for Pax6 and GFP on coronal sections 
at E15.5 
Adjacent 10μm coronal sections hybridized with a probe for Pax6 (A-D) or GFP (E-
H).  Background levels of staining are indicated in I) and J) which show non-
transgenic tissue hybridized with the GFP probe.  Boxed areas in A), E) and I) 
indicate the areas shown at high power in B)-D), F)-H) and J) respectively.  In the 
cortex Pax6 (B) and GFP (F) expression are confined to the ventricular zone.  
Thalamic expression of Pax6 and GFP appear similar particularly in the ventricular 
zone.  In post-mitotic cells Pax6 appears more strongly expressed than GFP and is 
possibly also more widely expressed (compare C and G).  The region of the internal 
capsule can be seen to be surrounded by many GFP positive cells (H), but Pax6 
expression in this region is absent (D).  Images were converted to greyscale to allow 
the signal from the GFP probe to be more easily distinguished from background 
noise.  Ic, internal capsule; vz, ventricular zone.  Scale bars: 50µm in A, D and G; 




























Pax6 is expressed in a range of regions in the developing brain where some of its 
functions include cell adhesion, cell cycle progression, axon guidance and cortical 
patterning.  Due to its wide variety of functions there is a lot of interest in 
characterising its expression pattern and in examining the effect of loss of function 
mutations on brain development.  The development of a reliable tool for studying 
Pax6 would therefore be of great benefit to this area of research.  The results shown 
here allow an assessment of the reliability of the recently derived DTy54 reporter 
mouse as a marker for Pax6 expression. 
 
3.3.1 Expression of tauGFP in the developing eye and forebrain 
The tauGFP expression pattern seen in coronal sections of DTy54 embryos closely 
resembles the known Pax6 expression pattern at both E12.5 and E14.5.  One obvious 
difference between the two patterns, however, is the strong GFP labelling of cellular 
processes caused by the cytoskeletal rather than nuclear localisation of tauGFP.  This 
is particularly striking in axon bundles such as the optic nerve and the posterior 
commisure and could potentially provide a useful tool for studying the development 
of axonal tracts where the projecting cells are Pax6 positive. 
 
3.3.2 Co-localisation of Pax6 and tauGFP expression 
The discrepancy between the expression of Pax6 and tauGFP proteins, and the fact 
that this discrepancy increases over time, suggests that there may be a difference in 
the half-lives of the two proteins.  The expression pattern seen in the developing 
cortex in particular supports this, as here all the cells that are GFP positive/Pax6 
negative are derived from Pax6 positive progenitors.  This is backed up by evidence 
from in situ hybridization, as in the developing cortex there is a much closer 
correspondence between expression of Pax6 and GFP mRNA.  This is particularly 
striking at E15.5. 
 
The labelling of cellular processes by tauGFP also seems likely to be making a 
significant contribution to the areas that are GFP positive/Pax6 negative especially in 
the ventral telencephalon.  The band of GFP expression seen extending ventrally 
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from the VZ along the PSPB is most likely within the processes of the radial glial 
cells which are known to form a pallisade at this boundary (Stoykova et al., 1997).  
Although the radial glial fascicles cannot be clearly identified on the thin sections 
used here for immunofluorescence, tauGFP labelling of radial glial processes in the 
developing cortex can be clearly seen in thicker vibratome sections and as these 
radial glial cells are Pax6 positive, their labelling with tauGFP is to be expected.  
This could be shown definitively by performing double immunofluorescene for GFP 
and a radial glial marker such as RC2. 
 
There does, however, appear to be some uncoupling of the expression of the 
transgene from Pax6 expression in the ventral telencephalon.  At E15.5 tauGFP 
labelling can be seen in the region of the internal capsule where there are next to no 
Pax6 positive cells.  This tauGFP staining is very diffuse in appearance and seems 
likely to be present in cellular processes rather than cell bodies.  Cells in nuclei of the 
midbrain and hindbrain have been shown to project axons through the internal 
capsule to reach cortical targets (van der Kooy and Kuypers, 1979; Galindo-Mireles 
et al., 1985; Waterhouse et al., 1986; Deng et al., 2007; for review see Hornung, 
2003).  Given that Pax6 is expressed in the hindbrain, where it is required for the 
development of a number of brainstem nuclei, it is likely that the GFP positive axons 
seen traversing the internal capsule may have Pax6 positive cell bodies that lie within 
these nuclei (Engelkamp et al., 1999; Landsberg et al., 2005; Schmid et al., 2007).  
A detailed analysis of the expression patterns of Pax6 and tauGFP in the hindbrain 
might help to clarify this.  In situ hybridization at E15.5 clearly shows the presence 
of GFP mRNA in many cells surrounding the internal capsule where Pax6 
transcripts appear to be completely absent.  These cells are negative for tauGFP 
protein however suggesting that there may be some form of post-transcriptional 
regulation preventing the translation of tauGFP is these cells. 
 
There is also a population of Pax6 positive/GFP negative cells in the most ventral 
part of the telencephalon.  If these cells express GFP at all it is at levels below 
detection by either immunofluorescence or in situ hybridization.  This could be due 
to a difference in how expression is regulated in post-mitotic as opposed to 
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progenitor cells.  Pax6 has been shown to regulate its own transcription via a 
feedback mechanism (Kleinjan et al., 2004; Manuel et al., 2007).  When DTy54 is 
crossed onto the Pax6 overexpressing line Pax77+, which shows a 1.5-3 fold increase 
in Pax6 protein levels, production of tauGFP from the transgene is significantly 
reduced (Manuel et al., 2007).  Similarly there is a significant increase in tauGFP 
levels in Pax6sey/sey.DTy54, suggesting that the level of tauGFP may be inversely 
proportional to level of production of functional Pax6 (Manuel et al., 2007).  If, due 
to its region of insertion, the transgene is more sensitive to this feedback mechanism 
in post-mitotic cells than the endogenous locus this could result in a down-regulation 
of transcription from the transgene.  A difference in the regulation of expression 
between progenitors and post-mitotic cells could also help explain the expression 
pattern seen in the thalamus.  In the E15.5 thalamus, GFP can be seen in areas where 
Pax6 is not expressed but the diffuse appearance of the staining suggests that the 
GFP is present in cellular processes rather than in cell bodies.  By in situ 
hybridization however, both genes show similar expression patterns but with Pax6 
expressed more strongly and also perhaps more widely.  Unfortunately high levels of 
background staining make it difficult to be certain of the exact extent of GFP 
labelling. Interestingly, in the progenitor cells of the thalamus, the expression of both 
genes corresponds very closely, although a difference in the level of expression can 
still be seen.  This would also support the argument that Pax6 expression is regulated 
differently between post-mitotic and progenitor cells. 
 
Another possible explanation for the presence of Pax6 positive/GFP negative cells in 
the ventral telencephalon is that Pax6 is not being transcribed by these cells and the 
Pax6 protein is present as a result of cell-cell transfer.  Cell-cell transfer of the 
homeodomain transcription factor Engrailed has been demonstrated in vitro (Joliot et 
al., 1998).  There is also compelling evidence to suggest that such transfer may occur 
in vivo.  Engrailed has been shown to have access to a subcellular compartment in 
vivo that would allow it to be exported from the cell (Joliot et al., 1997).  Two 
overlapping sequences in the homeodomain (one for cellular export, the other for 
cellular uptake) that are highly conserved between homeodomain containing proteins 
have also been identified as necessary for cell-cell transfer (Joliot et al., 1998; 
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Maizel, et al., 1999; 2002).  Computer modelling of this mechanism of protein 
transfer has also demonstrated how it could be used to produce expression gradients 
and the sharp boundaries of expression seen between pairs of homeodomain 
transcription factors that can regulate their own and each others transcription 
(Holcman et al., 2007).  A recent paper by Sugiyama et al., (2008) demonstrates in 
vivo the transfer of Otx2 from retinal cells to parvalbumin cells in the visual cortex 
where it plays an important role in visual cortical plasticity.  Given this, cell-cell 
transfer cannot be ruled out as a possible explanation for the Pax6 positive/GFP 
negative population of cells seen here in the ventral telencephalon.  
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Chapter 4 – Microarray Experiment 
4.1 Introduction 
4.1.1 Previous Analyses of the development of Pax6sey/sey animals 
There is a large body of literature examining the role of Pax6 in the developing 
mouse brain (for review see Simpson and Price 2002; Manuel and Price 2005).  Pax6 
is known to play an important role in many of the developmental processes of the 
forebrain.  The correct navigation of thalamocortical and corticofugal axons requires 
Pax6 expression (Mastick et al., 1997; Pratt et al., 2000; Jones et al., 2002) and 
neuronal migration is disrupted in the absence of Pax6 (Carić et al., 1997; Talamillo 
et al., 2003).  Pax6 is also important in regulating cell adhesion in the forebrain 
(Stoykova et al., 1997; Tyas et al., 2003) and in controlling aspects of the cell cycle 
in cortical progenitor cells (Warren et al., 1999; Estivill-Torrus et al., 2002; Quinn et 
al., 2007). 
 
As a transcription factor Pax6 can regulate the expression of a range of other genes.  
A number of Pax6 target genes have been identified by in situ hybridization 
including Ngn2, Emx1, Mash1 and Gsh2 (Stoykova et al., 1996; 2000).  In order to 
gain a more complete insight into the genes whose expression is controlled by Pax6, 
however, a high throughput approach looking at the expression of many genes at 
once is required. 
 
4.1.2 How this study will add to our understanding of the role of Pax6 
A number of microarray studies have been carried out to investigate gene expression 
changes in the developing forebrain in response to the loss of functional Pax6 protein 
in both mouse and rat (Faedo et al. 2004; Arai et al. 2005; Holm et al. 2007).  The 
microarray experiment described here aims to build on the knowledge obtained from 
previous array studies by using a more refined technique to isolate the cells of 
interest for analysis.  The DTy54 mouse line makes it possible to isolate a population 
of cells, enriched for cells expressing Pax6, from the developing forebrain by 
fluorescence activated cell sorting (FACS).  This allows us to investigate more 
detailed questions as to the role of Pax6 in different populations of cells and to focus 
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more narrowly on the possible cell autonomous changes in gene expression in 
response to the loss of functional Pax6. 
 
The PSPB plays an important role in the development of the telencephalon and Pax6 
expression is critical for the normal formation of this structure (Stoykova et al., 
1997).  In order to better understand the role of Pax6 at the PSPB it was decided to 
carry out a microarray experiment to compare gene expression in cells of the lateral 
telencephalon, including the PSPB, that are being activated to express Pax6 in 
Pax6+/+ and Pax6Sey/Sey embryos at E12.5.  This would allow large numbers of genes 
to be analysed simultaneously and should identify any genes whose expression at the 
PSPB has been up- or down-regulated in Pax6Sey/Sey compared to wildtype embryos.  
It was decided to use E12.5 embryos as this is the earliest stage at which dissection 
of the PSPB seemed feasible. 
 
Before the microarray analysis could be carried out, however, it was necessary to 
devise a dissection strategy that would allow the cells of interest to be isolated in a 
completely reproducible manner.  GFP expression in DTy54 not only reports where 
Pax6 is expressed, it also mirrors the gradient of expression seen in the developing 
dorsal telencephalon (Tyas et al., 2006).  As Pax6 is most highly expressed at the 
PSPB, this region can be easily identified in DTy54 embryos by the high level of 
GFP. This region can be dissected under a fluorescence microscope, the cells 
dissociated and the GFP positive cells isolated by FACS.  As the reporter construct is 
independent of the endogenous Pax6 locus it can also be crossed onto small eye mice 
to generate Pax6Sey/Sey.DTy54+ embryos for comparison.  The accuracy and 
reproducibility of the dissection was assessed in Pax6+/+.DTy54+ embryos by real-
time RT-PCR and FACS analysis of dorsal, lateral and ventral telencephalic tissue.  
This strategy allows the role of Pax6 to be investigated in a well defined population 







4.2.1 Developing a method to isolate the cells of interest 
In order to look at gene expression specifically in Pax6 expressing cells at the PSPB 
it was necessary to dissect out this region of the telencephalon accurately and 
consistently, before dissociating the cells and isolating those expressing the DTy54 
reporter by FACS.  GFP is highly expressed at the PSPB as this is the region of 
highest Pax6 expression in the telencephalon and so this region can be readily 
visualised under fluorescence, aiding accurate dissection. 
 
4.2.1.1 Dissection Technique for isolating the PSPB 
First the brain was isolated by an incision between the eye and the base of the brain 
and the skin and membranes were removed (Fig. 4.1 A).  The telencephalic lobes 
were dissected away from the rest of the brain by an incision on either side of the 
diencephalon and the two lobes were then separated (Fig. 4.1 B).  A small incision 
was made, just dorsal to the PSPB, at the rostral end of each lobe and another at the 
caudal end (dashed lines in Fig. 4.1 B).  These incisions allowed the lobes to be 
flattened, by folding back the dorsal telencephalon (in direction of arrows in Fig. 4.1 
B), so that the ventricular surface was uppermost.  In this orientation the stripe of 
intense GFP expression at the PSPB could be clearly seen (Fig. 4.1 C-E).  The tissue 
could then be divided into three pieces with cuts being made on either side of the 
PSPB as labelled by GFP expression (Fig. 4.1 F-H).  The same dissection technique 
was also used to isolate the equivalent areas from Pax6sey/sey.DTy54+ embryos (Fig. 
4.1 I-P). 
 
4.2.1.2 FACS analysis of dissection 
In order to check the accuracy of the dissection, cells from dorsal, lateral (including 
the PSPB) and ventral regions of the Pax6+/+.DTy54+ telencephalon were dissociated 
and analysed by FACS. As the GFP expression pattern recapitulates the gradient of 
Pax6 expression in the developing cortex, with strongest expression at the PSPB, one 
would expect to see more cells with a higher level of GFP expression in samples 
from lateral compared with dorsal telencephalon.  Samples from the ventral 
telencephalon would be expected to have very few GFP positive cells as the Pax6  
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Figure 4.1: Dissection of telencephalon from Pax6+/+.DTy54+ and 
Pax6sey/sey.DTy54+ embryos at E12.5, into dorsal, lateral and ventral 
regions  
Dissection of the telencephalon from E12.5 Pax6+/+.DTy54+ (A-H) and 
Pax6sey/sey.DTy54+ (I-P) embryos.  A) and I) show GFP fluorescence overlaid on a 
bright-field image of the whole brain, viewed from above, after skin and membranes 
have been removed.  Broken red lines indicate where incisions were made to isolate 
the telencephalic lobes.  B) and J) show the cut medial surface of the telencephalic 
lobe with GFP fluorescence overlaid on a bright-field image, broken red lines 
indicate where incisions were made at the rostral and caudal ends of the lobe.  The 
tissue was flattened by folding back the dorsal telencephalon in the direction of the 
arrows in B) and J).  The flattened telencephalic lobe with the ventricular surface 
uppermost is shown under bright-field (C and K) and GFP fluorescence (D and L).  
An overlay of bright-field and GFP is shown in E and M.  Broken red lines indicate 
where incisions were made to divide the tissue into dorsal, lateral and ventral 
regions.  The dissected tissue is shown under bright-field (F and N), GFP 
fluorescence (G and O).  An overlay of bright-field and GFP is shown in H and P.  

















Figure 4.2: FACS analysis of dorsal, lateral and ventral telencephalic 
cells 
Frequency histograms of cell number against GFP fluorescence for samples of cells 
from A) the telencephalon of non-transgenic controls and (B-D) the dorsal, lateral 
and ventral parts of the DTy54 telencephalon.  Cells from the lateral telencephalon 
show a higher average expression of GFP than cells in the dorsal telencephalon, with 
the GFP positive peak shifted to the right compared with dorsal samples (B and C).  

















positive population in this region is very small.  FACS analysis showed the profiles 
of GFP expression to be as expected in the different tissue samples (Fig. 4.2).  The 
lateral telencephalon not only contained a greater proportion of GFP positive cells 
but these cells also expressed GFP at a higher level.  This is shown by the shift to the 
right of the peak of the GFP expressing population (compare Fig. 4.2 B and C).  Only 
a tiny proportion of cells from the ventral telencephalon were GFP positive (Fig. 4.2 
D) which is unsurprising as this region is largely negative for Pax6. 
 
4.2.1.3 RT-PCR analysis of dissection 
To further ensure that the dissections were as accurate as possible RNA was 
extracted from dorsal, lateral and ventral tissue samples for analysis by real time RT-
PCR.  The expression of a number of marker genes for dorsal, lateral and ventral 
regions was compared between samples.  The expression of the dorsal marker gene 
Ngn2 was significantly higher in tissue samples from dorsal regions compared with 
ventral tissue samples (Student’s t-test, p<0.01), where expression was almost 
entirely absent (Fig. 4.3 A).  The level of Ngn2 was also significantly higher in 
lateral than in ventral tissue samples (Student’s t-test, p<0.01).  Although expression 
levels in the lateral telencephalon were slightly lower than dorsal regions, this 
difference was not statistically significant. 
 
Expression of the ventral markers Mash1 and Dlx2 showed a pattern that was almost 
the exact opposite of that seen for Ngn2, with the highest level of expression seen in 
ventral tissue for both genes (Fig. 4.3 B and C).  For Mash1 the difference in 
expression between ventral and dorsal samples was statistically significant (Student’s 
t-test, p<0.01). The expression level of Mash1 in the lateral telencephalon was almost 
halfway between that seen in dorsal and ventral regions.  Although the difference in 
Mash1 expression between ventral and lateral telencephalon was not statistically 
significant, the level of Mash1 was significantly higher in lateral compared to dorsal 
regions (Fig. 4.3 B, Student’s t-test, p<0.05).  Dlx2 was highly expressed in ventral 
regions and expression was only slightly lower in lateral compared to ventral 
samples.  Dlx2 expression in dorsal regions was all but absent (Fig. 4.3 C).  The only 
 81
statistically significant difference in Dlx2 expression was between dorsal and ventral 
regions (Student’s t-test, p<0.01). 
 
The expression of Sfrp2 and Dbx1, which were used as markers of the lateral 
telencephalon, showed only slight differences in expression in different parts of the 
telencephalon.  For Sfrp2, dorsal and lateral telencephalon showed almost identical 
levels of expression with slightly lower expression in the ventral telencephalon (Fig. 
4.3 D).  However, there were no statistically significant changes in Sfrp2 expression 
between any of the regions of the telencephalon.  Dbx1 was most highly expressed in 
the ventral telencephalon (Fig. 4.3 E).  The level of Dbx1 in the lateral telencephalon 
was about half that seen in ventral regions, with slightly lower levels of expression 
seen in dorsal tissue.  Again however, these changes in expression levels were not 
statistically significant. 
 
4.2.2 Carrying out the Microarray Experiment 
Having established that the PSPB could be accurately dissected from DTy54+ 
embryos, a microarray experiment was carried out to identify the downstream targets 
of Pax6 in this region.  The design of the microarray experiment was as follows: 
Pax6 expressing cells of the PSPB were isolated by dissection followed by FACS.  
RNA was then extracted from the cells of interest, fluorescently labelled and 
hybridized to the microarray chip.  A schematic illustration of the experimental 
protocol is shown in Figure 4.4. 
 
4.2.2.1 Collection of Microarray Samples 
To identify changes in gene expression at the PSPB in the absence of functional 
Pax6, specifically in a population of cells enriched for Pax6 expression, this region 
was isolated by dissection from E12.5 embryos that were either Pax6+/+.DTy54+ or 
Pax6sey/sey.DTy54+ as described above (Fig. 4.1).  The cells were then dissociated and 
sorted by FACS (Fig. 4.5).  Before experimental samples were sorted, dissociated 
telencephalic cells from a non-transgenic embryo were used to position the gate for 
collection so that no non-transgenic cells were within the gated region (Fig. 4.5 A).  
This was a very stringent cut-off that eliminated both GFP-negative cells and cells 
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Figure 4.3: Gene expression levels measured by real-time RT-PCR 
The expression of Ngn2, Mash1, Dlx2, Sfrp2, and Dbx1 is shown relative to levels of 
Gapdh as measured by real-time RT-PCR in the dorsal, lateral and ventral 
telencephalon.  Ngn2 is expressed at relatively high levels in dorsal and lateral 
telencephalon but is almost absent from ventral regions (A).  Mash1 and Dlx2 are 
expressed at very low levels dorsally with higher expression seen in lateral and 
ventral tissue (B and C).  Sfrp2 shows similar expression levels in all samples, with a 
slight decrease in expression from dorsal to ventral regions (D).  Dbx1 is also 
expressed in all regions with highest expression seen ventrally and slightly lower 
levels of expression in dorsal and lateral regions.  Differences in expression were 
examined by t-test and statistically significant differences are indicated as follows: * 
























































































Figure 4.4: Schematic outline of microarray experiment 
The basic steps of the microarray experiment are outlined for both Pax6+/+.DTy54 
samples (left) and Pax6sey/sey.DTy54 samples (right).  GFP expression at the 
ventricular surface of the telencephalic lobes is shown (top) with the area to be 
dissected indicated by broken red lines.  Cells were then dissociated and the GFP 
positive cells isolated by FACS.  RNA was extracted from these cells, amplified and 
labelled with Cy5 (red) or Cy3 (green) fluorescent dyes.  The two RNA samples 
were then combined and hybridized to an Agilent® G4122A whole mouse genome 















with low levels of GFP when the experimental samples were sorted (Fig. 4.5 B and 
C).  For samples from Pax6+/+.DTy54+ embryos almost 70% of cells expressed high 
levels of GFP and were included in the gated region, around 75% of cells were 
within the gated region for Pax6sey/sey.DTy54+ samples.  In order to ensure that no 
technical errors occurred while sorting was being carried out the purity of the GFP 
positive cell population was checked by analysing a small number of cells from this 
population for levels of GFP fluorescence (Fig. 4.5 D and E).  If sorting has occurred 
as expected then the proportion of cells falling within the sort gate should be close to 
100%.  The samples used for the microarray experiment all had a purity of 97% or 
higher when this analysis was carried out.   
 
To ensure that the GFP positive population isolated for analysis by microarray was 
indeed enriched for Pax6 expressing cells, immunocytochemistry for Pax6 was 
carried out on both the GFP positive and GFP negative populations of cells (Fig. 4.6 
A).  Cells were then analysed by flow cytometry.  This proved to be a very difficult 
experiment technically and due to misidentified plug dates and the degradation of 
cells during the experimental procedure only one sample, from E13.5 embryos, gave 
usable results (Fig. 4.6).  Telencephalic cells from a GFP negative littermate, 
incubated without primary antibody were used as a negative control (Fig. 4.6 B and 
C).  Almost all cells in the GFP positive cell population were also positive for Pax6 
(Fig. 4.6 D and E; cells to the right of the line in E are Pax6 positive).  The GFP 
negative cell population contained a mixture of Pax6 positive and negative cells, but 
the proportion of Pax6 positive cells in the population was lower than for the GFP 
positive cell population (Fig. 4.6 F and G; cells to the right of the line in G are Pax6 
positive) and these cells were more likely to be expressing Pax6 at a lower level than 
Pax6 positive cells from the GFP positive population (compare Fig. 4.6 E and G).   
 
Pax6sey/sey.DTy54+ embryos were easily identifiable due to absence of eyes, but as the 
Pax6sey/+ phenotype is not evident until E14.5 it was impossible to distinguish 
between Pax6sey/+.DTy54+ and Pax6+/+.DTy54+ embryos at E12.5.  This meant that 
the Pax6+/+.DTy54+ littermates of Pax6sey/sey.DTy54+ embryos could not be used as 
they could not be identified without genotyping by PCR and so embryos for the 
 87
Figure 4.5: FAC sorting of samples for microarray  
Graphs of fluorescent intensity plotted against cell number.  The fluorescent profile 
of telencephalic cells from a non-transgenic embryo is shown in A.  This was used to 
establish where the gate should be placed.  The fluorescent profile of cells from the 
E12.5 lateral telencephalon of Pax6+/+.DTy54+ and Pax6sey/sey.DTy54+ embryos are 
shown in B) and C) respectively.  The population of cells falling within the gated 
region were collected for analysis by microarray.  The percentage of cells falling 
within the gated region is indicated on the graph.  D) and E) show the fluorescent 
profile, after sorting, of the gated cells in A) and B) respectively, demonstrating that 
























Figure 4.6: Immunocytochemisty and flow analysis of FAC sorted cells 
Cells from the lateral telencephalon on E13.5 embryos were sorted and both GFP 
positive (Population 1) and GFP negative (Population 2) cells were collected for 
analysis by immunocytochemistry (A).  Data from non-transgenic telencephalic cells 
incubated without primary antibody is shown in B and C.  Cells from Population 1 
labelled with a Pax6 antibody are shown in D and E; similarly labelled cells from 
Population 2 are shown in F and G.  B, D and F show forward and side scatter 
profiles of the cell populations.  Events included in the region R1 are deemed intact 
cells and the Pax6 labelling of these cells, measured by A647 fluorescence, is shown 
in C, E and G respectively.  Cells with a measured fluorescence to the left of the 
vertical line in C, E and G are deemed to be negative for Pax6 expression, while 



































 Pax6+/+.DTy54+ microarray samples were generated separately.  In order to collect 
enough GFP positive cells to provide a sufficient amount of RNA for a microarray 
experiment, it was necessary to pool tissue samples.  Each microarray sample 
consisted of tissue pooled from four different embryos.  Where possible the embryos 
in an individual sample were all littermates to help limit biological variation within 
samples.  However, in most cases, especially for Pax6sey/sey.DTy54+ samples, 
embryos were collected from two or more litters.  Collection of Pax6sey/sey.DTy54+ 
samples proved to be particularly challenging as this genotype was found less 
frequently than predicted by normal Mendelian inheritance (Table 4.1).  Chi squared 
analysis showed a significant difference in the distribution of genotypes observed 
compared with the expected distribution (p-value<0.001).  Interestingly this 
difference was only seen when the DTy54 transgene was carried by the male (p-
value<0.001; Table 4.2).  When the female was transgenic there was no significant 
difference in the genotype distribution (p-value=0.125; Table 4.3). 
 
RNA was extracted from the GFP positive cells immediately after sorting to 
minimise the amount of RNA degradation.  To ensure that the RNA was of high 
quality each sample was analysed using the Agilent® Bioanalyser.  This assigns an 
RNA integrity number (RIN) of between 1 and 10 to each RNA sample, where 10 
indicates high quality, intact RNA and 1 indicates poor quality RNA that is almost 
totally degraded (Schroeder et al. 2006).  The bioanalyser output for the samples 
used in the microarray experiment is shown in (Fig. 4.7).  All but one of the RNA 
samples used for the microarray had RINs of 9.3 or higher (Table 4.4).   The 
Bioanalyser was unable to generate an RIN for sample Sey19 as there was very little 
RNA in this sample.   
 
4.2.2.2 Hybridization of the microarrays 
There were 5 microarrays available to be hybridized, but due to a number of 
problems encountered in collecting the RNA samples it was not practical to 
hybridize all of the arrays on the same day.  The RNA in many of the initial samples  
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Genotype Pax6+/+/Pax6sey/+ Pax6+/+/Pax6sey/+.DTy54+ Pax6sey/sey Pax6sey/sey.DTy54+
Observed numbers of 
embryos 315 318 71 64 
Expected numbers of 
embryos 288 288 96 96 
 
Table 4.1: Distribution of genotypes collected at E12.5, from all crosses, compared with the expected Mendelian 
distribution 
Chi squared analysis shows a significant difference in the distribution of genotypes (p-value < 0.001). 
 
Genotype Pax6+/+/Pax6sey/+ Pax6+/+/Pax6sey/+.DTy54+ Pax6sey/sey Pax6sey/sey.DTy54+
Observed numbers of 
embryos 142 144 24 24 
Expected numbers of 
embryos 125.25 125.25 41.75 41.75 
 
Table 4.2: Distribution of genotypes collected at E12.5, from crosses where the DTy54 transgene was carried by the 
male, compared with the expected Mendelian distribution 
Chi squared analysis shows a significant difference in the distribution of genotypes (p-value < 0.001). 
 
Genotype Pax6+/+/Pax6sey/+ Pax6+/+/Pax6sey/+.DTy54+ Pax6sey/sey Pax6sey/sey.DTy54+
Observed numbers of 
embryos 77 93 17 28 
Expected numbers of 
embryos 80.625 80.625 26.875 26.875 
 
Table 4.3: Distribution of genotypes collected at E12.5, from crosses where the DTy54 transgene was carried by the 
female, compared with the expected Mendelian distribution 











Array Samples RINs 
1 WT12; Sey11 9.8; 9.8 
2 WT16; Sey14 10; 9.8 
3 WT17; Sey18 9.7; 9.3 
4 WT17; Sey18 9.7; 9.3 
5 WT12; Sey19 9.8; na 
Table 4.4: Samples hybridized to each array and their associated RNA 









Figure 4.7: Analysis of RNA quality 
Graphical output from the bioanalyser for 6 of the 7 unique RNA samples used in the 
microarray experiment.  A-C show WT samples 12, 16 and 17 respectively and D-F 
show Sey samples 11, 14 and 18.  The 18S and 28S ribosomal peaks can be clearly 
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collected was badly degraded when assessed on the bioanalyser and had to be 
discarded leaving only 2 samples of each genotype.  Because of the length of time 
required to generate Pax6sey/sey.DTy54+ embryos, it was decided to hybridize the 
good quality samples and to hybridize the remaining samples as soon after collection 
as possible.  This resulted in the arrays being hybridized in three batches as follows: 
Arrays 1 and 2 were hybridized together; array 3 was hybridized on its own; and 
finally arrays 4 and 5 were hybridized together.  For reasons given below the same 
RNA samples were hybridized to both array 3 and array 4 and data from array 4 
replaces the data from array 3 in the analysis. 
 
While this strategy was not ideal, it did allow the initial normalisation and quality 
control of the first three datasets to be carried out before the final two arrays were 
hybridized.  These quality control steps, described below, identified the dataset from 
array 3 as an outlier when compared to the data from arrays 1 and 2.  As the 
collection of the last Pax6sey/sey.DTy54+ samples was taking far longer than was 
feasible, it was therefore decided to use one of the remaining arrays to repeat the 
hybridization of the samples hybridized to array 3.  It was hoped that the array would 
prove to be a technical rather than a biological outlier and that the technical errors 
that had occurred during the initial hybridization would be eliminated, or at least 
reduced, on repetition of the experiment. 
 
4.2.2.3 Quality control and normalisation 
A number of quality control steps were carried out to assess the hybridization of the 
arrays.  Scatterplots of the array data were used to ensure that the general appearance 
of the data was as expected, with most genes showing no change in expression 
between Pax6+/+.DTy54+ and Pax6sey/sey.DTy54+ samples.  One would expect to see a 
graph in which most of the points rest on, or close to, a line representing no change 
in expression between the two samples.  Apart from array 5, in which many genes 
with large changes in expression levels can be seen, scatterplots suggest that 
hybridization occurred as expected (Fig. 4.8).  Scatterplots, however, only provide an 
overview of hybridization on a given array and give little indication of the quality of 
the individual samples hybridized to the array.  In order to determine if any of the  
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Figure 4.8: Scatterplots of array data 
Scatterplots of the data from arrays 1-5 are shown in A-E respectively.  The 
fluorescent intensity measurement for each spot from the Pax6sey/sey.DTy54 sample 
(x-axis) is plotted against the fluorescent intensity of the Pax6+/+.DTy54 sample for 
that spot (y-axis). 
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individual RNA samples were outliers, a comparison of the expression values 
measured for each sample was carried out, using a method called single dye pairs.  
This involved producing a series of graphs in which the intensity values measured for 
each sample was plotted against the expression values measured for every other 
sample (Fig. 4.9 and 4.10).   
 
As with the scatterplots, one would expect to see a graph in which most of the points 
rest on, or close to, a line representing no change in expression between the two 
samples.  When this analysis was done on the first three sets of array data, both 
samples hybridized to array 3 were identified as outliers.  When data from either of 
these samples was plotted against data from any of the samples hybridized to arrays 
1 and 2 the graphs produced showed a much wider spread of data-points than 
expected (Fig. 4.9).  Data from any pairing of the samples hybridized to arrays 1 and 
2 on the other hand produced a graph in which the data-points were tightly clustered 
around a relatively straight line.   
 
After all arrays had been hybridized this analysis was repeated with data from arrays 
1, 2, 4 and 5 (data from array 3 is replaced by data from array 4).  This clearly 
identifies sample Sey19 as a problem sample as it produces a graph that deviates 
greatly from expected regardless of which other sample it is plotted against (Fig. 
4.10).  In summary, initial quality control checks on the array data suggest that in 
general hybridization occurred as expected, but data from arrays 3 and 5 should be 
treated with caution. 
 
Data from all arrays was then normalised to minimise variation both within and 
between arrays.  Firstly background noise was removed using Edwards’ algorithm 
(Edwards, 2003).  This is a non-linear method of removing background which uses a 
smoothing function rather than simply subtracting the background signal from the 
probe signal.  This helps prevent the loss of data from regions where the background 
signal is high.  Non-linear differences within arrays arise from differences in the 
efficiency of incorporation of the two dyes used to label the samples (Yang et al., 
2002).  Loess normalisation was carried out to remove non-linear differences from  
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Figure 4.9: Single dye pairs (samples from 3 arrays) 
Raw data from each individual sample hybridized to the first three arrays is plotted 
against every other sample to determine the general quality of the hybridizations.  
Graphs on the lower left hand side are mirror images of the graphs on the upper right 
hand side, with samples plotted on opposite axes.  Both samples from array 3 (Sey18 
and WT17) can be seen to be outliers as, apart from when they are plotted against 














Figure 4.10: Single dye pairs 
Raw data from each individual sample hybridized is plotted against every other 
sample to determine the overall quality of the dataset.  Graphs on the lower left hand 
side are mirror images of the graphs on the upper right hand side, with samples 
plotted on opposite axes.  Sample Sey19 can be identified as a problem sample due 
to the high proportion of spots that fail to cluster around the line of no change in 
















within each array (Cleveland, 1979; Yang et al., 2002).  For this the data was plotted 
on an MA plot, where M is the log2 expression ratio for Pax6sey/sey.DTy54+ compared 
with wildtype samples and A is the signal intensity from each spot on the array.  
Loess normalisation was used to linearise the data by applying a locally weighted 
regression model to the data, a subset at a time.  The linearised data was then centred 
on a log2 expression ratio of zero, representing no change in expression for the 
majority of genes (Fig. 4.11).  This normalisation step highlights the improvement in 
the quality of data when the hybridization of samples from array 3 was repeated 
(note the large number of genes with very low expression in Fig. 4.11 C' compared 
with D' and also the wider spread in the distribution of the data).  It also identifies the 
dataset from array 5 as an outlier due to the large number of probes for which the 
hybridization signal was very low, or for which extreme fold changes were measured 
(boxed area in Fig. 4.11 E', compare with 4.11 A'-D'). 
 
In order to carry out comparisons between data from different arrays it was necessary 
to remove differences between arrays that were not due to biological variation.  To 
do this the distribution of log2 ratios of expression for Pax6sey/sey.DTy54+ compared 
with wildtype samples was plotted on a boxplot for each array.   These plots clearly 
show that the log ratio distributions of arrays 1 and 2 are much narrower than those 
of arrays 4 and 5 (Fig. 4.12).  Any comparison between data from these 4 arrays 
would be skewed towards the results measured from array 4 and 5 due to the larger 
fold changes in the data from these arrays.  To prevent the data being skewed in this 
manner and to allow accurate comparisons to be made between arrays it is necessary 
to normalise these differences in the distribution of log2 ratios.  The distribution of 
data from each array was normalised to match the average distribution across all 
arrays using median absolute deviation measurements (Yang et al., 2002).  This 
method is based on the assumption that the differences in distribution are due to 
hybridization differences rather than to biological variation.  This is a reasonable 
assumption as there were only small differences in distribution between arrays 
hybridized on the same day, while arrays hybridized on different days had large 
differences in the distribution of log2 ratios (compare data from arrays 1 and 2 with 
data from array 4 and 5 in Fig. 4.12). 
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Figure 4.11: MA plots 
RNA abundance (A) plotted against log2 fold change in expression in 
Pax6sey/sey.DTy54+ samples compared to wildtype (M) is shown for all arrays before 
(A-E) and after (A'-E') Loess normalisation.  The appearance of array 3 can be seen 
to be greatly improved on repetition of the hybridization (compare B and B' with C 
and C').  The problems with array 5 are only slightly improved on normalisation (see 

























Figure 4.12: Boxplots of log-ratio distributions of raw data 
The log-ratio distributions for each array, before normalisation, are shown.  50% of 
all spots fall within the boxed area for each array and the wide horizontal lines show 
the limits between which 75% of all spots fall.  Arrays 3 and 4 can be seen to have a 
much wider range of log-ratios than arrays 1 and 2.  Differences in log-ratio 
distribution were equalised using median absolute deviation measurements. 
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 Normalisation performed as expected, but did little to improve the appearance of 
data from array 5 (see the boxed areas in Fig 4.11 E').  The poor quality of the small 
eye sample hybridized to this array combined with the large number of outliers still 
present after normalisation seemed likely to bias the results.  It was therefore decided 
to exclude array 5 from the analysis of the results.  As the design of the microarray 
experiment did not include the use of a common reference sample, log ratios cannot 
be compared directly between different arrays as differences in the log ratio of a 
given gene could arise due to changes in the expression level of that gene in either of 
the samples hybridized to the array.  Instead the comparison is made between three 
Pax6+/+.DTy54+ and three Pax6sey/sey.DTy54+ samples which are treated as array-
independent biological replicates.  Preliminary analysis assigned p-values to each 
log2 fold change value using an empirical Bayes moderated t-test (Efron and 
Tibshirani, 2002).  This is a variation on the Students t-test which allows more 
accurate p-values to be estimated when the n-number is small, but there are a lot of 
other data available.  In this case it takes advantage of the large number of probes 
present on each array and the fact that the expression of the majority of genes will 
remain unchanged to calculate p-values where there is only an n of 3 for each 
biological condition.   
 
When statistical tests are repeated many times differences can be identified as being 
statistically significant just by chance.  This is a particular problem with microarray 
data due to the large volume of data.  If p<0.05 is taken as statistically significant 
then 5% of all tests carried out will give a significant result even where there is no 
significant difference (a false positive).  In order to generate p-values for each probe 
on the microarray 43,000 t-tests were carried out.  If 5% of these are identified as 
statistically significant just by chance then 2150 probes will be wrongly identified.  It 
is therefore necessary to correct p-values to account for this effect of multiple testing 
(Smith et al., 1987).  P-values were adjusted using the Benjamini-Hochberg 
algorithm which increases the size of all p-values helping to minimise the number of 
false positives in the data (Benjamini and Hochberg, 1995).  The effect of correcting 
for multiple testing is shown in figure 4.13, with a dramatic reduction in the number  
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Figure 4.13: Volcano plots showing effect of p-value adjustment 
Log2 fold change plotted against significance (-log10 of p-value) before (A) and after 
(B) p-values were corrected for multiple testing.  The vertical lines on the graph 
indicate a fold change of +/-2 and the horizontal line indicates a p-value of 0.1 (a p-
value of 0.05 would lie slightly above this line).  The genes of interest therefore are 
those genes in the upper left and right regions of the graph.  The number of genes in 






















of probes with significant p-values, from 9096 to 943, after adjustment (compare Fig. 
4.13 A and B). 
 
4.3 Discussion 
4.3.1 Validation of a dissection technique to isolate the PSPB 
In order to develop a dissection strategy that would allow the accurate and consistent 
isolation of the lateral telencephalon, containing the PSPB, FACS analysis and real-
time RT-PCR were carried out on dissected telencephali.  The results of this analysis 
indicated that the region of the PSPB could indeed be accurately dissected.  FACS 
analysis showed a high proportion of GFP positive cells in both dorsal and lateral 
cell populations as would be expected given that dorsal to the PSPB Pax6 is 
expressed throughout the VZ.  Cells from the lateral telencephalon also express 
higher levels of GFP than those of the dorsal telencephalon.  This corresponds well 
with the gradient of expression shown by both Pax6 and its GFP reporter with 
highest expression seen abutting the PSPB.  The population of cells from the ventral 
telencephalon contained very few that were GFP positive, representing the small 
Pax6 positive population in a tissue that is mainly Pax6 negative. 
 
The accuracy of the dissection was also supported by gene expression patterns as 
analysed by real-time RT-PCR.  Ngn2 is a marker of the developing cortex and has 
an expression boundary at the PSPB (Gradwhol et al., 1996).  It was therefore 
expected to be found at high levels in dorsal and lateral dissections and to be all but 
absent in ventral tissue; this was shown to be the case.  Mash1 and Dlx2 have an 
opposite expression pattern to that of Ngn2, being expressed at high levels in the 
ventral telencephalon (Bulfone et al., 1993; Guillemot and Joyner, 1993).  These 
genes also have expression boundaries abutting the PSPB, and so their presence in 
the region defined here as lateral telencephalon is unsurprising.  As expected, 
expression in the dorsal telencephalon is extremely low with Dlx2 in particular being 
almost undetectable.   
 
The results for the expression levels of Dbx1 and Sfrp2 were unexpected as they do 
not correspond with the previously published expression patterns of these genes at 
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E12.5.  The telencephalic expression of Sfrp2 at E12.5 has been shown by in situ 
hybridization to be largely confined to a small area of the VZ abutting the PSPB, 
although there is also some expression in the caudal ganglionic eminence (Kim et al., 
2001).  This would explain the level of expression seen in ventral tissue samples.  
Sfrp2 has not been shown to be expressed in the more dorsal parts of the pallium at 
E12.5 but the results shown here suggest that Sfrp2 may be expressed throughout the 
pallium at this age with very similar levels of Sfrp2 expression measured in both 
dorsal and lateral samples.   
 
Telencephalic expression of Dbx1 at E12.5 has been shown to be restricted to the VZ 
of the ventralmost part of the pallium (Medina et al., 2004), yet the results shown 
here indicate a much wider expression pattern extending throughout the 
telencephalon.  The high level of expression seen in the ventral telencephalon may be 
due, in part, to contamination from the adjacent eminentia thalami where Dbx1 is 
highly expressed (Medina et al., 2004).  It is possible that Dbx1 is expressed at low 
levels throughout the telencephalon and that this expression is being identified here 
due to the greater sensitivity of RT-PCR compared with in situ hybridization. 
  
The fact that the expression patterns of Ngn2, Mash1 and Dlx2 were exactly as was 
expected and that the FACS results also suggest that the tissue was dissected 
accurately supports the idea that the differences seen here for expression of Dbx1 and 
Sfrp2 compared with published data are due more to the use of a more sensitive 
technique than to errors of dissection, although there may be some contamination of 
ventral samples as mentioned above.  This could be tested for by measuring the 
levels of expression of genes expressed in the eminentia thalami but not in the 
ventral telencephalon. As the region of interest is the lateral telencephalon including 
the PSPB, contamination of ventral samples is not cause for concern.  On the whole 
these results suggested that the dissection technique being used is sufficiently 
accurate and consistent to be reliably used to isolate the lateral telencephalon of 
E12.5 Pax6+/+.DTy54+ embryos for the collection of material for a microarray 
experiment.  A comparable region, identified by anatomical landmarks and GFP 
expression, can be dissected from Pax6sey/sey.DTy54+ embryos. 
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4.3.2 Collecting sufficient material for the experiment 
To investigate the specific roles of Pax6 at the PSPB in the developing telencephalon 
a microarray experiment was designed to identify genes whose expression was 
significantly up- or down-regulated, in the Pax6 expressing cells of this region, in 
embryos without functional Pax6 protein.  This experiment relies on the use of the 
Pax6-GFP reporter mouse, DTy54, to enrich for the cells of interest by using the 
dissection strategy described in chapter 3 followed by cell dissociation and FACS.  
To ensure that there was indeed enrichment for the cells of interest; 
immunocytochemistry was performed on cells after sorting.  This experiment 
suggests that the vast majority of cells in the GFP positive population are also Pax6 
positive, but that not all Pax6 positive cells are included in this population.  The 
proportion of GFP negative cells that were found to be Pax6 positive in this 
experiment seems surprisingly high.  There were, however, a number of technical 
problems with the experiment.  After sorting the cells began to degrade rapidly, 
significantly decreasing the number of cells available for analysis, and this was a 
particular problem with the GFP negative cells, probably because they were much 
fewer in number to begin with.  The need to use a secondary antibody, due to the 
unavailability of a fluorescently conjugated Pax6 antibody, meant that there was an 
increased number of wash steps, with associated pipetting and centrifuging, which 
may have increased the degree of degradation of the samples.  It is also possible that 
trapping of unbound antibody within cells may have artificially increased the 
measured levels Pax6 signal.  In spite of this it seems clear that the GFP positive 
population is enriched for Pax6 expressing cells, particularly those expressing high 
levels of Pax6; but not all Pax6 positive cells are included in the GFP positive 
population.  There are also a small number of Pax6 negative cells that are included in 
the GFP population, although these are minimal. 
 
Each sample for the microarray was composed of tissue pooled from 4 embryos, 
from the same litter where possible.  Pax6+/+.DTy54+ embryos were produced by 
crossing CD1 mice with Pax6+/+.DTy54+ animals.  As the litters produced from this 
cross usually contained between 3 and 6 Pax6+/+.DTy54+ embryos, collecting these 
samples did not present a problem.  Difficulties arose when collecting 
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Pax6sey/sey.DTy54+ samples however, as this genotype was under-represented in the 
litters collected.  These embryos were generated by mating Pax6sey/+.DTy54+ to 
Pax6sey/+ animals, with males and females of both genotypes being used.  Due to the 
greater availability of Pax6sey/+ females, however, in most cases the DTy54 transgene 
was carried by the male.  Although Pax6sey/sey animals die at birth there is no 
evidence in the literature to suggest that they have a reduced viability in utero, and so 
it seems likely that the DTy54 transgene may be having a deleterious effect on the 
survival of these embryos.  When chi-squared analysis was carried out, taking into 
account on which side of the cross the transgene was present, Pax6sey/sey.DTy54+ 
embryos were only under-represented when the male was transgenic and not when 
the transgene was carried by the female.  In order to establish exactly what effect the 
DTy54 transgene is having on the distribution of embryos in these litters it would 
have been necessary to genotype by PCR to distinguish between Pax6+/+ and 
Pax6sey/+ embryos.  Unfortunately it was not feasible to collect tissue samples for 
PCR while attempting to collect samples for the microarray experiment and so it is 
not known if the number of Pax6sey/+.DTy54+ embryos is affected.  It seems unlikely 
that the transgene has an effect on the number of Pax6+/+.DTy54+ embryos as there is 
no evidence of an under representation of this genotype in the DTy54 mouse colony.   
 
It is important to note that although the DTy54 transgene is treated here as a null 
allele for Pax6, it can in fact produce a short form of the Pax6 protein lacking the 
paired domain (Kleinjan et al., 2006).  Mice carrying 12 copies of the transgene have 
micropthalmia and, occasionally, cataracts but there is no apparent eye phenotype in 
mice carrying six copies of the transgene.  Evidence from a similar reporter line, 
using a BAC transgene, suggests that expression of this Pax6 isoform is restricted to 
the eye and that it is not expressed in the brain (Kim and Lauderdale, 2006).  
Although it seems unlikely, given its very restricted expression pattern, that this 
protein could result in Pax6sey/sey.DTy54+ embryos being present at a lower than 
Mendelian ratio, an effect on viability caused by this protein cannot be ruled out.  
Another explanation, given that the under-representation is seen only when the 
transgene is carried by the male, may be that the production of Pax6sey.DTy54+ 
sperm is effected.  This could be investigated by collecting younger embryos and 
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examining the distribution of genotypes.  If Pax6sey/sey.DTy54+ embryos are under-
represented because of a reduction in Pax6sey.DTy54+ sperm then one would expect 
them to be under-represented at all ages.  If on the other hand they are under-
represented because of impaired viability then at younger ages the distribution of 
genotypes should more closely resemble the Mendelian ratio. 
 
4.3.3 Array Hybridization and Quality Control 
The under-representation of Pax6sey/sey.DTy54+ embryos caused massive delays in the 
collection of the microarray samples.  This resulted in RNA samples being stored for 
long periods at -70ºC, during which time the RNA in many samples began to 
degrade.  The quality of a number of samples was so poor that they could not be used 
with any degree of confidence and so replacement samples had to be collected.  To 
prevent further samples being lost by degradation during storage it was decided to 
hybridize samples as soon after collection as possible.  This approach was less than 
ideal, increasing the risk of technical variation between arrays that were hybridized 
on different days and therefore not necessarily under identical conditions.  It was 
preferable however to take this risk and to use high quality RNA samples than to 
hybridize all the arrays together using RNA of poorer quality. 
 
In the end this hybridization strategy had a number of benefits as it was possible to 
carry out the initial normalisation steps on the first three arrays hybridized before the 
samples had been collected for the remaining two arrays.  This allowed the dataset 
from array 3 to be identified as an outlier with both samples hybridized to the array 
showing very different data distributions compared to the samples on the other 
arrays.  In general the level of expression seen across all genes was lower on array 3 
making it more difficult to identify differentially expressed genes as it is difficult to 
accurately measure low levels of expression.  The difference in the quality of data 
from this array compared to data from arrays 1 and 2 is probably due to problems 
during sample processing as array 3 was hybridized on a different day.  Although 
statistically it would still have been better to collect 4 new samples for the remaining 
2 arrays, due to time constraints and the scarcity of Pax6sey/sey.DTy54+ embryos, it 
was decided to repeat the hybridization of the samples hybridized to array 3.  This 
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proved to be the right decision as the results from the second hybridization were 
much more comparable with the data from arrays 1 and 2. 
 
Unfortunately the last array to be hybridized had to be excluded from the final 
analysis due to the poor quality of the data.  Hybridization across the chip was very 
uneven, with localised areas of high over- and under-expression and a number of 
saturated spots.  Analysis of the individual samples hybridized to this array indicated 
that the problems were most likely due to the Pax6sey/sey.DTy54+ sample.  This was 
not altogether surprising as the yield of RNA in this sample was extremely low.  
After amplification and labelling only 500ng RNA was recovered.  This falls a long 
way short of the 750ng RNA that Agilent® recommends should be hybridized to the 
array for each sample.  The low quantity of RNA also meant that the bioanalyser was 
unable to generate a RIN for this sample and although both the 18S and 28S 
ribosomal peaks were present it is possible that the sample had already begun to 
degrade.  Under more favourable circumstances this sample would not have been 
used, but due to time constraints it was not considered feasible to discard it and to 
attempt to collect a replacement sample.  The need to exclude this array from the 
final analysis reduces the n number for each condition to 3, thereby reducing the 
statistical power of the experiment.  This is not an insurmountable problem, it does 
mean however, that care must be taken to validate any conclusions drawn from the 
data by other means.  A detailed analysis of the data from arrays 1, 2 and 4 will be 
described in the next chapter. 
 
 117
Chapter 5 – Analysis of Microarray Results 
5.1 Introduction 
One of the great advantages of a microarray based study is that theoretically it should 
be able to identify all genes whose level of expression changes under the conditions 
being investigated.  Finding good ways to analyse this data, however, can prove 
challenging.  Simple fold change analysis can be useful for narrowing down the list 
of candidate target genes; however, the selection of the fold change cut-off is very 
arbitrary and can lead to the exclusion of interesting, regulated genes from the 
analysis.  With the rapid increase in the use of microarrays in recent years there has 
been a concurrent increase in the tools available to analyse the data generated from 
this research.  A wide variety of software packages, many freely available on the 
internet, have been developed to convert the lists of genes produced by microarray 
experiments into useful biological information.  These programmes allow large gene 
lists to be analysed efficiently, helping to circumvent the problems associated with 
the vast quantities of data arising from a microarray experiment.  Many of these tools 
are based around the gene annotation systems of the Gene Ontology (GO) 
Consortium and the Kyoto Encyclopaedia of Genes and Genomes (KEGG).  These 
databases classify genes in terms of their biological functions and the biological 
pathways in which they act.  Analysis of a gene set in terms of these classifications 
allows long lists of genes to be broken down into groups of genes with common 
functions, thereby aiding the interpretation of the data. 
 
The analysis of the microarray data generated from the comparison of gene 
expression at the PSPB between Pax6+/+.DTy54+ and Pax6sey/sey.DTy54+ embryos at 
E12.5 is described here.  Firstly the data were examined to determine if the 
experiment accurately identified genes which were expected to show a change in 
expression by comparing them with genes previously reported to lie downstream of 
Pax6.  Secondly a comparison was made with a recently published microarray study 
on changes in gene expression in the entire Pax6sey/sey telencephalon.  Finally the data 
were analysed in terms of GO and KEGG annotations using a variety of more or less 
stringent fold change cut-offs to identify the biological functions of the regulated 
genes, and thus gain insight into the role of Pax6 at the PSPB. 
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5.2 Results 
Analysis of the microarray data identified 943 probes with a significant change in 
expression in Pax6sey/sey.DTy54+ compared with Pax6+/+.DTy54+.  411 of these were 
up-regulated (Appendix A) and 532 were down-regulated (Appendix B).  Initially the 
complete dataset was compared with the published literature on Pax6 and with a 
recent microarray experiment by Holm et al., (2006).  The functions and processes in 
which the regulated genes are involved were then analysed.  This was done using a 
variety of different fold change cut-offs to select the genes of interest.  The cut-offs 
used were genes with a significant fold change of >|1.5| (labelled red in Appendices 
A and B), genes with a significant fold change of >|2.0| (labelled green in 
Appendices A and B) and finally all genes with a significant change in expression 
were analysed, regardless of the magnitude of that change. 
 
5.2.1 Comparison with previously published targets of Pax6 
In order to investigate how well the microarray results recapitulate what is already 
known about downstream targets of Pax6, a list was compiled of genes that show a 
change in expression levels in the telencephalon of Pax6 mutant mice, aged between 
E9.5 and E16.5, as identified by in situ hybridization or immunohistochemistry.  The 
array data for these genes was then examined to determine if it concurred with the 
published data.  Although some existing known targets might be expected to be 
found in the array data, the differences in the experimental paradigm used here 
compared to previous studies are such that complete agreement between the datasets 
is not expected.  Overall there appears to be a good degree of correspondence 
between the published literature and the results presented here, particularly among 
the up-regulated gene set (Fig. 5.1).  In the literature 16 genes have been identified as 
being up-regulated in response to a loss of Pax6 expression (Table 5.1; Fig. 5.1 B).  
This study identified 10 of these genes (labelled blue in Appendix A) as having a 
significant up-regulation at the PSPB in Pax6sey/sey.DTy54+ and another 1 that was 
up-regulated and had a p-value approaching significance (Arx; fold change=1.736, p-
value=0.061).  Of the remaining 5 genes, 4 showed no statistically significant change 
in expression.  The final gene, Emx2, was found to be significantly down-regulated 
(p-value=0.025), with a fold change of -1.594. 
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Table 5.1: Genes up-regulated in Pax6sey/sey in the literature 
Genes previously identified as up-regulated in the telencephalon of Pax6 mutant 
embryos aged between E9.5 and E16.5, by in situ hybridization or 
immunohistochemistry, compared with the observed fold change found in this 
microarray study.  P-values as estimated by empirical Bayes t-test and corrected for 
multiple testing are also shown.  Group A contains genes for which the change in 
expression measured by microarray was in agreement with published data.  Group B 
are genes reported to show a change in expression in the literature but that were not 
found to be significantly altered in this study.  Group C consists of Emx2 which is 
reported to be up-regulated in the literature but was found to be significantly down-
regulated by microarray. 
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Gene Reference Observed Fold Change p-value 
 
Dlx1 
Stoykova et al., 1996; 2000; 
Hallonet et al., 1998; 
2.715 0.013 






Toresson et al., 2000; Yun et 
al., 2001; Stenman et al., 
2003 
2.9 0.012 
Ki67 Toresson et al., 2000 2.134 0.023 
Gad1 Yun et al., 2001; Schuurmans et al., 2004 1.677 0.025 
Lhx6 Stoykova et al., 2000 15.439 0.008 
Mash1 
Toresson et al., 2000; 
Stoykova et al., 2000; Yun et 
al., 2001; Muzio et al., 2002; 





Faedo et al., 2004 1.994 0.017 
Olig2 Heins et al., 2002 1.542 0.029 
Vax1 
Hallonet et al., 1998; 
Stoykova et al., 2000 
1.483 0.025 
A
     
Arx Visel et al., 2007 1.736 0.061 
Fzd2 Visel et al., 2007 1.327 0.106 
Er81 Yun et al., 2001 1.237 0.329 
mTsh Caubit et al., 2005 -1.59 0.099 
Six3 Stoykova et al., 2000 -1.189 0.119 
B
     
Emx2 Muzio et al., 2002 -1.594 0.025 C
 
Table 5.1: Genes up-regulated in Pax6sey/sey in the literature 
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Gene Reference Observed Fold Change p-value 
 
Emx1 Toresson et al., 2000; Muzio et al., 2002 -1.584 0.03 
Neurod1 Visel et al., 2007 -2.885 0.007 
Neurod6 Schuurmans et al., 2004; Visel et al., 2007 -6.816 0.009 
Ngn2 
Toresson et al., 2000; Stoykova et al., 
2000; Yun et al., 2001; Heins et al., 2002; 
Stenman et al., 2003; Visel et al., 2007 
-10.201 0.014 
Pde1b Visel et al., 2007 -2.221 0.011 
R-Cad(Cdh4) Stoykova et al., 1997 -2.003 0.012 
SDF1(Cxcl12) Tiveron et al., 2006 -2.129 0.012 
Sema5a Jones et al., 2002 -1.995 0.013 
Tbr1 Stoykova et al., 2000;  -2.25 0.027 
Tbr2 Muzio et al., 2002; Visel et al., 2007 -4.549 0.009 
VGLUT2(Slc17a6) Schuurmans et al., 2004 -2.683 0.007 
Robo2 Jiménez et al., 2002 -1.373 0.03 
Trim9 Visel et al., 2007 -1.386 0.044 
A
     
Sema3c Jones et al., 2002 -1.199 0.137 
Neurod4 Visel et al., 2007 -1.360 0.08 
Dbx1 Yun et al., 2001 -1.215 0.16 
Delta-catenin Duparc et al., 2006 -1.308 0.094 
Lhx2 Yun et al., 2001 -1.043 0.806 
Lrp5 Visel et al., 2007 -1.016 0.945 
Nrg1 Assimacopoulos et al., 2003 -1.107 0.278 
Tenascin-C Stoykova et al., 1997; Götz et al., 1998 -1.181 0.179 
VGLUT1(Slc17a7) Schuurmans et al., 2004 -1.173 0.210 
Wnt7b Kim et al., 2001 -1.266 0.131 
Odz Visel et al., 2007 1.754 0.064 
Ngn1 Visel et al., 2007 1.034 0.804 
Sfrp2 Kim et al., 2001; Muzio et al., 2002 1.185 0.361 
Tgfα Assimacopoulos et al., 2003 1.055 0.564 
D930015E06Rik Visel et al., 2007 1.257 0.324 
B
Table 5.2: Genes down-regulated in Pax6sey/sey in the literature 
Genes previously identified as down-regulated in the telencephalon of Pax6 mutant embryos 
aged between E9.5 and E16.5, by in situ hybridization or immunohistochemistry, compared 
with the observed fold change found in this microarray study.  P-values as estimated by 
empirical Bayes t-test and corrected for multiple testing are also shown.  Group A contains 
genes for which the change in expression measured by microarray was in agreement with 
published data.  Group B are genes reported to show a change in expression in the literature 
but that were not found to be significantly altered in this study.   
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Figure 5.1: Comparison with genes identified in the literature as 
downstream of Pax6 
Venn diagrams showing the degree of overlap between genes previously identified as 
downstream of Pax6 in the developing telencephalon and genes showing a 
significant regulation of >|1.5| fold at the PSPB.  The number of genes identified 
from the literature is shown on the left and the number found in this study is shown 
on the right.  A) shows data for all regulated genes, and this is divided into genes up-
regulated or down-regulated in the literature in B) and C) respectively.  Colour 












Figure 5.2: comparison with microarray data published by Holm et al., 
(2007) 
Venn diagrams showing the degree of overlap between genes identified by 
microarray as downstream of Pax6 in the developing telencephalon at E12.5 and 
genes showing a significant regulation of >|1.5| fold at the PSPB.  The number of 
genes identified by Holm et al., (2007) is shown on the left and the number found in 
this study is shown on the right.  A) shows data for all regulated genes, and this is 
divided into genes found to be up-regulated or down-regulated by Holm et al., in B) 
and C) respectively.  Colour coding corresponds to the labelling of genes in 
Appendices A and B. 
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Figure 5.1
A Complete gene set
B Up-regulated genes
C Down-regulated genes













Holm et al., 2007 This study
Holm et al., 2007 This study
Holm et al., 2007 This study
A similar trend was seen among genes previously identified as down-regulated in 
Pax6 mutants (Table 5.2; Fig. 5.1 C).  Of 28 genes reported to show a down-
regulation in expression, 13 were found to be significantly down-regulated in this 
study (labelled blue in Appendix B).  None of the remaining 15 genes were 
significantly regulated, although one of these genes, Odz, showed a reasonably large 
up-regulation (fold change=1.754) and this change in expression was approaching 
statistical significance (p=0.064).   
 
5.2.2 Comparison with recently published microarray data 
A recently published paper by Holm et al. (2007) described a microarray experiment 
comparing gene expression between wildtype and small eye cortex and ganglionic 
eminences at E12 and E15.  (As Holm et al. defined the day of vaginal plug as E0 
and for the purposes of this study it was defined as E0.5, their E12 embryos should 
be the same age as the embryos analysed here.)  As the dissected region, containing 
the PSPB, analysed in this study contains cells from both cortex and LGE, 
microarray data was compared with changes in expression in both of these regions at 
E12 as found by Holm et al. (2007).  A summary of this comparison is shown in 
tables 5.3 and 5.4. 
 
Similar to the results of the comparison with regulated genes, identified by in situ 
hybridization or immunohistochemistry, there was a marked degree of overlap 
between the two datasets.  Of the 114 genes found to be up- or down-regulated by 
>|1.5| fold by Holm et al., 38 showed a similar statistically significant change in 
expression at the PSPB (Fig. 5.2).  If these two sets of genes had been chosen 
randomly from the mouse genome, which contains ~23000 genes, then an overlap of 
only 2.3 genes would be expected between them*.  Holm et al. identified 50 genes 
that were up-regulated by >1.5 fold; 10 of these were identified as significantly up-
regulated in this study (Fig.5.2 B; genes labelled yellow in Appendix A) and a 
further 2 were up-regulated with p-values approaching significance (p=0.055 and 
0.054).  Of the remaining 38 genes, (one of which was represented twice in the Holm 
et al. data), none were significantly up-regulated at the PSPB.  It is interesting to note 
                                                 
* Expected overlap was calculated as follows:  
(Number of genes identified by Holm et al. × Number of genes identified in this study) / 23000 
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Data from Holm et al., 2007 Data from this study  
Gene Fold Change 
Cortex 
Fold Change  
GE Fold Change p-value 
 
Asb4 5.91 --- 4.502 0.004 
5031439A09Rik 2.88 1.77 5.06 0.007 
Mash 1 2.27 --- 2.88 0.012 
Dlx1 2.01 --- 2.715 0.013 
Dlx2 2.77 --- 2.454 0.014 
Calb1 2.52 --- 3.614 0.018 
Ccnd1 1.64 --- 2.279 0.022 
Peg3 1.81 --- 2.536 0.028 
Zic4 1.87 --- 2.06 0.029 
Sulf2 1.61 --- 2.053 0.029 
A 
      
Dlk1 5.05 --- 1.502 0.055 
Kcnd2 1.93 --- 1.279 0.054 B 
      
Rian 2.31 --- 2.001 0.102 
MBII-343 
(Rian) 2.58 --- 2.001 0.102 
Foxd1 2.48 --- 1.524 0.233 
Fstl 1.85 --- 1.428 0.156 
Gtl2 3.28 --- 1.421 0.170 
Gpc3 2.41 --- 1.260 0.097 
Otx2 3.24 --- 1.303 0.111 
Igf2 1.64 --- 1.282 0.122 
Cdh11 1.81 --- 1.237 0.126 
Ogn 2.63 --- 1.326 0.135 
Igf1 2.21 --- 1.155 0.145 
Emb 1.93 --- 1.143 0.196 
Col1a2 2 --- 1.176 0.263 
Sepp1 1.54 --- 1.106 0.271 
Id3 2.59 --- 1.118 0.288 
Serpine2 1.94 --- 1.114 0.306 
BCMP1 2.55 --- 1.134 0.309 
Gsn 1.74 --- 1.109 0.369 
Stx8 2.08 --- 1.173 0.409 
Tex15 2.49 --- 1.074 0.415 
Anxa5 1.59 --- 1.081 0.546 
Anxa2 1.85 --- 1.065 0.548 
1110004P15Rik 
(Ahnak) 2.28 --- 1.109 0.582 
Id1 2.2 --- 1.077 0.583 
Zfhx4 2.23 --- 1.069 0.590 
Fgf17 2.33 --- 1.035 0.739 
Cnn2 1.7 --- 1.031 0.757 
































Data from Holm et al., 2007 Data from this study  
Gene Fold Change 
Cortex 
Fold Change  
GE Fold Change p-value 
 
Cxcl14 1.86 --- -1.237 0.109 
Rgs16 1.57 --- -1.314 0.223 
Hbb-bh1 2.88 1.8 -1.181 0.231 
Lgals1 2.02 --- -1.123 0.418 
Wif1 2.7 --- -1.065 0.488 
S100a11 1.62 --- -1.038 0.780 
Lum 2.07 --- -1.022 0.88 
Bmp4 1.7 --- -1.014 0.908 






      
2610024A01Rik 
(Tmem163) 1.78 --- -2.121 0.039 
Arl4 1.94 --- -1.465 0.034 
D
 
Table 5.3 Comparison of genes found to be up-regulated in small eye relative to 
wildtype by Holm et al., (2007), along with the change in expression observed in this 
study.  P-values have been adjusted for multiple testing. --- indicates where fold 
change data was not available for a particular tissue.  Group A contains genes for 
which the change in expression measured in this study was in agreement with that 
measured by Holm et al.  Group B are genes for which there is an agreement 
between the changes in expression, but this has not quite reached statistical 
significance in this study.  Group C are genes reported to show a change in 
expression by Holm et al., but that were not found to be significantly altered in this 
study.  Group D are genes found to be significantly down-regulated in this study but 












Data from Holm et al., 2007 Data from this study  
Gene Fold Change 
Cortex 
Fold Change  
GE Fold Change p-value 
 
Uncx4.1 --- -2.66 -3.834 0.005 
NeuroD1 --- -3.85 -2.885 0.007 
Lhx9 --- -2.79 -4.633 0.007 
Slc17a6 --- -3.04 -2.683 0.007 
Epha3 -3.53 -2.04 -2.402 0.008 
NeuroD6 -4.18 -4.11 -6.816 0.009 
Tbr2 -2.75 -3.33 -4.549 0.009 
Pde1b -3.43 -1.74 -2.221 0.011 
Cdh4 --- -2.06 -2.003 0.012 
NeuroD2 -2.00 --- -2.792 0.013 
Sema5a -2.93 --- -1.995 0.013 
AP2-γ -3.14 -2.00 -5.648 0.014 
Ngn2 -2.11 -8.75 -10.241 0.014 
Slc1a3 -2.22 --- -5.288 0.014 
9430059P22Rik 
(Shisa2; Tmem46) -2.88 --- -2.925 0.014 
Rlbp1 -3.55 -1.61 -2.368 0.017 
Serpini1 --- -1.82 -2.377 0.017 
Syt4 --- -1.96 -1.707 0.017 
2900026H06Rik 





Bhlhb5 --- -1.95 -2.00 0.023 
Pcdh8 --- -1.83 -1.847 0.023 
9430077C05Rik 
(Etl4; BC026657) -3.17 --- -2.169 0.026 
Tbr1 -1.61 -1.91 -2.25 0.027 
Nfia -2.15 --- -1.898 0.032 
Tgfβ2 -2.05 --- -1.581 0.038 
Id4 -1.71 --- -1.706 0.043 
A
      
E130201N16Rik 
(Prr15) -4.38 --- -1.378 0.024 
Syn2 -1.65 --- -1.38 0.048 
B
      
Snca --- -1.76 -1.626 0.055 
Mab21l1 --- -2.74 -2.144 0.056 C
      
Cyb561 --- -1.62 -1.355 0.061 
Dkk3 -1.80 --- -1.36 0.081 
Fhl1 -2.12 --- -1.34 0.089 
Catnd2 (Ctnnd2) -3.26 --- -1.308 0.094 
Hnt --- -1.85 -1.282 0.13 
Asph --- -1.89 -1.194 0.136 
Nr2f2 --- -2.22 -1.17 0.148 
2700033K02Rik 
(Nr2f2) --- -2.91 -1.17 0.148 
Ppp1r1c --- -1.92 -1.159 0.149 













Data from Holm et al., 2007 Data from this study  
Gene Fold Change 
Cortex 
Fold Change  
GE Fold Change p-value 
 
TN-C --- -2.03 -1.181 0.179 
Gria1 --- -1.66 -1.335 0.214 
1810020C19Rik 
(Alkbh3) -2.04 --- -1.229 0.215 
Cav -2.03 --- -1.171 0.22 
Hpca -1.71 --- -1.116 0.237 
2010011I20Rik -1.86 --- -1.18 0.269 
Nfib -1.92 --- -1.165 0.38 
Aldo3 (Aldoc) -5.52 --- -1.081 0.44 
Sfrp1 -2.61 --- -1.128 0.496 
Inhbb -1.86 --- -1.455 0.61 
Sez6 -1.92 --- -1.043 0.751 
Satb2 -2.12 --- -1.017 0.887 
Slc15a2 -2.62 --- 2.015 0.064 
Plxna2 -2.11 --- 1.358 0.097 
Bcl11b -1.72 --- 2.03 0.139 
Wnt7a -3.04 --- 1.176 0.251 
Epha5 -2.14 --- 1.158 0.373 
Sox3 -2.34 --- 1.081 0.396 
Ndr2 -2.04 --- 1.093 0.429 
Mt3 -1.79 --- 1.106 0.435 
Nfix -2.08 --- 1.067 0.449 
Ngn1 -2.20 -2.23 1.034 0.804 











      
Sstr2 -2.60 --- --- ---  
 
Table 5.4 Comparison of genes found to be down-regulated in small eye relative to 
wildtype by Holm et al., (2007), along with the change in expression observed in this 
study.  P-values have been adjusted for multiple testing.  --- indicates where data was 
not available for a particular tissue.  Group A contains genes for which the change in 
expression measured in this study was in agreement with that measured by Holm et 
al.  Group B are genes for which there is an agreement between the changes in 
expression, but in this study it has not reached the |1.5| fold change cut off set by 
Holm et al. (2007).  Group C are genes for which there is an agreement between the 
changes in expression, but this has not quite reached statistical significance in this 
study.  Group D are genes reported to show a change in expression by Holm et al., 
but that were not found to be significantly altered in this study.  Sstr2 has not been 
included in any of these groups as data on this gene was not available from this 
study. 
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however that 2 of these genes were significantly down-regulated with relatively large 
changes in expression (Tmem163: FC= -2.121; adjusted p-value=0.039 and Arl4: 
FC= -1.465; adjusted p-value=0.034; Table 5.3) 
 
Among the 64 genes that Holm et al. found to show a greater than 1.5 fold down-
regulation were 28 genes identified by this study as significantly down-regulated at 
the PSPB, with an absolute fold change of >1.5 (Table 5.4; Fig. 5.2 C; genes labelled 
yellow in Appendix B).  A further 2 genes were found to be significantly down-
regulated, but by <|1.5| fold.  The expression of 33 of the remaining 34 genes was not 
significantly altered at the PSPB, although one gene, Slc15a2, showed a large up-
regulation (2.015 fold) and had a p-value that was approaching significance (adjusted 
p-value=0.064).  The final gene found to be downregulated by Holm et al. was Sstr2 
but data for this gene at the PSPB was unavailable.  This was surprising as the 
microarray used (Agilent®, G4122A) is supposed to cover the whole mouse genome.  
Sstr2 is a somatostatin receptor and other Sstr genes on the microarray showed no 
significant changes in expression.   
 
5.2.3 Identification of over-represented themes in the microarray data 
Having established that the microarray data generated in this study corresponds well 
both with previously published array data and with Pax6 targets identified by other 
means, the dataset was then analysed as a whole.  Microarray studies generally use 
an arbitrary fold change cut-off of between |1.5| and |2|, in conjunction with a 
statistically significant p-value, to identify genes of interest.  Here genes with an 
absolute fold change of greater than 1.5 and an adjusted p-value less than 0.05 were 
identified as potential candidates for Pax6 regulation (genes labelled red in 
Appendices A and B).  Using these criteria 625 probes, representing 462 genes, were 
found to be significantly regulated in Pax6sey/sey.DTy54+ compared with 
Pax6+/+.DTy54+.  Of these, 354 probes (representing 218 known genes) were 
downregulated and 271 probes (representing 244 known genes) were up-regulated.  
The 20 most up-regulated and 20 most down-regulated genes are listed in tables 5.5 
and 5.6 respectively.   
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Gene Fold Change p-value
Adjusted  
p-value
Lhx6 15.439 5.82E-06 0.008 
Smad2 9.677 4.26E-05 0.014 
Titf1 7.406 1.02E-06 0.005 
Mpped2 7.186 3.93E-05 0.014 
Gpr177 5.060 4.51E-06 0.007 
Btbd9 4.658 1.84E-05 0.012 
Asb4 4.502 7.89E-07 0.004 
Rbbp4 4.146 1.66E-04 0.025 
Calb1 3.614 8.34E-05 0.018 
Lhx8 3.538 4.55E-05 0.014 
Ube2s 3.006 8.41E-04 0.045 
Nkx6-2 2.910 3.02E-07 0.004 
Gsh2 2.906 1.75E-05 0.012 
Ascl1 2.888 2.22E-05 0.012 
Arfl4 2.729 3.36E-06 0.007 
B230215L15Rik 2.725 1.38E-04 0.023 
Dlx1 2.715 3.35E-05 0.013 
MGC73635 2.709 2.27E-05 0.012 
Fxc1 2.623 8.08E-07 0.004 
Hist1h1e 2.621 4.52E-05 0.014 
 
Table 5.5 The 20 genes found to be most up-regulated at the PSPB with their 











Gene Fold Change p-value
Adjusted  
 p-value
Neurog2 -10.241 3.95E-05 0.014 
Neurod6 -6.816 8.01E-06 0.009 
BC020078 -6.408 4.59E-05 0.014 
Prdm8 -6.185 2.47E-05 0.012 
Tcfap2c -5.648 3.71E-05 0.014 
Slc1a3 -5.288 3.46E-05 0.014 
Nhlh1 -5.151 1.61E-06 0.005 
TC1651696 -5.053 3.03E-05 0.013 
TC1574886 -4.645 6.06E-04 0.040 
Lhx9 -4.633 3.41E-06 0.007 
Eomes -4.549 6.83E-06 0.009 
Has2 -3.848 7.49E-06 0.009 
Uncx4.1 -3.834 1.35E-06 0.005 
Sema6d -3.801 1.17E-05 0.009 
Nrn1 -3.726 2.78E-06 0.007 
Chst8 -3.696 4.07E-06 0.007 
Slc17a6 -3.686 2.19E-05 0.012 
Rabgap1l -3.666 2.11E-05 0.012 
Celsr1 -3.637 1.75E-04 0.025 
3110035E14Rik -3.531 3.06E-05 0.013 
 
Table 5.6 The 20 genes found to be most down-regulated at the PSPB with their 
associated fold change, p-value and the p-value after adjustment for multiple testing. 
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This set of significantly regulated genes was further analysed to identify any themes 
in the biological function of genes regulated by Pax6.  There are a number of 
annotation systems available that provide information on the biological function of 
genes.  Two of the most commonly used are those of the Gene Ontology Consortium 
(GO) and the Kyoto Encyclopaedia of Genes and Genomes (KEGG).  There are a 
number of programmes that use these annotation systems to analyse gene sets freely 
available on the internet.  Two such programmes are WebGestalt (WEB-based GEne 
SeT AnaLysis Toolkit; Zhang et al., 2005), and FunNet.  These programmes both use 
GO and KEGG gene annotations to identify categories that are over-represented in a 
set of genes of interest.  Analysis of those genes identified as being regulated by 
Pax6 gave similar results when analysed with each of these programmes, however 
the graphs used here to illustrate these results were all generated using FunNet. 
 
The GO database describes genes in terms of three ontologies – biological process, 
molecular function and cellular component.  Within each of these ontologies are GO 
terms which are organised hierarchically in parent – child relationships (see Fig. 5.3 
for example).  Genes can be members of many different GO categories, allowing 
them to be described in more or less specific detail.  Using this parent – child 
organisation FunNet is able to provide a variety of descriptions of the regulated gene-
set.  These range from detailed descriptions giving the most precise information 
available on the biological roles of the transcripts to much less specific overviews of 
the general functions of the gene-set as a whole.  
 
Analysis of the biological processes in which the regulated genes are involved shows 
that transcription factors and genes involved more generally in the regulation of 
transcription are significantly over-represented in both the up-regulated and down-
regulated transcripts (Fig. 5.4).  This fits well with the role of Pax6 as a high level 
transcription factor regulating many transcription pathways.  Analysis of the up-
regulated transcripts shows an over-representation of genes with a role in the cell 
cycle, and more specifically genes involved in DNA replication and repair, mitosis 
and cell division (Fig. 5.4).  This increase in the expression of genes involved in the 
cell cycle would be compatible with the shortening of the cell cycle in Pax6sey/sey
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Figure 5.3: Example of the parent-child relationships used in the GO 
database 
The term neuron migration (shown in red) is used as an example to demonstrate the 
organisation of the gene ontology database.  Every term will have parent terms 
(shown in blue) and all genes associated with a specific term are also associated with 
the parent terms.  In this example any genes involved in neuron migration will also 
be listed with genes involved in cell migration and the generation of neurons.  Parent 
terms can have many child terms and examples of some of the other child terms for 
cell migration and the generation of neurons are shown in yellow.  Genes involved in 
neuron migration can be divided into those involved either in the inward or outward 
migration of deep nuclear neurons.  These are the two child terms of neuron 





















 embryos at E12.5 reported by Estivill-Torrus et al. (2002).  The processes that the 
down-regulated genes are involved in are more specifically associated with neuronal 
development.  The general processes of forebrain, brain and nervous system 
development are all significantly over-represented, demonstrating the importance of 
Pax6 as a potent neurogenic gene.  The processes of neuron differentiation and 
migration along with axonogenesis and axon guidance are also over-represented in 
the down-regulated gene set (Fig. 5.4). 
 
GO analysis into the molecular functions of the regulated gene list again emphasises 
the importance of Pax6 in controlling the expression of other transcription factors, 
with transcription factor activity over-represented in both the up- and down-regulated 
gene sets (Fig. 5.5).  The categories of DNA, nucleotide, protein and microtubule 
binding are all over-represented in the up-regulated transcripts.  This fits well with 
the analysis of biological processes, complementing the processes of both 
transcription and cell division.  The functions of the down-regulated transcripts are 
biased heavily towards transcription and the regulation of transcription (Fig. 5.5).  
This again supports the processes in which these genes are involved as many of the 
genes promoting neural differentiation and development do so by influencing 
transcription. 
 
The KEGG database annotates genes in relation to the biological pathways and 
processes in which they are involved.  Analysis of the regulated gene set based on 
KEGG annotations identified a number of pathways that were over-represented.  The 
pathways over-represented in the down-regulated transcripts were the TGF-β 
signalling pathway and axon guidance pathways (Fig. 5.6).  TGF-β signalling is very 
important in establishing correct patterns of gene expression in the developing 
forebrain (Shimagori et al., 2004) and so the down-regulation of a number of its 
components in the absence of Pax6 expression is perhaps unsurprising.  Axon 
guidance pathways would also be expected to be down-regulated as axon navigation 
has been shown to be disrupted in Pax6sey/sey embryos (Mastick et al., 1997; Pratt et 
al., 2000; Jones et al., 2002).   
 
 136
Figure 5.4: GO analysis of biological processes for genes with >|1.5| 
fold change 
Graph showing the top 12 over-represented biological processes in the set of genes 
with a significant (p<0.05) fold change of >|1.5| in Pax6sey/sey.DTy54 compared with 
Pax6+/+.DTy54 for both up- and down-regulated genesets, as defined by the gene 
ontology database.  Processes over-represented among the up-regulated gene set are 
mainly involved with the cell cycle and cell division while processes over-
represented in the down-regulated gene set are more concerned with neuronal 
development.  Transcription and its regulation are highly over-represented in both 
the up- and down-regulated gene sets.  Transcriptional domain coverage is calculated 
as the number of transcripts in each significantly overrepresented theme expressed as 
a percentage of the number of transcripts annotated by at least one significantly over-




























Figure 5.5: GO analysis of molecular functions for genes with >|1.5| fold 
change 
Graph showing the molecular functions, as defined by the gene ontology database, 
over-represented in the set of genes with a significant (p<0.05) fold change of >|1.5| 
in Pax6sey/sey.DTy54 compared with Pax6+/+.DTy54.  Molecular functions over-
represented among the up-regulated gene set include nucleotide and protein binding 
while the functions over-represented in the down-regulated gene set include metal 
ion binding.  Transcription factor activity is highly over-represented in both the up- 
and down-regulated gene sets.  Transcriptional domain coverage is calculated as the 
number of transcripts in each significantly overrepresented theme expressed as a 
percentage of the number of transcripts annotated by at least one significantly over-















Figure 5.6: KEGG analysis for genes with >|1.5| fold change 
Graph showing the processes and pathways, described in the Kyoto encyclopaedia of 
genes and genomes, over-represented in the set of genes with a significant (p<0.05) 
fold change of >|1.5| in Pax6sey/sey.DTy54 compared with Pax6+/+.DTy54.  Among the 
up-regulated themes are the cell cycle and the associated themes of DNA replication 
and the p53 signalling pathway.  The down-regulated themes are axon guidance and 
TGF-ß signalling.  Transcriptional domain coverage is calculated as the number of 
transcripts in each significantly overrepresented theme expressed as a percentage of 
the number of transcripts annotated by at least one significantly over-represented 















 The KEGG pathways over-represented by the up-regulated transcripts include the 
cell cycle and its associated pathways of DNA replication and the p53 signalling 
pathway, all of which would be expected to be identified given the results of the GO 
analysis.  The Wnt signalling pathway and components of the adherens junction are 
also over-represented.  Similar to TGF-β signalling, Wnt signalling is critically 
important in the development of the forebrain and so it is not surprising that Pax6 
regulates some of the components of this pathway; indeed Sfrp2, an inhibitor of Wnt 
signalling, has been shown to be downstream of Pax6 (Kim et al., 2001).  The over-
representation of components of the adherens junction is also to be expected as Pax6 
is known to play a role in cell adhesion, with altered cell adhesive properties seen in 
Pax6sey/sey embryos (Stoykova et al., 1997; Tyas et al., 2003).  There are also a 
number of cancer pathways with an over-representation of gene members among the 
up-regulated gene-set. 
 
5.2.4 Analysis of genes with a change in expression of >|2| fold 
In order to determine if genes showing the largest changes in expression on the loss 
of Pax6 are associated with the same themes identified above or if genes with large 
fold changes are associated with a specific subset of these themes, the analysis was 
repeated using a cut-off of +/- 2 fold change in expression to isolate the genes of 
interest (genes labelled green in Appendices A and B).  In general the themes 
identified as over-represented were very similar between genes with >|1.5| fold 
change and those with >|2| fold change across the three categories of biological 
processes, molecular function and KEGG pathways; there were however some 
notable differences.  The biological processes of pattern specification, neuron fate 
commitment and inner ear morphogenesis were over-represented among genes up-
regulated >2 fold at the PSPB, but not in the set of genes up-regulated >1.5 fold (Fig. 
5.7).  Among down-regulated transcripts the processes of hindbrain development and 
synaptic vesicle endocytosis were found to be over-represented specifically in the set 
of genes down-regulated >2 fold.   
 
The molecular functions over-represented among genes with larger fold changes are 
heavily biased towards functions involved in transcription regulation (Fig. 5.8).  This 
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Figure 5.7: GO analysis of biological processes for genes with >|2.0| 
fold change 
Graph showing the top 12 over-represented biological processes in the set of genes 
with a significant (p<0.05) fold change of >|2.0| in Pax6sey/sey.DTy54 compared with 
Pax6+/+.DTy54 for both up- and down-regulated genesets, as defined by the gene 
ontology database.  Transcriptional domain coverage is calculated as the number of 
transcripts in each significantly overrepresented theme expressed as a percentage of 
the number of transcripts annotated by at least one significantly over-represented 



























Figure 5.8: GO analysis of molecular functions for genes with >|2.0| fold 
change 
Graph showing the molecular functions, as defined by the gene ontology database, 
over-represented in the set of genes with a significant (p<0.05) fold change of >|2.0| 
in Pax6sey/sey.DTy54 compared with Pax6+/+.DTy54.  Transcriptional domain 
coverage is calculated as the number of transcripts in each significantly over-
represented theme expressed as a percentage of the number of transcripts annotated 
by at least one significantly over-represented theme.  The number of genes in each 








Figure 5.9: KEGG analysis for genes with >|2.0| fold change 
Graph showing the processes and pathways, described in the Kyoto encyclopaedia of 
genes and genomes, over-represented in the set of genes with a significant (p<0.05) 
fold change of >|1.5| in Pax6sey/sey.DTy54 compared with Pax6+/+.DTy54.  
Transcriptional domain coverage is calculated as the number of transcripts in each 
significantly overrepresented theme expressed as a percentage of the number of 
transcripts annotated by at least one significantly over-represented theme.  The 











 is highly similar to the profile of genes showing a fold change >|1.5|, with the 
exception of metal ion and transition metal ion binding both of which are absent 
when the analysis is restricted to genes with a fold change >|2|.  Analysis of KEGG 
pathways identified a second cell adhesion pathway as up-regulated among genes 
with a higher fold change, with genes involved in focal adhesion as well as adherens 
junction formation over-represented (Fig. 5.9).  Axon guidance was the only over-
represented KEGG pathway in the down-regulated gene set, with TGFβ signalling no 
longer over-represented when genes with a down-regulation between 1.5 and 2 fold 
are excluded from the analysis. 
 
5.2.5 Analysis of all significantly regulated genes  
Due to the volume of data produced by microarray experiments it can be easy to 
under analyse the results by focusing exclusively on genes that have large changes in 
expression levels and ignoring smaller changes that are none the less significant.  In 
an attempt to avoid this pitfall, all genes showing a significant change in expression 
were analysed, regardless of the magnitude of that change (Appendices A and B).  It 
is important to bear in mind that even small changes in gene expression can produce 
large downstream effects and also that large changes that occur in subsets of cells 
within the dissected tissue can be masked. 
 
To determine if genes with small, but significant changes in expression at the PSPB 
have a similar functional profile to genes with a significant fold change >|1.5|, the set 
of all genes with adjusted p-values <0.05, were analysed, regardless of the magnitude 
of their fold change.  This analysis produced results that were, with some exceptions, 
the same as those obtained using fold change cut-offs of either 1.5 or 2.  Down-
regulated transcripts showed an over-representation of genes involved in the 
biological processes of dephosphorylation, asymmetric protein localisation and the 
ovulation cycle; three categories not identified when the analysis was carried out 
using either a 1.5 or 2 fold change cut-off (Fig. 5.10).  Analysis of molecular 
functions identified a number of functions, including cyclase and helicase activity, 
only over-represented when all significantly up-regulated transcripts were examined 
(Fig. 5.11).  The KEGG pathway “one carbon pool by folate”, which provides the  
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 Figure 5.10: GO analysis of biological processes for all genes with a 
significant change in expression 
Graph showing the top 12 over-represented biological processes in the set of all 
genes with a significant (p<0.05) change in expression in Pax6sey/sey.DTy54 compared 
with Pax6+/+.DTy54 for both up- and down-regulated genesets, as defined by the 
gene ontology database.  Transcriptional domain coverage is calculated as the 
number of transcripts in each significantly overrepresented theme expressed as a 
percentage of the number of transcripts annotated by at least one significantly over-



























Figure 5.11: GO analysis of molecular functions for all genes with a 
significant change in expression 
Graph showing the molecular functions, as defined by the gene ontology database, 
over-represented in the set of all genes with a significant (p<0.05) change in 
expression in Pax6sey/sey.DTy54 compared with Pax6+/+.DTy54.  Transcriptional 
domain coverage is calculated as the number of transcripts in each significantly over-
represented theme expressed as a percentage of the number of transcripts annotated 
by at least one significantly over-represented theme.  The number of genes in each 

















Figure 5.12: KEGG analysis for all genes with a significant change in 
expression 
Graph showing the processes and pathways, described in the Kyoto encyclopaedia of 
genes and genomes, over-represented in the set of all genes with a significant 
(p<0.05) change in expression in Pax6sey/sey.DTy54 compared with Pax6+/+.DTy54.  
Transcriptional domain coverage is calculated as the number of transcripts in each 
significantly overrepresented theme expressed as a percentage of the number of 
transcripts annotated by at least one significantly over-represented theme.  The 














one-carbon groups for the de novo synthesis of purines and pyrimidines, is also 
uniquely identified when this gene-set is analysed (Fig. 5.12).  The colorectal cancer 
pathway is identified as over-represented among the up-regulated transcripts, 
regardless of the fold change cut-off used, but when all significantly changed 
transcripts are analysed this pathway was also over-represented in the down-
regulated gene-set.  An overview of the overlap of themes identified as over-
represented using different fold change cut-offs is shown for the up-regulated 
transcripts in Figure 5.13 and for the down-regulated transcripts in Figure 5.14. 
 
5.3 Discussion 
5.3.1 Comparison with genes previously identified as regulated by Pax6 
The microarray data presented here correlates well with previously identified Pax6 
targets half of which were found to show a similar change in expression that was 
deemed statistically significant.  Given that the published literature used for 
comparison was reporting on changes in gene expression throughout the 
telencephalon and at a variety of ages between E9.5 and E16.5, it is unsurprising that 
there are a number of discrepancies when compared with the results of this 
microarray experiment.  Indeed among the genes where there are discrepancies 
between the microarray data and previously published literature there are only 2 
which are directly comparable on the basis of age (Six3; Stoykova et al., 2000 and 
Sfrp2; Muzio et al., 2002).   
 
Age is not the only factor that may be contributing to the differences in the observed 
changes in expression.  As the RNA samples used for this microarray experiment 
were extracted from a small population of cells at the PSPB, changes in expression 
occurring outwith these cells will not be detected.  Expression of Six3 is mainly 
confined to postmitotic cells in the ventral telencephalon and as these cells were 
largely excluded from the microarray experiment it is unsurprising that the measured 
change in expression for this gene does not correspond with that found by Stoykova 
et al., (2000).  Normal expression of Six3 in the mantle zone of the LGE extends 
dorsally into the mantle zone of the ventral pallium in Pax6sey/sey embryos.  The use 
of RNA from samples enriched for Pax6 positive cells from the PSPB, means that the  
 157
Figure 5.13: Summary of the degree of correspondence between over-
represented themes in the up-regulated geneset using different criteria 
to define the genes of interest 
 The top row lists the over-represented themes uniquely identified when different 
criteria were used to define the genes of interest.  From left to right: All genes with a 
significant increase in expression, genes with a significant up-regulation of >1.5 fold 
and genes with a significant up-regulation of >2.0 fold.  The middle row lists over-
represented themes common to all significantly up-regulated genes and genes with an 
up-regulation of >1.5 fold (on the left) and themes common to genes with a 
significant up-regulation of either >1.5 or >2.0 fold (on the right).  The bottom row 
lists the themes found to be over-represented in the up-regulated geneset regardless 
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Figure 5.14: Summary of the degree of correspondence between over-
represented themes in the down-regulated geneset using different 
criteria to define the genes of interest 
 The top row lists the over-represented themes uniquely identified when different 
criteria were used to define the genes of interest.  From left to right: All genes with a 
significant decrease in expression, genes with a significant down-regulation of >1.5 
fold and genes with a significant down-regulation of >2.0 fold.  The middle row lists 
over-represented themes common to all significantly down-regulated genes and 
genes with a down-regulation of >1.5 fold (on the left) and themes common to genes 
with a significant down-regulation of either >1.5 or >2.0 fold (on the right).  The 
bottom row lists the themes found to be over-represented in the down-regulated 






















































 mantle zone cells showing this up-regulation of Six3 would have been largely 
excluded from the microarray analysis. 
 
The failure to detect a significant change in the expression of Sfrp2 at the PSPB is 
less easily explained.  According to the previously published data Sfrp2 expression is 
essentially abolished at the PSPB in the absence of Pax6 (Kim et al., 2001; Muzio et 
al., 2002); but microarray analysis of this region shows no down-regulation of 
expression.  It is possible however that in situ hybridization for Sfrp2 does not 
provide an accurate indication of its expression levels as data from real time RT-PCR 
analysis, described in chapter 4, suggest that the gene is much more widely expressed 
in the telencephalon than previously reported.  By real time RT-PCR, higher levels of 
Sfrp2 were detected in the dorsal telencephalon than at the PSPB, although according 
to published in situ hybridization results Sfrp2 expression is confined to the PSPB.  
Assuming these RT-PCR results are accurate, this suggests that significant amounts 
of Sfrp2 expression go undetected by in situ hybridization. 
 
It seems likely that both the tissue under investigation and the age of that tissue 
contribute to the difference in the reported change in expression of the membrane 
bound protein Odz compared to that measured at the PSPB.  In contrast to the 1.7 
fold up-regulation measured in this experiment Visel et al., (2007) reported a down-
regulation of Odz in Pax6sey/sey embryos at E15.5.  Their study, however, was focused 
on the developing cortical plate and they do not report on what is happening at the 
PSPB.  It is therefore entirely possible that Odz is up-regulated at the PSPB in 
Pax6sey/sey at E12.5 and is then down-regulated in more dorsal regions at later stages 
of development.   
 
Emx2 also shows a significant change in expression at the PSPB in the opposite 
direction to that previously reported in Pax6sey/sey embryos (Muzio et al., 2002).  At 
E11 Emx2 is up-regulated in the developing cortex; however in the wildtype Emx2 is 
only expressed at very low levels adjacent to the PSPB and when it is up-regulated in 
Pax6sey/sey embryos the region of up-regulation does not extend into the ventral 
pallium and so would not be detected in this microarray experiment.  Due to the very 
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low levels of Emx2 expression at the PSPB, any down-regulation in this region 
would be very difficult to detect by in situ hybridization. 
 
5.3.2 Comparison with results of a recently published array 
The initial most striking difference between the two sets of array data compared here 
is in the numbers of Pax6 targets identified.  The study by Holm et al., (2006) found 
only 114 genes with a change in expression of >|1.5| fold, whereas analysis of the 
Pax6 expressing cells at the PSPB identified 462 significantly regulated genes with 
that magnitude of fold change.  There are a number of potential reasons for this.  The 
two studies were carried out using different microarray platforms (Affymetrix and 
Agilent) and difficulties have been reported when comparing data across platforms 
and across laboratories (Li et al., 2002; Tan et al., 2003).  The recent MicroArray 
Quality Control (MAQC) project was a large scale study designed to accurately 
assess the reproducibility of microarray results, across both different laboratories and 
microarray platforms (MAQC Consortium, 2006).  One aspect of this project was the 
comparison of one-colour and two-colour platforms which were found to show a 
high degree of reproducibility (Patterson et al., 2006), suggesting that it is not 
unreasonable to compare microarray studies from different laboratories carried out 
using different microarray platforms. 
 
If discrepancies arising from the use of different microarray platforms are accepted 
to be small, then the differences in the number of identified target genes must be 
accounted for by other means.  One potential reason for this difference is that the 
RNA samples used in this study were from cells sorted to enrich for the Pax6 
positive population.  It is possible that many of the changes in expression seen here 
occur specifically in cells that normally express high levels of Pax6.  Such changes 
in expression would have been diluted in the study by Holm et al. due to the 
inclusion of RNA from adjacent Pax6 negative tissue and so the measured fold 
change may have fallen below the 1.5 fold cut off used.  It is also possible that cells 
in the Pax6 negative tissue may show a fold change in the opposite direction to that 
seen in Pax6 positive cells, resulting in an overall change of zero when the 
expression level is measured across the whole tissue.  The inclusion of RNA from 
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Pax6 negative tissue would also explain why some of the genes identified as 
downstream of Pax6 by Holm et al. were not identified in this study.  Genes whose 
expression level is changed in cells that would not normally express Pax6 are 
unlikely to be identified in this study as the experimental design was such that these 
cells were largely excluded from the population of interest before RNA extraction 
(see chapter 4, Fig. 4.5 and 4.6).  In spite of the differences in the two datasets there 
is still a remarkable degree of correspondence between them, strongly suggesting 
that both experiments are accurately identifying genes downstream of Pax6 
expression. 
  
Given the differences in the design of the two experiments a complete 
correspondence between the two datasets was not to be expected.  Indeed the degree 
of correspondence observed here is quite remarkable.  There were, however, a 
number of genes that showed a change in expression at the PSPB that was in the 
opposite direction to that measured by Holm et al. (2007).  Arl4 was significantly 
down-regulated 1.465 fold at the PSPB, but showed an up-regulation of almost two 
fold in the cortex.  Arl4 has recently been shown, in vitro, to have a role in cell 
adhesion through recruitment to the plasma membrane of one of the major activators 
of the cell adhesion molecule Arf6 (Hofmann et al., 2007).  Changes in cell adhesion 
have been documented in Pax6sey/sey embryos at E12.5, specifically in dorsal as 
opposed to ventral telencephalon (Stoykova et al., 1997; Tyas et al., 2003).  It is 
possible, as the PSPB is at the interface between dorsal and ventral regions, that there 
may be different changes occurring here compared with more dorsal regions.  As 
FACS was used to enrich for the Pax6 expressing population at the PSPB, and 
therefore for progenitor cells, another possibility is that the difference is due to 
different changes occurring in progenitor versus differentiating cells.  This may also 
explain the significant down-regulation of Tmem163 at the PSPB compared to the 
up-regulation seen in the cortex and the large up-regulation of Slc15a2 which was 





5.3.3 Over-represented themes in the microarray data 
The microarray data was analysed using a number of different criteria to identify 
genes of interest.  The following three groups were examined: 1) genes with a 
significant change in expression of >|1.5| fold; 2) genes with a significant fold 
change >|2.0| and 3) all genes with a statistically significant change in expression.  
These three sets of genes were analysed to identify over-represented GO terms and 
KEGG pathways.  This analysis produced very consistent results with a number of 
themes over-represented across all gene-sets.  The important role played by Pax6 in 
controlling gene expression in the developing forebrain is emphasised in the results.  
Transcription factors and their regulators make up the greatest proportion of genes in 
both the up- and down-regulated gene sets, clearly underlining the position of Pax6 
as a master regulator of transcription via the regulation of other transcription factors.  
Many of the general processes of neural development are significantly down-
regulated in the absence of Pax6 demonstrating the potent neurogenic effect of the 
gene.    
 
A variety of other themes were identified as either up- or down-regulated in the 
absence of Pax6 at the PSPB.  Some of these, such as the cell cycle and cell 
adhesion, were expected given what is already known of role of Pax6 in the 
developing telencephalon, while others provide new insights into Pax6 function.  
Some of these unexpected themes included cancer pathways, DNA repair and 
signalling and metabolic pathways, the biological significance of which are discussed 
below.  Another highly over-represented function was protein binding, but a closer 
examination of the individual genes in this group revealed that the majority of them 
were transcription factors.  As the activity of many transcription factors is regulated 
through the binding of co-factors it is not altogether surprising that a gene-set highly 
enriched in transcription factors would show an over-representation of genes 
involved in protein binding. 
 
5.3.3.1 Cell cycle 
Cell cycle processes are prominent themes in the up-regulated gene set.  This is 
consistent with the important role of Pax6 in regulating cell cycle progression in the 
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cortical ventricular zone (Warren et al., 1999; Estivill-Torrus et al., 2002; Quinn et 
al., 2007).  While alterations in the cell cycle are well documented in Pax6sey/sey, the 
data from this experiment provides the opportunity to examine more closely the 
genetic changes underlying this phenotype and if a particular stage of the cell cycle is 
affected more than others.  The up-regulated genes appear to be dispersed through all 
stages of the cell cycle as can be seen on the KEGG diagram of this pathway (Fig. 
5.15; genes in red are significantly up-regulated).  Many more genes than those 
represented in this figure are involved in the cell cycle, as many genes are not 
annotated in the KEGG database.  Combining annotations from both the KEGG and 
GO databases identifies a wide range of cell cycle related functions and processes 
over-represented among up-regulated genes. 
 
Genes such as polymerase and members of the minichromosome maintenance 
complex which are involved in DNA replication are significantly up-regulated.  
There is also an over-representation of genes with helicase function.  As helicases are 
required for unravelling the DNA double helix these genes would clearly have an 
important role to play during DNA replication.  Further evidence that Pax6 plays a 
significant role in regulating DNA replication is provided by the observed up-
regulation of genes involved in the production of the dNTPs required for this process 
(the metabolic pathway is described below).  Genes which act later in the cell cycle 
also lie downstream of Pax6.  These include genes involved in chromosome 
condensation and nucleosome assembly, with seven members of the histone cluster 
family of genes significantly up-regulated.  A number of microtubule binding 
proteins, such as Mapre1 and Nusap1, are also significantly up-regulated.  These 
genes have a role in the organisation of the mitotic spindle, the correct alignment of 
chromosomes during mitosis and in cytokinesis (Green et al., 2005; Ribbeck et al., 
2007; Raemaekers et al., 2003).   
 
Overall the data suggests that at E12.5 in Pax6sey/sey embryos, there is an increase in 
cell cycling in the region of the PSPB.  This may be caused either by an increase in 
the proportion of cells undergoing mitosis or a shortening of cell cycle length.  
Recent results published by Quinn et al., (2007) found no evidence of a shortening of 
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Figure 5.15: Diagram of genes involved in the cell cycle 
The genes involved in the different stages of the cell cycle and their interactions with 
each other, as annotated in the KEGG database, are outlined here.  Genes identified 
in this study as being significantly up-regulated in the absence of Pax6 are show in 
red.  Image taken from the website of the KEGG database (www.genome.jp/kegg). 
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Figure 5.15
the cell cycle in the neocortex of Pax6sey/sey embryos at this age.  It is possible, given 
their unique position at the boundary between dorsal and ventral telencephalon, that 
the cells analysed here respond differently, in terms of cell cycle kinetics, to a loss of 
Pax6 compared with cells located more dorsally in the developing cortex.  Given the 
large number of cell cycle related genes identified here it seems likely that many of 
them may be indirect targets of Pax6, something which cannot be determined from 
this study.  It would be interesting however, to determine how many of these genes 
are direct Pax6 targets, either by ChIP analysis or by using bioinformatics 
approaches to search for Pax6 binding sites in the regulatory sequences of these 
genes. 
 
5.3.3.2 Cancer pathways 
Pax6 has been shown to be expressed in human tumour cells derived from tumours 
of the colon and bladder (Salem et al., 2000).  Over-expression of Pax6 can also 
cause the development of pancreatic tumours in mice (Yamaoka et al., 2000). In 
spite of this evidence that Pax6 can act as an oncogene, the identification of prostate, 
pancreatic, thyroid and colorectal cancer pathways as being up-regulated in the 
developing forebrain seems at first glance to make little sense.  Indeed, if anything, 
one might expect cancer pathways to be down-regulated in the absence of functional 
Pax6.  It is important to bear in mind however that these pathways have been 
identified because a number of the genes involved in the pathways are up-regulated 
and not necessarily the pathway itself, as genes may have very different roles in 
different tissues and at different stages of development.  Indeed a closer examination 
of the actual genes involved in these cases shows that all of the genes identified as 
being part of these pathways are also part of one or more of the other pathways over-
represented among the up-regulated transcripts.  For example CyclinD1, involved in 
all the cancer pathways identified, is also involved in the cell cycle and in the Wnt 
and p53 signalling pathways.  Similarly Smad 2 and 4, involved in colorectal and 
pancreatic cancers, also have a role in the cell cycle, adherens junctions and the Wnt 
signalling pathway.  The fact that genes involved in the colorectal cancer pathway 
are over-represented in both the up- and down-regulated transcripts when all 
significantly altered genes are considered also suggests that these pathways are over-
 169
represented here through having many genes in common with other pathways which 
are regulated by Pax6. 
 
5.3.3.3 Signalling pathways 
Analysis of the microarray data on the basis of the KEGG annotations of the 
regulated genes identified the TGFβ and Wnt signalling pathways as over-
represented.  This was surprising given that there was no indication of an over-
representation of signalling molecules in the results from GO analysis.  A closer 
examination of the members of the Wnt signalling pathway which are up-regulated 
in Pax6sey/sey reveals that the genes in question are, for the most part, localised to the 
nucleus and are not, in themselves, signalling molecules.  Of the seven genes in this 
pathway that are up-regulated by >1.5 fold four of them, Smad1 and 2 and CyclinD1 
and 2, have a role in cell cycle regulation.  This suggests that the identified up-
regulation of the Wnt signalling pathway may be an artefact of more general changes 
in the expression of cell cycle regulators.  Alternatively, given that inhibitors of Wnt 
signalling have been shown to be down-regulated in the Pax6sey/sey (Kim et al., 2001; 
Muzio et al., 2002) it may be that the cell cycle changes seen in these embryos are 
due, in part at least, to an increase in Wnt signalling. 
  
The down-regulation of members of the TGFß signalling pathway was not 
unexpected as Pax6 has been shown to be downstream of the BMP family of TGFß 
signalling molecules (Timmer et al., 2002).  It is surprising however that TGFß2 and 
BMP receptor type 1b are themselves significantly downregulated in Pax6sey/sey 
suggesting that there may be a feedback loop between Pax6 and this signalling 
pathway. 
 
5.3.3.4 Metabolic pathways 
The data presented here identifies two metabolic pathways as being over-represented 
among genes up-regulated at the PSPB in the absence of Pax6.  Taurine and 
hypotaurine metabolism is over-represented among genes with a >1.5 fold increase 
in expression in Pax6sey/sey.  Taurine is the most abundant amino acid in the 
mammalian brain and hypotaurine is an intermediary product of taurine biosynthesis; 
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cysteine is converted first to cysteine sulfinic acid (CSA) then to hypotaurine and 
finally to taurine (for review see Dominy et al., 2004).  Two enzymes have been 
isolated from brain tissue that can catalyse the conversion of CSA to hypotaurine – 
glutamic acid decarboxylase (Gad) and cysteine sulfinic acid decarboxylase (Csad).  
In vitro investigations of Gad activity, however, reveal that it has a very low affinity 
for CSA and only efficiently converts CSA to hypotaurine when CSA is present at 
much higher concentrations than are normally found in vivo; its catalysis of this 
reaction is also inhibited in the presence of glutamic acid for which Gad has a much 
higher affinity (Tappaz et al., 1992).   
 
The members of the taurine and hypotaurine metabolic pathway found to be up-
regulated in this study were Gad1 and 2.  Given that Gad is not thought to be 
important for normal physiological taurine biosynthesis it seems likely that these 
genes are up-regulated for other reasons.  Given the increase in interneuron migration 
to the cortex in Pax6sey/sey it is likely that their role in the production of gamma amino 
butyric acid is more important here.  If this pathway was truly up-regulated in 
response to a loss of Pax6 then other members of the pathway might be expected to 
show a trend towards up-regulation, even if this did not reach statistical significance.  
Upon investigation however, other enzymes in the pathway were found to show a 
trend in the opposite direction.  Cysteine dioxygenase, which catalyses the 
conversion of cysteine to CSA, was slightly down-regulated (fold change = -1.238; 
adjusted p-value=0.096), and Csad also showed a decrease in expression which was 
approaching significance (fold change = -1.712; adjusted p-value=0.058).  Given 
this, it seems highly unlikely that Pax6 plays a role in regulating the taurine and 
hypotaurine metabolic pathway. 
 
The second metabolic pathway identified as over-represented in the up-regulated 
gene-set is “one carbon pool by folate”.  This pathway provides the one-carbon 
groups critical for the de novo synthesis of purines and pyrimidines.  It is important 
in the regulation of cellular dNTP levels and therefore in DNA synthesis and cell 
cycle progression.  Cells grown in the absence of folate, the substrate of this 
pathway, show a decrease in intercellular pools of nucleotides and this was 
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associated with a delay in cell cycle progression (James et al., 1993).  Given the 
degree of up-regulation of the cell cycle processes in the array data it is perhaps 
unsurprising that the metabolic process required to provide the raw materials for 
DNA replication is also up-regulated.  Four key enzymes in this pathway are 
significantly up-regulated in Pax6sey/sey, two of them with a fold change greater than 
1.5, suggesting that this may represent an important mode of cell cycle regulation for 
Pax6.  The significant up-regulation of a number of genes coding for enzymes with 
cyclase activity also supports a role for Pax6 in regulating cellular levels of dNTPs. 
 
5.3.3.5 Themes unrelated to telencephalic development 
A number of themes were identified as over-represented that are entirely unrelated to 
telencephalic development.  When a fold change of >|2.0| is used to identify genes of 
interest, inner ear morphogenesis is over-represented in the up-regulated gene-set, 
while hindbrain development is over-represented among down-regulated genes.  The 
identification of hindbrain development is not particularly surprising as a) many 
genes involved in forebrain development might reasonably be expected to have a role 
in the development of other parts of the brain and b) Pax6 is expressed in the 
hindbrain and may regulate the expression of a similar set of genes in this region.  
Indeed the two genes in this group are Ngn1 and Tbr1, both of which have well 
established roles in forebrain development.   
 
The three genes identified as playing a part in inner ear morphogenesis are all 
transcription factors and are present in many of the other over-represented groups.  
As a given transcription factor can be involved in the development of a range of 
tissues it is easy to understand how the type of analysis used here might result in the 
identification of certain terms as over-represented where the over-representation is 
simply an artefact of the type of genes being investigated.  This would also explain 
why the ovulation cycle was over-represented in the down-regulated gene-set when 
all significantly regulated genes were considered.  The genes in this group, Nhlh2 




5.3.4 A closer look at some genes whose regulation by Pax6 may be 
particularly relevant at the PSPB 
While a number of genes identified in this study have previously been reported to 
show alterations in expression in the absence of Pax6, many novel Pax6 targets have 
also been identified.  Some of these genes are reported to be involved in processes 
like interneuron migration and axon guidance, which are severely disrupted in 
Pax6sey/sey embryos.  Therefore they could potentially provide interesting insights into 
the role of Pax6 at the PSPB.  Among these is doublecortin-like kinase (Dclk), a 
microtubule associated protein that has been shown to be involved in the radial 
migration of cortical neurons (Deuel et al., 2006; Koizumi et al., 2006) and in 
cortical interneuron migration (Fricourt et al., 2007).  Inactivation of Dclk, by RNA 
interference in brain slices, causes a delay in the migration of interneurons from the 
ganglionic eminences and fewer calbindin positive interneurons reach the cortex of 
Dclk-/- mice (Friocourt et al., 2007). 
 
Given this phenotype it is surprising that Dclk is down-regulated in this study, as 
Pax6sey/sey mice have been shown to have an increase in the number of interneurons 
migrating to the cortex (Chapouton et al., 1999).  One possible explanation for this 
would be that different subtypes of interneurons are affected differently in Pax6sey/sey 
embryos with some subtypes showing a decrease in migration and others showing a 
large increase, resulting in an overall increase in the total number of cortical 
interneurons.  A delay in the migration of calbindin positive interneurons in Pax6 
mutant mice has also been reported (Jiménez et al., 2002).  This study found that at 
E13 calbindin positive cells were completely absent from the developing cortex of 
Pax6sey/sey embryos, but that by E16 numbers had recovered to levels seen in 
wildtype controls.  This finding would be consistent with the Dclk-/- phenotype 
described by Friocourt et al. (2007). 
 
Lhx6, the gene with the largest up-regulation is this study, is normally expressed in 
the MGE and in interneurons where it is essential for their normal migration from the 
ganglionic eminences to the cortex (Alifragis et al., 2004; Liodis et al., 2007).  
Although its up-regulation here could be due to the presence of more migrating 
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interneurons in the vicinity of the PSPB in Pax6sey/sey this seems unlikely because a) 
at E12.5 interneurons are only beginning to reach the PSPB and enter the cortex and 
b) interneurons would not be expressing GFP and so would have been excluded from 
the experiment during cell sorting.  A study by Kroll and O’Leary (2005) suggests 
that dorsal telencephalic progenitors ectopically expressing ventral marker genes in 
Pax6sey/sey produce interneurons characteristic of the LGE.  Although they found no 
evidence that Lhx6 expressing interneurons, characteristic of the MGE, were being 
produced by these cells, even a very small number of Lhx6 positive cells could cause 
Lhx6 expression to appear up-regulated on the microarray given the absence of Lhx6 
expression in this area in the wildtype. 
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Chapter 6 – Validation of Candidate Pax6 Target Genes 
Identified by Microarray
6.1 Introduction 
It is important to validate the accuracy of microarray data, particularly when the 
number of biological replicates in an experiment is small as this makes statistical 
analysis of the data less robust.  Validation steps allow the identification of genes for 
which a significant change in expression was measured due to artefact.  These genes 
can then be eliminated from further investigation.  There are a variety of ways in 
which validation can be carried out.  The overall performance of an array study can 
be validated by comparison with previously published literature to determine if genes 
known to show a change in expression in the condition under investigation have been 
successfully identified.  Experimental validation of the gene expression 
measurements can also be carried out.  In situ hybridization can provide useful 
information about the spatial expression pattern of a gene of interest and may also 
confirm large changes in expression levels.  As it is not a quantitative technique 
however, small changes in expression levels may go undetected.  The failure of in 
situ hybridization to confirm a change in expression identified by microarray is 
therefore not evidence that the change in question is due to artefact and would need 
to be supported by experiments using more quantitative techniques.  The most 
common quantitative methods used for validation of microarray data are real time 




The delays encountered in generating the RNA samples for the microarray 
experiment meant that the amount of validation that could be carried out was limited 
due to time constraints.  Validation of the performance of the microarray experiment 
by comparison with the literature on Pax6 was carried out and is described in the 
previous chapter.  Experimental verification by in situ hybridization of a small 
number of genes, showing large changes in expression in Pax6sey/sey compared to 
wildtype, is described here. 
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Figure 6.1: Ngn2 expression 
In situ hybridization for Ngn2 expression in the telencephalon of Pax6+/+ (A and B) 
and Pax6sey/sey (C and D) embryos at E12.5 is shown.  B and D are high power 
images of the boxed areas in A and C respectively.  Ngn2 is widely expressed in the 
diencephalon and in the VZ of the dorsal telencephalon in wildtype where it has a 
sharp boundary of expression at the PSPB (dashed red line in B).  In Pax6sey/sey Ngn2 
expression is retracted away from the PSPB – note the distance between the dashed 
red line indicating the normal extent of Ngn2 expression and the dashed blue line 
indicating its new expression boundary in D.  Ctx, cortex; di, diencephalon; lge, 














Ngn2 was the most highly down-regulated gene on the microarray with a fold change 
of –10.241 (adjusted p-value=0.014).  In situ hybridization analysis of Ngn2 
expression in coronal sections at E12.5 confirms this down-regulation at the PSPB 
(Fig. 6.1).  In the wildtype Ngn2 can be seen to be widely expressed in the VZ of the 
dorsal telencephalon with a sharp boundary of expression at the PSPB (Fig. 6.1 A 
and B).  In contrast in Pax6sey/sey, expression of Ngn2 is retracted dorsally away from 
the PSPB (Fig. 6.1 C and D).  Ngn2 is also expressed at lower levels in the dorsal 
telencephalon of Pax6sey/sey compared with wildtype. 
 
6.2.2 Lhx6 
The gene with the greatest up-regulation in expression on the microarray was Lhx6 
with a fold change of 15.439 (adjusted p-value=0.008).  This change can also be seen 
by in situ hybridization (Fig 6.2).  Lhx6 is normally expressed in postmitotic cells of 
the MGE and in the interneurons migrating from this tissue to the cortex (Alifragis et 
al., 2004; Liodis et al., 2007).  It is not normally expressed in the region of the PSPB, 
except where it is present in interneurons crossing the boundary en route to the 
cortex.  This pattern of expression can be clearly seen by in situ hybridization (Fig. 
6.2 A-C).  The level of expression of Lhx6 in the MGE of Pax6sey/sey embryos can be 
seen to be much higher than in the wildtype and expression can also be seen 
extending into the LGE (Fig. 6.2 D).  A number of very strongly labelled cells can be 
seen in that part of the tissue that would have been included in the dissection of the 
PSPB (arrows in Fig. 6.2 E and F). 
 
6.2.3 Gsh2 
Gsh2 was another gene that was significantly up-regulated at the PSPB (fold 
change=2.906; adjusted p-value=0.012).  Validation by in situ hybridization confirms 
this up-regulation of expression (Fig. 6.3).  Ectopic expression of Gsh2 dorsal to its 
normal boundary of expression at the PSPB can also be seen in Pax6sey/sey embryos.  
Gsh2 is normally expressed throughout the VZ of the MGE and LGE, with a sharp 
boundary at the PSPB (dashed red line in Fig. 6.3 B).  In the absence of Pax6, Gsh2 
expression is up-regulated throughout its normal telencephalic expression domain  
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Figure 6.2: Lhx6 expression 
In situ hybridization for Lhx6 expression in the telencephalon of Pax6+/+ (A-C) and 
Pax6sey/sey (D-F) embryos at E12.5 is shown.  The labelled boxed areas in A and D 
correspond to the areas shown in B, C, E and F.  In Pax6+/+ Lhx6 is expressed in 
post-mitotic cells of the MGE (A) and is absent from the region of the PSPB (B and 
C).  In Pax6sey/sey Lhx6 can be seen to be expressed at much higher levels in the MGE 
(D).  Many Lhx6 positive cells can also be seen in the LGE (D).  A number of 
strongly labelled cells are present at the ventral extremity of the PSPB (arrows in E 
and F).  Ctx, cortex; lge, lateral ganglionic eminence; mge, medial ganglionic 




















Figure 6.3: Gsh2 expression 
In situ hybridization for Gsh2 expression in the telencephalon of Pax6+/+ (A and B) 
and Pax6sey/sey (C and D) embryos at E12.5 is shown.  B and D are high power 
images of the boxed areas in A and C respectively.   In Pax6+/+ Gsh2 is expressed in 
the VZ of the medial and lateral ganglionic eminences (A) and has a sharp 
expression boundary at the PSPB (dashed red line in B).  By comparison VZ cells of 
the ganglionic eminences express Gsh2 at much higher levels in Pax6sey/sey (C).  
Ectopic expression of Gsh2 can also be seen in Pax6sey/sey embryos, with strongly 
labelled cells located dorsal to its normal boundary of expression (dashed red line in 
D).  The new expression boundary is indicated by the dashed blue line.  Ctx, cortex; 
lge, lateral ganglionic eminence; mge, medial ganglionic eminence.  Scale bars: 
100µm in A and C; 50µm in B and D 
 181
Figure 6.3











and is also ectopically expressed at high levels in VZ cells on the dorsal side of the 
PSPB (Fig. 6.3 C and D). 
 
6.3 Discussion 
The data presented here confirms the changes in expression of Ngn2 and Gsh2 
measured by microarray at the PSPB in Pax6sey/sey compared to wildtype embryos.  
The down-regulation of Ngn2, and the dorsal retraction of its boundary of expression 
away from the PSPB in Pax6sey/sey embryos, is well documented (Toresson et al., 
2000; Stoykova et al., 2000; Yun et al., 2001; Heins et al., 2002; Stenman et al., 
2003).  The up-regulation of Gsh2 and the expansion of its area of expression to 
include more dorsal regions in the absence of functional Pax6 are also in accordance 
with previously published data (Toresson et al., 2000; Yun et al., 2001; Stenman et 
al., 2003).   
 
While levels of Lhx6 have been reported to be increased in Pax6sey/sey embryos 
(Stoykova et al., 2000), that increase was not seen at the PSPB but in the MGE and 
extending into the LGE.  Cells from the MGE would have been excluded from the 
samples investigated by microarray and so any increase in expression in these cells 
could not have been identified.  The results shown here suggest that the large 
increase in Lhx6 measured on the microarray is due to a small number of cells, 
expressing the gene at very high levels and located sufficiently close to the PSPB to 
have been included in the dissection.  As Lhx6 is not normally expressed in this 
region, the presence of even a few highly expressing cells in the sample would be 
sufficient to give a large fold change measurement. 
 
These Lhx6-positive cells labelled close to the PSPB in Pax6sey/sey embryos lie in a 
region where the number of Pax6 expressing cells is relatively small.  It is important 
to determine if these cells do co-express Pax6 and Lhx6.  Double in situ 
hybridization for Pax6 and Lhx6 expression would allow confirmation that the Lhx6 
positive cells in this region also express Pax6.  If this does not prove to be the case a 
possible explanation for the failure to remove these cells from the microarray 
samples during sorting could be the imperfect correlation between Pax6 and GFP 
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expression seen in the ventral telencephalon and described in chapter 3.  Indeed 
analysis of Pax6 expression in cells sorted by FACS demonstrates that not all of the 
strongly GFP-positive cells, isolated by FACS for analysis by microarray, express 
Pax6, although they may have expressed it previously (Chapter 4, Fig. 4.6). 
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Chapter 7 – Discussion and Future Work 
7.1 Review of the preceding chapters 
This thesis has described the validation of the DTy54 mouse line, a transgenic 
reporter line designed for the investigation of the role of Pax6 during development.  
The GFP-reporter system has been shown here to accurately report the majority of 
Pax6 expression, although there are some discrepancies between Pax6 and GFP 
expression patterns, particularly at later stages of development, and it is important to 
consider these differences carefully when designing experiments using DTy54+ 
animals.  Two main issues, as described in chapter 3, were identified.  Firstly, in 
some cells the protein half-life for tauGFP appears to be longer than for Pax6.  This 
is most clearly seen in the cortex at E15.5.  Secondly, there appears to be a difference 
in the regulation of expression from the transgene compared with the endogenous 
Pax6 locus when Pax6 is expressed in post-mitotic cells, as seen in the thalamus and 
ventral telencephalon. 
 
The successful use of DTy54+ animals to investigate the role of Pax6 at the PSPB is 
described in chapters 4 and 5.  TauGFP expression allowed the accurate dissection of 
the PSPB and the subsequent enrichment for the Pax6 expressing population of cells 
in this region by FACS.  Microarray analysis of RNA extracted from these cells, 
isolated from Pax6+/+.DTy54+ and Pax6sey/sey.DTy54+ embryos at E12.5, allowed the 
identification of genes that lie downstream of Pax6 expression in this region of the 
telencephalon.  Validation of the changes in gene expression that occur in the 
absence of functional Pax6, measured by microarray, for Ngn2, Gsh2, and Lhx6 is 
described in chapter 6.  In situ hybridization confirms the large down-regulation of 
Ngn2 at the PSPB and the up-regulation of Gsh2 and Lhx6. 
 
Unfortunately, due to time constraints, I was unable to carry out a thorough 
validation of the microarray data.  Work is currently being carried out by others to 
complete the validation experiments both by examining a larger number of candidate 
genes by in situ hybridization and by measuring the levels of expression of these 
genes at the PSPB by real time RT-PCR.  These steps are particularly important 
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given the small number of biological replicates used for the microarray experiment 
(n=3 for each condition). 
 
7.2 The role of Pax6 at the PSPB 
It is clear from the analysis of the genes that show a change in their expression at the 
PSPB in response to a loss of functional Pax6 that Pax6 plays a variety of important 
roles in the development of this region of the telencephalon.  An outline of the 
processes and molecular pathways influenced by Pax6 expression is shown in figure 
7.1.  Some of the Pax6-regulated genes involved in these processes and their possible 
significance in terms of the development of the PSPB are discussed in detail below. 
 
7.2.1 Neurogenesis 
Pax6 is a strong promoter of neurogenesis and so the down regulation of this process 
in the absence of functional Pax6 is unsurprising.  The action of Pax6 in 
neurogenesis is mediated through a variety of transcription factors and their 
regulators.  These genes are significantly over-represented in the down-regulated set 
of genes.  Many of these transcription factors, including Ngn2, Neurod1, Neurod2 
and Neurod6, have been shown to be involved in nervous system development and in 
cell, and more specifically neuron, differentiation.  Neurod1 and Neurod2 can cause 
premature differentiation of neuronal precursors when ectopically expressed in 
Xenopus embryos (Lee et al., 1995; McCormick et al., 1996).  In these embryos 
Neurod1 and 2 are also capable of converting ectoderm cells into neurons.  Neurod1, 
2, and 6 are expressed in highly overlapping patterns in the developing CNS of rats 
(Schwab et al., 1998).  Analysis of Neurod6-/- mice however shows no obvious 
defects in neruonal development suggesting that Neurod6 function may be largely 
compensated for by Neurod1 and 2 (Schwab et al., 1998).   
 
Neurod1 has been shown to be required for the normal differentiation of granule cells 
in the cerebellum and hippocampus with these cells severely depleted in the absence 
of Neurod1 (Miyata et al., 1999).  Mice lacking both Neurod1 and Neurod6 show a 
more severe hippocampal phenotype and although granule cell precursors are 
produced in these mice, these cells fail to undergo terminal differentiation (Schwab  
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Figure 7.1: Summary of the roles of Pax6 at the PSPB 
Pax6-regulated processes at the PSPB are outlined.  Genes involved in the processes 
circled in red are over-represented among the genes down-regulated in response to a 
loss of Pax6 at the PSPB.  Processes circled in blue on the other hand are over-
represented in the set of genes up-regulated at the PSPB when Pax6 is lost.  Dashed 
arrows indicate processes whose alteration may mediate, at least in part, the effect 

















et al., 2000).  Neurod2-/- mice develop normally until about postnatal day 14 (P14; 
Olson et al., 2001).  Analysis of Neurod2-/- mice aged between P14 and P21 found 
that brain areas where Neurod2 is normally expressed showed higher rates of 
apoptosis and were smaller than in wildtype controls.  The cerebella of these mutants 
also showed a decrease in expression of genes that support the survival of granule 
cells (Olson et al., 2001).  It is possible that many of the neurogenic roles of Pax6 are 
mediated by Ngn2 as the expression of Neurod family members has been shown to 
lie downstream of Ngn2 expression (Mattar et al., 2008). 
  
7.2.2 Cell cycle 
A range of processes involved in all aspects of the cell cycle are significantly over-
represented in the genes up-regulated at the PSPB in Pax6sey/sey embryos.  Genes 
involved in everything from DNA replication to chromosome condensation and the 
formation of the mitotic spindle are all present.  It seems clear from the microarray 
data that the cell cycle is highly up-regulated at the PSPB in response to the loss of 
Pax6.  Given that there is a concurrent down-regulation of genes with a role in 
differentiation it is likely that the dividing cells are undergoing self-renewal rather 
than dividing to produce neurons.  An analysis of cell cycle kinetics in the E12.5 
cortex by Quinn et al., (2007) found no difference between wildtype and Pax6sey/sey 
embryos.  This suggests that the up-regulation of cell cycle genes found in this study 
may be unique to the cells of the PSPB.   Measurement of the cell cycle kinetics 
specifically at this boundary region would help clarify this. 
 
7.2.2.1 Metabolic pathways 
The over-representation of genes in the metabolic pathway “one carbon pool by 
folate”, which is essential for the synthesis of the purines and pyrimidines necessary 
for DNA replication, identifies a novel mechanism by which Pax6 may influence cell 
cycle kinetics.  If Pax6 normally represses the expression enzymes required in this 
pathway then DNA replication and hence cell division will be limited due to a 




7.2.2.2 Wnt signalling 
Analysis of the genes involved in the Wnt signalling pathway that are up-regulated at 
the PSPB in the absence of Pax6 suggests that this pathway may provide another 
means by which Pax6 can regulate the cell cycle.  Of the nine significantly up-
regulated genes in this pathway, six of them have a role in the cell cycle (Fig. 7.2).  
Genes common to both the Wnt signalling pathway and the cell cycle also show 
large changes in their level of expression in Pax6sey/sey embryos with Smad2, Lef1, 
CyclinD1 and CyclinD2 all having fold changes greater than 2. 
 
7.2.3 Axon guidance and cell migration 
Members of the key axon guidance gene families are represented in the down-
regulated geneset, including 2 Eph receptors (EphA3and A7), 4 members of the 
semaphorin family (Sema5A, 6A, 6D and 3G), Cxcl12, PlexinA4 and Robo2.  
Semaphorins comprise a large family of both secreted and transmembrane guidance 
molecules.  Of the semaphorins that are down-regulated at the PSPB in the absence 
of Pax6, three code for transmembrane proteins while the fourth, Sema3G, produces 
a secreted molecule.  Only one of the semaphorins identified in this experiment, 
Sema5A, has previously been reported to be down-regulated in Pax6sey/sey embryos 
(Jones et al., 2002).  The down-regulation of PlexinA4 is also interesting in the 
context of this family of guidance molecules as it has been shown to mediate 
signalling by both secreted and transmembrane semaphorins (Suto et al., 2005). 
 
It is possible that some of these axon guidance molecules also play a role in the 
guidance of neuron migration.  Cxcl12, for example, has been demonstrated to have a 
role in guiding migrating interneurons to their correct locations in the cortex 
(Tiveron et al., 2006; Li et al., 2008).  Sema6A has also been shown to have a role in 
migration during development of the cerebellum where it initiates the radial 
migration of granule cells (Kerjan et al., 2005).  The behaviour of cerebellar granule 
cells is altered in Pax6sey/sey embryos (Swanson et al., 2005) so it is possible that this 
phenotype is mediated in part by Pax6 regulation of Sema6A.  
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Figure 7.2: Diagram of genes involved in the Wnt signalling pathway 
The genes involved in the Wnt signalling pathway and their interactions with each 
other, as annotated in the KEGG database, are outlined here.  Genes identified in this 
study as being significantly up-regulated in the absence of Pax6 are show in red.  
Image taken from the website of the KEGG database (www.genome.jp/kegg). 
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Figure 7.2
The down-regulation of semaphorins at the PSPB, whose expression in the 
developing telencephalon is as yet unreported, provides new insights into how Pax6 
may be regulating axon guidance in this region.  A detailed analysis of the expression 
patterns of these genes in the telencephalon of both wildtype and Pax6sey/sey embryos 
is clearly warranted.  Knowing how the expression of these genes changes in the 
absence of Pax6 will hopefully allow a deeper understanding of both the normal 
development of the axonal tracts of the forebrain and how this development can be 
disrupted.  An investigation of the expression of the semaphorin receptor PlexinA4 
would also be useful in achieving this aim.   
 
Pax6 is important in regulating both the radial migration of neurons to the cortical 
plate and the tangential migration of interneurons from the ganglionic eminences to 
the cortex (Schmahl et al., 1993; Carić et al., 1997; Chapouton et al., 1999).  An 
increase in the number of interneurons crossing the PSPB to enter the cortex in the 
absence of Pax6 has been reported (Chapouton et al., 1999).  Given this, one might 
expect to see an increase in the levels of expression of genes involved in migration in 
Pax6sey/sey embryos rather than the decrease measured in this study.  It is possible, 
however, that as interneurons migrate in the intermediate and marginal zones to 
reach their final destinations that the genes guiding this migration were not identified 
in this study as the majority of post-mitotic cells were excluded from the population 
under investigation.  There is also convincing evidence to suggest that the increase in 
the number of interneurons seen in Pax6sey/sey is due not to an increase in migration 
but to a respecification of progenitor cells at the PSPB to a more ventral fate 
resulting in the ectopic production of interneurons (Kroll and O’Leary, 2005).  It 
seems likely therefore that the genes involved in migration that are down-regulated 
here may regulate either radial migration or the migration of cells from the PSPB to 
the amygdala along the lateral cortical stream (Carney et al., 2006). 
 
In spite of the confusion as to which cells are being affected in terms of migration by 
the changes in gene expression measured at the PSPB, this study does identify novel 
genes through which Pax6 regulation of migration may be mediated.  
Cholecystokinin (Cck) and cholecystokinin A receptor (Cckar) were perhaps the most 
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surprising genes to be identified.  Although there is a large body of literature on the 
role of Cck in the regulation of the neuroendocrine system and the regulation of food 
intake (for review see Chandra and Liddle, 2007; Valassi et al., 2008), knowledge 
about its role during embryonic development of the forebrain is much more limited.  
A role for Cck and Cckar in the migration of gonadotrophin-releasing hormone-1 
neurons has been reported (Giacobini et al., 2004), however the expression of these 
genes in an area other than the neuroendocrine system suggests they may have a 
more general role in the regulation of migration during development and it would be 
interesting to investigate this further. 
 
The zinc finger gene Fezf1 is also down-regulated at the PSPB in response to a loss 
of Pax6 and has been shown to have a role in both migration and axon guidance in 
the developing brain (Hirata et al., 2004; 2006a; Chen et al., 2005). Fezf1 
homozygous mutants produce fewer thalamocortical axons and these do not project 
normally to the cortex (Hirata et al., 2004).  The projections from layer 5 cortical 
neurons also display axon targeting defects in these mice (Chen et al., 2005), while 
in the developing olfactory bulbs defects in both axonal projections and the 
migration of interneuron precursors have been observed (Hirata et al., 2006a). A role 
for Fezf1 in boundary formation has also been demonstrated in the diencephalon 
where it helps to establish the zona limitans intrathalamica (Hirata et al., 2006b).  As 
the PSPB fails to form correctly in Pax6sey/sey embryos the identification of genes 
with a previously reported role in boundary formation warrants further investigation.  
Given its variety of roles in telencephalic development it is likely that the loss Fezf1 
may contribute to a number of aspects of the PSPB phenotype seen in Pax6sey/sey 
embryos. 
 
7.2.3.1 Cell adhesion 
It is possible that the up-regulation of genes with a role in the formation of adherens 
junctions and focal adhesions may contribute to the axon guidance phenotype seen in 
Pax6sey/sey embryos.  Cells that form tighter intercellular connections may be more 
tightly packed and this could create a less permissive environment for axons to 
navigate through.  Indeed the cells of the PSPB have been reported to be more tightly 
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packed in Pax6sey/sey compared to wildtype embryos at E15.5 and E18.5 (Jones et al., 
2002). 
 
7.2.4 Framework for Pax6 Function at the PSPB 
The importance of maintaining the correct spatio-temoporal expression pattern of 
Pax6 for the normal development of the telencephalon has been well established 
(Schmahl et al., 1993; Carić et al., 1997; Götz et al., 1998; Estivill-Torrus et al., 
2002; Manuel et al., 2007; Quinn et al., 2007).  During cortical neurogenesis Pax6 
helps to regulate the cell cycle kinetics of the cortical progenitor cells in which it is 
expressed, and these are altered by changes in the levels of Pax6 (Estivill-Torrus et 
al., 2002; Manuel et al., 2007; Quinn et al., 2007).  The orderly radial migration of 
newly born neurons also relies on Pax6 to maintain the normal morphology of the 
radial glial cells which guide the movement of these neurons to their correct 
locations in the cortical plate (Anton et al., 1996; Carić et al., 1997; Götz et al., 
1998).  At the PSPB Pax6 has been shown to act with Gsh2 in a cross-repressive 
manner to establish a sharp boundary of gene expression separating the very different 
histogenetic fields of the dorsal and ventral telencephalon (Toresson et al., 2000; 
Yun et al., 2001; Carney et al., 2009).  The breakdown of the regulation of axon 
guidance and cell migration has also been demonstrated at the PSPB in Pax6sey/sey 
embryos (Chapouton et al., 1999; Pratt et al., 2000; Hevner et al., 2002; Jones et al., 
2002; Carney et al., 2006).  The microarray data presented in this thesis provides 
further evidence to support these roles for Pax6 during neurogenesis while adding to 
the current body of literature by identifying novel targets for the Pax6 regulation of 
these complicated processes.  The role of Pax6 as a high level transcription factor 
that acts via the regulation of a wide range of other transcription factors is also 
demonstrated by the large numbers of transcription factors present in both the up- 
and down-regulated gene sets. 
 
An analysis of the microarray data generated in this study suggests that, at the PSPB, 
the predominant role of Pax6 is to promote exit from the cell cycle and 
differentiation along a neural lineage.  The loss of functional Pax6 results in massive 
up-regulation of genes involved in all aspects of the cell cycle with a concurrent 
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down-regulation of markers of differentiation and neurogenesis (a small subset of the 
cell cycle genes affected are shown in Fig. 5.15).  This indicates that progenitor cells 
at the PSPB may continue to undergo self-renewal when they lack the neurogenic 
stimulus provided by Pax6 expression.  Further support of this is provided by the 
observed down-regulation of markers of the SVZ and early cortical plate such as 
Tbr2, Neurod6 and Lhx9 suggesting that there is an absence/reduction of progression 
of differentiation from VZ to SVZ and hence to a cortical plate identity when 
functional Pax6 is lost in these cells.  As there is convincing evidence that the cell 
cycle kinetics of progenitor cells in the dorsal pallium of Pax6sey/sey embryos are 
unaltered at E12.5 (Quinn et al., 2007), it is likely that this represents an action of 
Pax6 that is specific to the distinct set of progenitors located adjacent to the PSPB at 
this stage. 
 
It is clear from the significant changes in the expression of genes involved in axon 
guidance and cell migration that Pax6 also contributes to the specialised nature of the 
PSPB as an important developmental boundary across which movement is tightly 
regulated.  Both these developmental processes are over-represented in the down-
regulated gene set.  The concurrent over-representation of genes with a role in 
regulating cell adhesion in the up-regulated gene set is also of note in this context as 
the level of adhesion between cells can be important in providing a permissive 
environment through which to migrate/navigate.   As this data was collected from 
E12.5 embryos it is likely that the contribution of guidance molecules is not as large 
as it might be at later stages as at this age interneurons are only beginning to cross 
the PSPB and the majority of axons have yet to reach the boundary.  The over-
representation of these biological processes at this early stage emphasise the 
important role played by Pax6 in establishing the functional as well and the gene 
expression components of the PSPB.  The down-regulation of genes involved in cell 
migration may also be contributed to by the reduction in differentiation to a neural 
fate with a concurrent decrease in migration away from the VZ towards the pial 
surface.   
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The data presented here demonstrates that Pax6 is involved in a number of important 
processes at the PSPB.  It seems likely however that at E12.5 the key role for Pax6 in 
this region is to maintain the progression of VZ cells from self-renewal to the 
production of cells of a neural lineage by promoting cell cycle exit and neurogenesis. 
 
7.3 Conclusion 
This study has identified a number of novel Pax6 target genes whose expression is 
altered at the PSPB in response to a loss of functional Pax6.  The roles of these genes 
are such that they are likely to contribute to the PSPB phenotype seen in Pax6sey/sey 
embryos.  Further analysis of these genes will help to elucidate how Pax6 functions 
in establishing this important developmental boundary and how defects in the 
formation of the PSPB contribute to the errors in axon guidance and migration that 
are prominent components of the Sey phenotype.  
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 Up-regulated Genes  Appendix A   
 
Gene Fold Change p-value
Adjusted  
 p-value
    Lhx6 15.439 5.82E-06 0.008 
    Smad2 9.677 4.26E-05 0.014 
    Titf1 7.406 1.02E-06 0.005 
    Mpped2 7.186 3.93E-05 0.014 
    Gpr177 5.060 4.51E-06 0.007 
    Btbd9 4.658 1.84E-05 0.012 
    Asb4 4.502 7.89E-07 0.004 
    Rbbp4 4.146 1.66E-04 0.025 
    Calb1 3.614 8.34E-05 0.018 
    Lhx8 3.538 4.55E-05 0.014 
    Ube2s 3.006 8.41E-04 0.045 
    Nkx6-2 2.910 3.02E-07 0.004 
    Gsh2 2.906 1.75E-05 0.012 
    Ascl1 2.888 2.22E-05 0.012 
    Arfl4 2.729 3.36E-06 0.007 
    B230215L15Rik 2.725 1.38E-04 0.023 
    Dlx1 2.715 3.35E-05 0.013 
    MGC73635 2.709 2.27E-05 0.012 
    Fxc1 2.623 8.08E-07 0.004 
    Hist1h1e 2.621 4.52E-05 0.014 
    Hnrpa0 2.601 5.70E-04 0.039 
    Dek 2.548 2.84E-04 0.030 
    Ube2s 2.548 7.86E-04 0.044 
    Peg3 2.536 2.19E-04 0.028 
    Chmp4b 2.533 4.02E-05 0.014 
    Glcci1 2.527 3.96E-06 0.007 
    Raly 2.491 1.47E-04 0.024 
    Glcci1 2.465 5.18E-05 0.015 
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    2810417H13Rik 2.459 1.60E-04 0.024 
    BC059842 2.457 2.96E-06 0.007 
    Dlx2 2.454 4.80E-05 0.014 
    Mpped2 2.431 4.08E-05 0.014 
    Hnrpa0 2.418 2.27E-05 0.012 
    Atbf1 2.396 7.58E-04 0.043 
    Zic3 2.385 3.67E-05 0.014 
    5830457O10Rik 2.360 7.51E-05 0.017 
    Uhrf1 2.357 2.91E-04 0.031 
    Ccnd2 2.351 7.68E-04 0.044 
    Prrx1 2.349 2.34E-05 0.012 
    Sox2 2.319 8.40E-04 0.045 
    Dlx6os1 2.289 8.58E-04 0.045 
    Ccnd1 2.279 1.26E-04 0.022 
    Taf15 2.237 8.24E-05 0.018 
    Mcm6 2.227 2.53E-04 0.029 
    Hist1h4d 2.202 2.48E-04 0.029 
    Rac1 2.197 3.42E-04 0.032 
    Igf1r 2.147 7.57E-05 0.017 
    Lxn 2.146 7.47E-05 0.017 
    Lef1 2.145 6.18E-05 0.017 
    Tmem123 2.136 4.56E-05 0.014 
    Mki67 2.134 1.40E-04 0.023 
    Gad2 2.120 4.45E-04 0.036 
    Actb 2.114 3.62E-04 0.032 
    Lmnb1 2.104 4.28E-04 0.035 
    Hist1h2ak 2.096 7.28E-04 0.043 
    Lsr 2.095 3.12E-04 0.031 
    Klhl13 2.082 1.06E-03 0.050 
 220







    Zic4 2.063 2.66E-04 0.030 
    Cdca7 2.059 1.59E-04 0.024 
    Sulf2 2.053 2.41E-04 0.029 
    Tmem16a 2.047 4.64E-07 0.004 
    Gucy1a3 2.046 2.06E-04 0.027 
    Sox6 2.046 6.14E-04 0.040 
    Stk33 2.039 8.74E-06 0.009 
    Slco3a1 2.038 2.00E-04 0.027 
    Asb4 2.023 1.77E-05 0.012 
    Pmch 2.014 4.81E-04 0.037 
    Hmx3 2.007 1.07E-03 0.050 
    Notch1 2.006 1.14E-04 0.021 
    4930506M07Rik 2.004 2.78E-04 0.030 
    Glo1 2.002 8.57E-05 0.018 
    Dnmt1 2.001 1.06E-03 0.050 
    Dlx6os1 1.994 7.83E-05 0.017 
    Gucy1a3 1.992 9.17E-06 0.009 
    Melk 1.991 9.75E-06 0.009 
    Ches1 1.987 7.19E-04 0.043 
    Slc18a2 1.975 1.26E-05 0.010 
    Grb10 1.971 1.54E-04 0.024 
    Hist1h2af 1.963 3.36E-04 0.032 
    Ywhaz 1.962 2.03E-04 0.027 
    Casc5 1.959 3.53E-04 0.032 
    Mapre1 1.957 4.77E-04 0.037 
    Slc18a2 1.956 4.88E-05 0.014 
    Arvcf 1.955 9.37E-04 0.047 
    Smad4 1.950 9.88E-05 0.019 
    Ptges3 1.949 7.73E-04 0.044 
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    Nucks1 1.924 9.47E-04 0.047 
    Rbp1 1.912 5.11E-04 0.038 
    Kifc1 1.910 5.31E-04 0.038 
    Espl1 1.907 5.65E-04 0.039 
    Dlx5 1.903 5.16E-04 0.038 
    Thoc4 1.900 7.32E-04 0.043 
    Gucy1b3 1.899 3.60E-06 0.007 
    Top2a 1.897 5.18E-05 0.015 
    Ccdc5 1.897 2.36E-04 0.029 
    Clstn2 1.895 9.53E-04 0.047 
    Spag5 1.894 6.86E-05 0.017 
    Msi2 1.880 1.96E-04 0.027 
    Hist1h2ai 1.880 7.44E-04 0.043 
    Plagl2 1.875 7.84E-06 0.009 
    Gpr88 1.874 1.42E-04 0.023 
    Cks1b 1.873 4.40E-04 0.035 
    Sox9 1.871 3.08E-04 0.031 
    Uhrf1 1.871 1.30E-04 0.022 
    ENSMUST00000076113 1.861 4.87E-04 0.037 
    Epha4 1.861 3.35E-04 0.032 
    Phgdh 1.855 4.65E-04 0.036 
    Aph1a 1.853 2.16E-05 0.012 
    Syt1 1.851 4.75E-04 0.036 
    LOC627585 1.850 1.05E-03 0.050 
    Arrdc4 1.850 1.51E-04 0.024 
    Atbf1 1.847 6.72E-04 0.041 
    Tspan7 1.840 1.21E-04 0.022 
    Tcof1 1.838 9.44E-04 0.047 
    Aldh1a3 1.837 1.69E-04 0.025 
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    Hspa4 1.833 4.04E-04 0.034 
    Rnaseh2a 1.831 2.13E-04 0.028 
    Prrx1 1.829 7.08E-05 0.017 
    Nusap1 1.827 4.34E-05 0.014 
    S100pbp 1.824 1.23E-04 0.022 
    Glo1 1.824 9.07E-05 0.018 
    Rhoa 1.822 6.09E-04 0.040 
    Kif15 1.820 4.02E-05 0.014 
    Slc10a4 1.814 2.78E-05 0.013 
    Cdk6 1.812 2.48E-04 0.029 
    B130054P17 1.809 3.57E-06 0.007 
    Ubtf 1.801 7.28E-04 0.043 
    2410025L10Rik 1.799 3.43E-04 0.032 
    Cdca2 1.796 4.24E-05 0.014 
    Slc10a4 1.793 9.08E-05 0.018 
    Smc2 1.779 3.05E-05 0.013 
    Ung 1.779 4.51E-05 0.014 
    Nuf2 1.774 6.26E-05 0.017 
    Sfrs9 1.773 2.92E-04 0.031 
    Hoxa9 1.772 1.57E-05 0.011 
    5730410E15Rik 1.770 7.34E-05 0.017 
    Tyms 1.765 2.07E-04 0.027 
    Slc25a13 1.756 3.32E-05 0.013 
    Hmgn2 1.756 1.95E-04 0.027 
    Tanc1 1.753 3.14E-04 0.031 
    Nkx2-2 1.751 1.33E-04 0.022 
    Mcm3 1.742 8.04E-04 0.044 
    Gga1 1.739 7.79E-04 0.044 
    5730437N04Rik 1.738 8.13E-05 0.018 
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    Hist1h1b 1.738 4.88E-04 0.037 
    Tacc3 1.736 3.23E-04 0.032 
Pdlim1     1.735 3.56E-05 0.014 
    Nrxn3 1.730 0.044 
 
7.92E-04 
Ebf1    1.725 3.56E-04 0.032 
    Tmcc3 1.719 1.53E-04 0.024 
    Tcfap2e 1.715 2.24E-04 0.028 
    Taf1 1.714 6.60E-05 0.017 
    Pask 1.712 1.24E-04 0.022 
    Pdzrn3 1.710 8.88E-04 0.046 
    D1Ertd471e 1.710 4.17E-04 0.034 
    ENSMUST00000092884 1.708 2.91E-04 0.031 
    Nrip1 1.706 9.80E-04 0.048 
    Csrp1 1.703 4.06E-05 0.014 
    Hs6st2 1.703 4.15E-05 0.014 
    Wnk1 1.702 2.46E-04 0.029 
    Eif2c2 1.700 6.29E-04 0.040 
    Hist1h2aa 1.698 3.99E-04 0.034 
    Atad2 1.694 4.98E-04 0.037 
    Rxfp3 1.694 1.25E-05 0.010 
    Mcm3 1.693 5.27E-04 0.038 
    2410015N17Rik 1.692 7.16E-04 0.043 
    Dtl 1.691 3.73E-05 0.014 
    Baz2a 1.690 7.41E-04 0.043 
    Kif20a 1.689 3.26E-04 0.032 
    Slc16a1 1.688 3.74E-04 0.033 
    Foxp2 1.688 6.84E-04 0.042 
    Hspa12a 1.683 3.29E-04 0.032 
    Slc16a1 1.678 2.69E-04 0.030 
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    Smoc1 1.677 3.73E-05 0.014 
    Gad1 1.677 1.66E-04 0.025 
    Cenpq 1.673 2.12E-04 0.028 
    Nts 1.671 4.15E-04 0.034 
    Myb 1.667 3.27E-05 0.013 
    Ypel4 1.667 7.79E-05 0.017 
    Rbp1 1.664 5.81E-04 0.039 
    Bub1b 1.661 1.06E-03 0.050 
    AU020206 1.660 7.94E-04 0.044 
    Hist2h2aa1 1.657 8.46E-04 0.045 
    Col18a1 1.652 5.25E-04 0.038 
    Ranbp1 1.648 6.25E-04 0.040 
    Grip1 1.647 5.19E-04 0.038 
    Tpx2 1.646 3.73E-04 0.033 
    Rnd3 1.643 9.52E-04 0.047 
    Sulf2 1.643 2.90E-04 0.031 
    Kpna2 1.643 1.01E-03 0.049 
    NAP102645-1 1.642 6.14E-04 0.040 
    Ntn1 1.634 4.33E-05 0.014 
    Ckap5 1.634 4.51E-04 0.036 
    BC085271 1.632 3.12E-04 0.031 
    Cdh22 1.627 4.70E-04 0.036 
    Tmpo 1.627 2.40E-04 0.029 
    Esco2 1.627 2.95E-05 0.013 
    Chaf1b 1.625 9.21E-04 0.047 
    Pdk1 1.623 9.50E-05 0.019 
    Onecut2 1.620 3.94E-04 0.034 
    Smc2 1.619 3.61E-04 0.032 
    BX513654 1.617 2.21E-04 0.028 
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    Zfp668 1.617 6.16E-04 0.040 
    Rif1 1.616 5.72E-04 0.039 
Gtf2h1     1.607 3.18E-04 0.032 
    Zc3h11a 1.604 1.99E-04 0.027 
    5730590G19Rik 1.603 2.21E-05 0.012 
    Vwc2 1.601 5.57E-05 0.016 
    Exoc6b 1.599 1.36E-04 0.023 
    Tiam2 1.598 2.65E-04 0.030 
    Hoxb3 1.597 2.06E-05 0.012 
    Rprm 1.596 8.01E-04 0.044 
    Lmo1 1.591 3.28E-04 0.032 
    Cenpb 1.590 3.00E-04 0.031 
    NAP028759-1 1.590 6.67E-04 0.041 
    Tcf19 1.587 2.76E-04 0.030 
Klhdc4     1.587 2.19E-04 0.028 
Slc12a2     1.585 1.44E-04 0.023 
    Dnajb6 1.579 7.29E-04 0.043 
    Rad54l 1.578 2.76E-04 0.030 
    Cdc6 1.576 3.47E-05 0.014 
    Ranbp2 1.573 4.18E-04 0.034 
    Nol8 1.572 6.62E-04 0.041 
    Rffl 1.572 7.61E-05 0.017 
    Myb 1.568 6.49E-05 0.017 
    Upf1 1.566 7.57E-04 0.043 
    Bmper 1.562 3.51E-04 0.032 
    2610528E23Rik 1.562 5.66E-04 0.039 
    Ddx6 1.560 4.49E-04 0.036 
Frap1     1.559 1.04E-03 0.050 
Prrx1     1.558 5.80E-05 0.016 
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Gene Fold Change p-value
Adjusted  
 p-value
    Rffl 1.557 6.13E-04 0.040 
    Ogg1 1.557 2.62E-04 0.030 
    Hells 1.554 8.15E-04 0.044 
    Hook3 1.547 1.01E-03 0.049 
    Thrap3 1.547 1.57E-04 0.024 
    3110006E14Rik 1.547 8.90E-04 0.046 
    Mthfd2 1.543 1.96E-04 0.027 
    Ttrap 1.542 7.58E-04 0.043 
    Olig2 1.542 2.41E-04 0.029 
    LOC666704 1.539 1.04E-03 0.050 
    Eif1a 1.539 1.93E-04 0.027 
    Kif7 1.539 4.14E-05 0.014 
    S100a10 1.538 1.14E-04 0.021 
    1500003O22Rik 1.537 1.07E-04 0.020 
    Mrps5 1.534 1.18E-04 0.021 
    Accn1 1.534 4.02E-04 0.034 
    Fgf14 1.534 4.19E-05 0.014 
    Arhgap11a 1.533 1.12E-04 0.021 
    Timeless 1.533 6.68E-04 0.041 
    2600005C20Rik 1.532 3.61E-05 0.014 
    Usf1 1.532 6.68E-04 0.041 
    Cenpp 1.532 9.20E-04 0.047 
    Sox9 1.530 6.42E-04 0.041 
    Nphp1 1.529 7.71E-04 0.044 
    Gm784 1.529 9.39E-05 0.018 
    Rrm2 1.528 8.15E-04 0.044 
    Jarid2 1.527 2.22E-04 0.028 
    Nat13 1.523 5.71E-04 0.039 
    Ncapg 1.521 2.97E-04 0.031 
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Gene Fold Change p-value
Adjusted  
 p-value
    Hist1h4d 1.521 8.24E-04 0.045 
    Oip5 1.521 7.33E-04 0.043 
    Tac1 1.519 1.60E-04 0.024 
    Pprc1 1.519 2.41E-04 0.029 
    Fancl 1.519 2.73E-04 0.030 
    Cdk2 1.516 1.04E-04 0.020 
    Olig1 1.509 5.55E-04 0.039 
    Pola2 1.507 8.92E-05 0.018 
    Hip2 1.506 9.24E-05 0.018 
    Sfi1 1.505 9.16E-04 0.047 
    Chek1 1.501 6.27E-05 0.017 
    Fkbp8 1.498 5.92E-04 0.040 
    Asf1b 1.498 5.79E-04 0.039 
    Lima1 1.495 8.44E-04 0.045 
    2810416G20Rik 1.494 4.74E-04 0.036 
    Plscr1 1.494 1.14E-04 0.021 
    Rcl1 1.493 8.85E-04 0.046 
    Tmem48 1.492 1.33E-04 0.022 
    Ankrd43 1.491 3.13E-05 0.013 
    Mnd1 1.491 4.56E-05 0.014 
    Tlk1 1.490 6.60E-04 0.041 
    AK032303 1.489 9.00E-04 0.047 
    5830446M03Rik 1.486 6.05E-04 0.040 
    8430408O14 1.485 3.48E-04 0.032 
    Nlk 1.483 7.94E-04 0.044 
    Dusp7 1.483 5.61E-04 0.039 
    Vax1 1.483 1.66E-04 0.025 
    Rras2 1.482 3.22E-04 0.032 
    Gins3 1.474 1.53E-04 0.024 
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Gene Fold Change p-value
Adjusted  
 p-value
    Ubqln4 1.471 1.15E-04 0.021 
    Trerf1 1.470 2.54E-04 0.029 
    Mettl5 1.470 2.54E-04 0.029 
    Tbl1x 1.467 4.19E-04 0.034 
    Rbm28 1.465 9.97E-04 0.049 
    Zfp179 1.464 2.51E-04 0.029 
    Zfp469 1.464 6.67E-04 0.041 
    Prkar2a 1.458 4.21E-04 0.034 
    Pitpnb 1.455 6.14E-04 0.040 
    4930442E04Rik 1.454 1.31E-04 0.022 
    Tnrc15 1.454 8.31E-04 0.045 
    Ube1l2 1.453 7.41E-04 0.043 
    Fgd1 1.452 2.45E-04 0.029 
    Spef1 1.450 2.82E-04 0.030 
    Cenpl 1.447 5.76E-04 0.039 
    Papd1 1.444 9.81E-04 0.048 
    ENSMUST00000050565 1.442 2.33E-04 0.029 
    Nol3 1.441 3.82E-04 0.033 
    Has3 1.439 7.06E-04 0.043 
    Tor1b 1.438 1.02E-03 0.049 
    Setd8 1.437 4.14E-04 0.034 
    Fbln1 1.433 8.60E-04 0.045 
    Rif1 1.431 2.37E-04 0.029 
    Tmtc2 1.430 7.98E-04 0.044 
    Utp14a 1.430 8.93E-05 0.018 
    Top2a 1.430 7.13E-05 0.017 
    Rpsa 1.430 3.34E-04 0.032 
    Nap1l5 1.427 4.64E-04 0.036 
    E2f7 1.425 6.42E-04 0.041 
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Gene Fold Change p-value
Adjusted  
 p-value
    Nkx2-3 1.425 2.19E-04 0.028 
    Luc7l2 1.424 5.98E-04 0.040 
    Onecut1 1.424 7.94E-05 0.017 
    Gpt2 1.422 1.07E-03 0.050 
    Elovl5 1.420 4.32E-04 0.035 
    Mmp17 1.419 2.68E-04 0.030 
    C330016O10Rik 1.416 6.48E-04 0.041 
    Trp53i13 1.416 4.36E-04 0.035 
    Cdc6 1.416 2.20E-04 0.028 
    Dhfr 1.416 4.60E-04 0.036 
    Ash1l 1.416 5.95E-04 0.040 
    Mgat4c 1.411 7.92E-04 0.044 
    Lars 1.410 5.17E-04 0.038 
    Arhgef1 1.410 9.82E-05 0.019 
    U2af2 1.409 2.29E-04 0.029 
    Ric3 1.408 3.90E-04 0.033 
    Slc39a9 1.408 8.66E-04 0.046 
    Slc35f1 1.404 4.66E-04 0.036 
    Zranb3 1.402 5.92E-04 0.040 
    ENSMUST00000103201 1.402 8.56E-04 0.045 
    TC1637709 1.400 4.17E-04 0.034 
    Foxp2 1.398 1.03E-03 0.049 
    Pbx1 1.397 2.09E-04 0.028 
    Chka 1.396 5.39E-04 0.038 
    Cx3cl1 1.395 7.81E-04 0.044 
    Lgi2 1.395 2.99E-04 0.031 
    Lef1 1.394 3.25E-04 0.032 
    Vstm2 1.392 1.54E-04 0.024 
    Nudt4 1.391 6.34E-04 0.040 
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Gene Fold Change p-value
Adjusted  
 p-value
    Recql4 1.391 7.16E-04 0.043 
    E130304F04Rik 1.389 5.09E-04 0.038 
    Cdc45l 1.387 3.53E-04 0.032 
    Ckap2l 1.386 5.35E-04 0.038 
    Sub1 1.386 9.07E-04 0.047 
    3110001I20Rik 1.385 5.72E-04 0.039 
    Shh 1.385 5.17E-04 0.038 
    Stox2 1.380 1.06E-03 0.050 
    Foxo1 1.380 3.88E-04 0.033 
    Napb 1.379 5.85E-04 0.040 
    Dclre1a 1.377 8.40E-04 0.045 
    Chd1l 1.375 3.62E-04 0.032 
    Siae 1.372 1.98E-04 0.027 
    Shmt1 1.371 5.52E-04 0.039 
    Col18a1 1.371 3.10E-04 0.031 
    Ednrb 1.368 3.73E-04 0.033 
    Sgol2 1.368 1.76E-04 0.025 
    AK017340 1.367 6.00E-04 0.040 
    B2m 1.367 3.71E-04 0.033 
    Ptpru 1.366 1.07E-03 0.050 
    Pms1 1.364 5.76E-04 0.039 
    Ptch1 1.360 7.39E-04 0.043 
    Rab3b 1.359 7.00E-04 0.042 
    5730437N04Rik 1.354 6.47E-04 0.041 
    Senp8 1.352 7.11E-04 0.043 
    Usp24 1.351 7.84E-04 0.044 
    Casc5 1.351 1.87E-04 0.027 
    Ada 1.349 4.96E-04 0.037 
    Helb 1.347 6.58E-04 0.041 
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Gene Fold Change p-value
Adjusted  
 p-value
    Calb2 1.345 5.90E-04 0.040 
    Cmtm7 1.342 9.90E-04 0.049 
    Il16 1.342 3.37E-04 0.032 
    Clstn2 1.341 3.65E-04 0.032 
    Akap13 1.338 2.71E-04 0.030 
    Gnb4 1.338 8.01E-04 0.044 
    Nfe2l2 1.334 7.47E-04 0.043 
    Rapgef6 1.332 2.31E-04 0.029 
    Ccdc90a 1.332 3.72E-04 0.033 
    AU017455 1.332 9.79E-04 0.048 
    Dsn1 1.331 6.23E-04 0.040 
    Itm2a 1.330 8.87E-04 0.046 
    U2af2 1.327 7.70E-04 0.044 
    Casp7 1.323 7.81E-04 0.044 
    Hrasls3 1.320 3.58E-04 0.032 
    Ddx21 1.318 4.60E-04 0.036 
    Dcbld2 1.317 3.28E-04 0.032 
    Zfp324 1.317 3.56E-04 0.032 
    Sass6 1.316 3.60E-04 0.032 
    Cenpl 1.314 9.26E-04 0.047 
    Lhfp 1.309 9.30E-04 0.047 
    ENSMUST00000031768 1.308 6.61E-04 0.041 
    Calu 1.306 9.62E-04 0.048 
    Slc9a3r1 1.306 7.82E-04 0.044 
    Troap 1.302 5.59E-04 0.039 
    Pdxk 1.301 6.03E-04 0.040 
    Frmd6 1.300 4.64E-04 0.036 
    Slitrk3 1.297 8.67E-04 0.046 
    Fn1 1.297 1.06E-03 0.050 
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Gene Fold Change p-value
Adjusted  
 p-value
    D430042O09Rik 1.296 8.44E-04 0.045 
    Gsg2 1.294 8.27E-04 0.045 
    Bambi 1.293 9.59E-04 0.048 
    B3bp 1.290 9.75E-04 0.048 
    Tob2 1.288 7.32E-04 0.043 






 Down-regulated Genes Appendix B
 Gene Fold Change p-value
Adjusted 
p-value
    Neurog2 -10.241 3.95E-05 0.014 
    Neurod6 -6.816 8.01E-06 0.009 
    BC020078 -6.408 4.59E-05 0.014 
    Prdm8 -6.185 2.47E-05 0.012 
    Tcfap2c -5.648 3.71E-05 0.014 
    Slc1a3 -5.288 3.46E-05 0.014 
    Nhlh1 -5.151 1.61E-06 0.005 
    TC1651696 -5.053 3.03E-05 0.013 
    TC1574886 -4.645 6.06E-04 0.040 
    Lhx9 -4.633 3.41E-06 0.007 
    Eomes -4.549 6.83E-06 0.009 
    Has2 -3.848 7.49E-06 0.009 
    Uncx4.1 -3.834 1.35E-06 0.005 
    Sema6d -3.801 1.17E-05 0.009 
    Nrn1 -3.726 2.78E-06 0.007 
    Chst8 -3.696 4.07E-06 0.007 
    Slc17a6 -3.686 2.19E-05 0.012 
    Rabgap1l -3.666 2.11E-05 0.012 
    Celsr1 -3.637 1.75E-04 0.025 
    3110035E14Rik -3.531 3.06E-05 0.013 
    Sim1 -3.478 7.61E-04 0.043 
    Synpr -3.415 5.49E-06 0.008 
    Olfm1 -3.320 2.09E-05 0.012 
    C030019F02Rik -3.266 1.16E-04 0.021 
    Pcdh9 -3.136 7.48E-04 0.043 
    3110009O07Rik -3.076 4.31E-07 0.004 
    Mmp14 -2.961 5.62E-05 0.016 
    AK140658 -2.938 1.44E-06 0.005 
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 Gene Fold Change p-value
Adjusted 
p-value
    Tmem46 -2.925 3.49E-05 0.014 
    Pcdh9 -2.892 2.53E-05 0.012 
    Neurod1 -2.885 2.14E-06 0.007 
    Fezf1 -2.867 2.57E-05 0.012 
    Cbln2 -2.861 2.10E-05 0.012 
    Neurod2 -2.792 3.02E-05 0.013 
    Plxna4 -2.701 2.04E-05 0.012 
    Drbp1 -2.690 6.86E-05 0.017 
    Slc17a6 -2.683 2.76E-06 0.007 
    Acpl2 -2.663 3.30E-05 0.013 
    Abhd4 -2.646 5.35E-04 0.038 
    Bhlhb4 -2.643 2.68E-04 0.030 
    BC056349 -2.624 2.53E-06 0.007 
    Prdm16 -2.623 7.72E-04 0.044 
    Epha3 -2.612 6.75E-05 0.017 
    4933402J24Rik -2.608 7.98E-07 0.004 
    Abtb2 -2.579 1.61E-05 0.012 
    Amph -2.568 1.12E-05 0.009 
    Rwdd3 -2.533 6.11E-05 0.017 
    Sorbs2 -2.531 2.12E-05 0.012 
    D10Ertd610e -2.529 1.26E-04 0.022 
    2810406K13Rik -2.512 5.88E-06 0.008 
    A830082K12Rik -2.479 1.06E-05 0.009 
    C630002B14Rik -2.478 9.76E-06 0.009 
    Cbfa2t2 -2.471 3.56E-04 0.032 
    Kctd15 -2.470 8.02E-05 0.018 
    Nhlh2 -2.464 9.92E-06 0.009 
    Arpp21 -2.439 4.80E-06 0.008 
    Cck -2.432 1.24E-06 0.005 
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 Gene Fold Change p-value
Adjusted 
p-value
    Fjx1 -2.411 3.41E-04 0.032 
    AK081101 -2.403 6.67E-07 0.004 
    Epha3 -2.402 6.09E-06 0.008 
    TC1662444 -2.382 1.97E-04 0.027 
    Tnik -2.377 2.34E-06 0.007 
    Serpini1 -2.377 7.66E-05 0.017 
    Rlbp1 -2.368 7.29E-05 0.017 
    NAP032887-1 -2.360 3.61E-04 0.032 
    Galnt14 -2.356 1.07E-05 0.009 
    Wdr47 -2.348 1.04E-04 0.020 
    Dmrta1 -2.325 2.35E-04 0.029 
    Itm2b -2.306 5.04E-05 0.015 
    D12Ertd553e -2.301 1.13E-05 0.009 
    Nr2f1 -2.262 7.02E-05 0.017 
    Serinc5 -2.258 1.28E-05 0.010 
    Tbr1 -2.250 1.91E-04 0.027 
    Ppp1r14a -2.243 2.27E-04 0.028 
    D430039N05Rik -2.238 2.76E-04 0.030 
    C130076O07Rik -2.236 2.18E-05 0.012 
    X68951 -2.223 1.07E-05 0.009 
    Pde1b -2.221 1.42E-05 0.011 
    Trak1 -2.219 1.23E-04 0.022 
    C130038G02Rik -2.208 4.11E-04 0.034 
    Osbpl5 -2.199 4.74E-05 0.014 
    2610203C20Rik -2.194 7.71E-04 0.044 
    Ryr3 -2.193 2.61E-07 0.004 
    Actr3b -2.190 3.76E-05 0.014 
    Cbln2 -2.175 1.89E-05 0.012 
    Prss23 -2.169 5.89E-04 0.040 
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 Gene Fold Change p-value
Adjusted 
p-value
    BC026657 -2.169 1.85E-04 0.026 
    BC043118 -2.168 2.65E-05 0.012 
    CB590425 -2.145 3.56E-05 0.014 
    2310010M24Rik -2.145 1.07E-05 0.009 
    Cxcl12 -2.129 2.38E-05 0.012 
    Lrrn3 -2.122 6.98E-05 0.017 
    Tmem163 -2.121 5.58E-04 0.039 
    Ppp1r1a -2.111 2.50E-05 0.012 
    Glrx2 -2.108 6.55E-05 0.017 
    Cttnbp2 -2.108 1.14E-05 0.009 
    2610100L16Rik -2.107 2.90E-04 0.031 
    Cbln2 -2.107 1.46E-05 0.011 
    6620401M08Rik -2.102 1.42E-04 0.023 
    A830023I12Rik -2.101 1.06E-03 0.050 
    Sema3g -2.096 4.66E-05 0.014 
    Crkrs -2.091 1.04E-04 0.020 
    Ppp2r2b -2.090 3.09E-04 0.031 
    Stxbp1 -2.087 2.75E-04 0.030 
    Mfap4 -2.087 1.03E-04 0.020 
    Clk1 -2.086 2.42E-04 0.029 
    Bmf -2.080 4.41E-06 0.007 
    Helt -2.067 5.94E-05 0.016 
    D11Bwg0517e -2.061 2.69E-05 0.013 
    Ppp2r2b -2.054 7.88E-05 0.017 
    Spsb4 -2.045 1.01E-03 0.049 
    AK081751 -2.033 9.06E-05 0.018 
    Abcg1 -2.021 6.99E-06 0.009 
    Cdh4 -2.003 2.50E-05 0.012 
    Bhlhb5 -2.000 1.40E-04 0.023 
 237
 Down-regulated Genes Appendix B
Adjusted
 Gene Fold Change p-value
 
p-value
    Sema5a -1.995 3.25E-05 0.013 
    Dusp4 -1.991 8.89E-05 0.018 
    Tspan14 -1.981 2.85E-04 0.030 
    4933402J24Rik -1.980 1.95E-05 0.012 
    Slc16a2 -1.966 7.06E-04 0.043 
    Rab6b -1.959 6.07E-04 0.040 
    1300018I17Rik -1.955 4.36E-04 0.035 
    Ndrg4 -1.947 4.38E-05 0.014 
    Dhrs4 -1.940 8.60E-05 0.018 
    Fbxo6 -1.938 6.93E-05 0.017 
    9630041G16Rik -1.938 6.86E-06 0.009 
    Lhx9 -1.935 3.55E-04 0.032 
    Rpap1 -1.915 9.38E-05 0.018 
    TC1708996 -1.913 4.06E-04 0.034 
    Cyp51 -1.907 1.24E-04 0.022 
    Glrx2 -1.905 1.56E-04 0.024 
    Ptprd -1.904 5.18E-05 0.015 
    Nfia -1.898 3.40E-04 0.032 
    B230315N10Rik -1.893 5.63E-04 0.039 
    Cntn2 -1.891 8.09E-05 0.018 
    Olfr74 -1.883 3.55E-04 0.032 
    Itm2b -1.878 1.92E-04 0.027 
    LOC434179 -1.873 6.91E-04 0.042 
    Rkhd3 -1.865 2.74E-04 0.030 
    A730054J21Rik -1.865 1.19E-04 0.021 
    Prdm15 -1.861 2.75E-04 0.030 
    CK347075 -1.852 5.09E-04 0.038 
    Scrt2 -1.850 3.08E-04 0.031 
    Hs3st3b1 -1.850 9.44E-04 0.047 
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Adjusted
 Gene Fold Change p-value
 
p-value
    Dgkq -1.850 5.12E-04 0.038 
    St18 -1.849 6.76E-04 0.041 
    Pcdh8 -1.847 2.69E-04 0.030 
    F2r -1.845 7.97E-04 0.044 
    Plcd1 -1.840 1.88E-04 0.027 
    4931408A02Rik -1.838 5.49E-04 0.039 
    5330426P16Rik -1.830 9.80E-06 0.009 
    1190002H23Rik -1.829 2.87E-04 0.031 
    Unc45a -1.828 4.90E-04 0.037 
    3732412D22Rik -1.827 1.39E-04 0.023 
    Traf4 -1.826 5.89E-04 0.040 
    Ndrg1 -1.825 5.39E-05 0.015 
    Zfp740 -1.821 4.78E-04 0.037 
    Ankib1 -1.819 7.34E-04 0.043 
    Wdr22 -1.818 6.74E-06 0.009 
    9830124H08Rik -1.815 6.12E-04 0.040 
    4933427D14Rik -1.814 7.01E-04 0.042 
    Rhbdl3 -1.811 1.45E-04 0.023 
    Pik3r3 -1.807 2.39E-04 0.029 
    Cttnbp2 -1.807 1.49E-04 0.024 
    Phlda1 -1.804 5.80E-04 0.039 
    Abca1 -1.803 7.61E-05 0.017 
    Ebf3 -1.802 4.17E-05 0.014 
    Eif4a2 -1.799 1.61E-04 0.024 
    Egr1 -1.790 6.32E-04 0.040 
    Edg2 -1.789 3.33E-05 0.013 
    Tbc1d23 -1.784 4.31E-04 0.035 
    1500041B16Rik -1.780 9.28E-05 0.018 
    Tmem56 -1.778 2.29E-05 0.012 
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 Gene Fold Change p-value
Adjusted 
p-value
    Kcnn2 -1.777 8.60E-04 0.045 
    Baz2b -1.776 5.29E-04 0.038 
    Rab8b -1.767 1.53E-04 0.024 
    Wasf2 -1.767 3.67E-04 0.032 
    Slc4a10 -1.766 9.01E-06 0.009 
    Scube1 -1.764 8.44E-04 0.045 
    Sema6d -1.762 9.20E-05 0.018 
    Sesn1 -1.761 6.52E-04 0.041 
    Dcamkl1 -1.757 8.40E-05 0.018 
    Gadd45a -1.757 4.59E-04 0.036 
    Lrp11 -1.756 1.06E-03 0.050 
    Atp13a2 -1.755 3.92E-04 0.033 
    Zfyve27 -1.751 6.15E-04 0.040 
    Mzf6d -1.747 2.62E-04 0.030 
    Hdac9 -1.743 3.92E-05 0.014 
    Gramd1b -1.742 7.33E-04 0.043 
    Clk4 -1.736 5.37E-04 0.038 
    TC1650853 -1.733 2.88E-04 0.031 
    Dusp26 -1.730 1.55E-04 0.024 
    ENSMUST00000096347 -1.730 5.96E-04 0.040 
    5730409E15Rik -1.729 4.07E-05 0.014 
    Cckar -1.728 2.66E-04 0.030 
    C130076O07Rik -1.728 2.74E-04 0.030 
    Ivd -1.725 3.04E-04 0.031 
    BB180072 -1.715 2.18E-04 0.028 
    5031425E22Rik -1.715 2.58E-05 0.012 
    LOC436154 -1.709 3.21E-04 0.032 
    Syt4 -1.707 6.44E-05 0.017 
    Id4 -1.706 7.22E-04 0.043 
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 Gene Fold Change p-value
Adjusted 
p-value
    Prkce -1.706 7.72E-04 0.044 
    Kcnn2 -1.699 3.87E-04 0.033 
    NAP006594-001 -1.698 4.39E-04 0.035 
    LOC668644 -1.697 2.29E-04 0.029 
    Cotl1 -1.696 7.32E-04 0.043 
    Aplp1 -1.696 1.05E-03 0.050 
    Prei4 -1.695 1.61E-04 0.024 
    Clk4 -1.692 1.87E-05 0.012 
    NAP007437-001 -1.690 6.73E-05 0.017 
    AK038660 -1.689 7.25E-04 0.043 
    Tcte1 -1.687 3.02E-04 0.031 
    Has2 -1.686 7.58E-05 0.017 
    Foxk2 -1.683 6.45E-04 0.041 
    Ppp1r3g -1.683 7.30E-05 0.017 
    BC029127 -1.677 4.45E-04 0.036 
    Cntnap2 -1.674 6.70E-04 0.041 
    Kcnn2 -1.674 3.95E-04 0.034 
    Ift81 -1.674 3.74E-04 0.033 
    Mapre2 -1.673 3.69E-04 0.033 
    NAP026611-1 -1.672 1.91E-04 0.027 
    Cyp26b1 -1.670 5.26E-04 0.038 
    Mszf33 -1.669 4.66E-04 0.036 
    Slc25a27 -1.668 9.38E-04 0.047 
    Napa -1.666 8.32E-05 0.018 
    2310026E23Rik -1.666 3.05E-04 0.031 
    Slc26a11 -1.664 7.74E-05 0.017 
    EG382421 -1.661 7.32E-05 0.017 
    Id2 -1.660 7.16E-04 0.043 
    Tspyl4 -1.660 3.22E-04 0.032 
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 Gene Fold Change p-value
Adjusted 
p-value
    Pcdh9 -1.656 2.16E-05 0.012 
    Dixdc1 -1.654 7.05E-05 0.017 
    Frmd5 -1.653 4.91E-04 0.037 
    Slc30a10 -1.651 7.36E-05 0.017 
    AK038173 -1.650 5.66E-04 0.039 
    Gramd1b -1.649 5.71E-04 0.039 
    Rgs3 -1.649 2.36E-04 0.029 
    BC003993 -1.647 2.10E-04 0.028 
    1500011B03Rik -1.647 3.04E-04 0.031 
    C230098O21Rik -1.646 7.44E-04 0.043 
    Rhbdl3 -1.646 8.23E-05 0.018 
    2810409K11Rik -1.645 2.31E-04 0.029 
    Bmpr1b -1.644 5.96E-05 0.016 
    AI504432 -1.643 2.46E-05 0.012 
    Araf -1.642 3.50E-04 0.032 
    Casp9 -1.641 7.43E-05 0.017 
    Kcnn2 -1.640 5.60E-04 0.039 
    NAP102548-1 -1.640 7.56E-04 0.043 
    LOC433801 -1.637 2.56E-04 0.030 
    Cog3 -1.637 3.62E-04 0.032 
    Mtap4 -1.637 9.17E-04 0.047 
    Sharpin -1.637 8.75E-04 0.046 
    Rbm4b -1.632 3.99E-04 0.034 
    LOC671029 -1.632 6.21E-04 0.040 
    Kcnn2 -1.631 6.57E-04 0.041 
    4931428F04Rik -1.626 1.04E-03 0.050 
    Negr1 -1.625 8.27E-04 0.045 
    Jag1 -1.625 3.34E-04 0.032 
    Cul1 -1.621 7.15E-04 0.043 
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 Gene Fold Change p-value
Adjusted 
p-value
    LOC435970 -1.619 4.09E-04 0.034 
    Mszf81 -1.618 7.44E-04 0.043 
    Dcamkl1 -1.615 4.41E-04 0.035 
    NAP049942-1 -1.615 3.92E-04 0.033 
    Fbxl7 -1.614 3.20E-05 0.013 
    Serping1 -1.611 9.21E-04 0.047 
    Mterfd3 -1.609 1.07E-03 0.050 
    4922502B01Rik -1.608 6.53E-05 0.017 
    Map1lc3b -1.608 6.50E-04 0.041 
    AI836758 -1.606 7.53E-04 0.043 
    Cdc42ep4 -1.604 1.03E-03 0.049 
    AK039003 -1.600 8.84E-05 0.018 
    Chn2 -1.599 1.07E-03 0.050 
    BC021611 -1.599 1.05E-03 0.050 
    Polrmt -1.597 8.79E-04 0.046 
    Arih1 -1.596 4.15E-04 0.034 
    Cugbp2 -1.594 3.61E-04 0.032 
    Emx2 -1.594 1.64E-04 0.025 
    1700025G04Rik -1.588 4.57E-04 0.036 
    AB010317 -1.587 3.59E-04 0.032 
    Nxph1 -1.587 3.78E-04 0.033 
    Clk4 -1.586 3.10E-04 0.031 
    Slc39a11 -1.585 2.16E-04 0.028 
    Cntnap2 -1.585 4.54E-04 0.036 
    Dnajb6 -1.585 1.38E-04 0.023 
    Emx1 -1.584 5.01E-04 0.038 
    Rnf146 -1.584 1.02E-03 0.049 
    Slc25a27 -1.583 2.67E-04 0.030 
    E030049G20Rik -1.583 1.32E-04 0.022 
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 Gene Fold Change p-value
Adjusted 
p-value
    Nkd1 -1.582 2.97E-04 0.031 
    Cd200 -1.582 3.97E-04 0.034 
    Tgfb2 -1.581 5.25E-04 0.038 
    Capza1 -1.581 8.65E-04 0.046 
    Tmcc1 -1.580 1.84E-04 0.026 
    EG667885 -1.580 3.82E-04 0.033 
    D10627 -1.579 1.02E-03 0.049 
    2900062L11Rik -1.579 1.75E-04 0.025 
    Trappc3 -1.575 1.96E-04 0.027 
    Ddhd1 -1.573 1.82E-05 0.012 
    Efcbp2 -1.572 1.93E-04 0.027 
    Mapk7 -1.569 8.81E-04 0.046 
    Crmp1 -1.568 3.64E-04 0.032 
    Gamt -1.567 4.58E-04 0.036 
    6720467C03Rik -1.565 5.74E-05 0.016 
    Khdrbs2 -1.563 8.34E-04 0.045 
    Pts -1.562 5.91E-04 0.040 
    Kcnn2 -1.560 7.27E-04 0.043 
    Hnrph1 -1.560 1.04E-03 0.050 
    Gamt -1.560 2.69E-04 0.030 
    Adnp -1.556 1.28E-04 0.022 
    Zfp74 -1.554 1.08E-04 0.020 
    Pla2g4b -1.554 3.04E-04 0.031 
    Pepd -1.551 6.72E-04 0.041 
    Sesn1 -1.550 4.88E-05 0.014 
    Smad7 -1.549 1.98E-04 0.027 
    6620401M08Rik -1.543 5.26E-04 0.038 
    Nfil3 -1.542 1.00E-03 0.049 
    Mknk1 -1.541 6.94E-04 0.042 
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 Gene Fold Change p-value
Adjusted 
p-value
    Pkia -1.539 1.31E-04 0.022 
    9430025M13Rik -1.538 7.11E-05 0.017 
    Prokr1 -1.537 9.09E-05 0.018 
    Atf2 -1.535 2.77E-04 0.030 
    Pcdh9 -1.535 1.72E-04 0.025 
    Cyfip2 -1.534 2.04E-04 0.027 
    Prei4 -1.532 3.12E-04 0.031 
    4933426M11Rik -1.531 4.86E-04 0.037 
    Galk2 -1.531 6.08E-04 0.040 
    Mafb -1.528 9.98E-04 0.049 
    Slc2a13 -1.526 8.54E-05 0.018 
    AW208599 -1.524 7.08E-04 0.043 
    Rnf146 -1.524 1.53E-04 0.024 
    5730507N06Rik -1.524 5.13E-04 0.038 
    Sema6a -1.524 2.88E-05 0.013 
    Crtac1 -1.522 3.59E-04 0.032 
    5330438D12Rik -1.520 7.57E-04 0.043 
    Mar-04 -1.518 1.38E-04 0.023 
    Zfp51 -1.518 5.33E-04 0.038 
    Nudt6 -1.517 4.33E-04 0.035 
    Mrcl -1.515 3.49E-04 0.032 
    Atp2a2 -1.515 6.19E-04 0.040 
    Odc1 -1.513 5.79E-04 0.039 
    Gamt -1.511 4.86E-04 0.037 
    Rb1cc1 -1.511 7.16E-04 0.043 
    Lcorl -1.510 2.06E-04 0.027 
    BC043301 -1.508 1.93E-04 0.027 
    Zfp553 -1.502 1.03E-03 0.049 
    LOC631232 -1.502 9.79E-04 0.048 
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 Gene Fold Change p-value
Adjusted 
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    Nckap1 -1.499 2.54E-04 0.029 
    3110023B02Rik -1.499 6.07E-04 0.040 
    Gcg -1.499 5.24E-04 0.038 
    Lypd6 -1.498 1.99E-04 0.027 
    EG631624 -1.497 3.98E-04 0.034 
    AK052115 -1.496 1.09E-04 0.020 
    A930009L07Rik -1.495 2.19E-04 0.028 
    Setd6 -1.494 1.61E-04 0.024 
    Tbc1d19 -1.491 4.78E-04 0.037 
    Pgm2l1 -1.491 2.96E-04 0.031 
    Tnik -1.491 1.03E-04 0.020 
    Gabrg2 -1.488 4.46E-04 0.036 
    A930038C07Rik -1.487 6.66E-04 0.041 
    Pnrc1 -1.486 7.91E-04 0.044 
    Hspa4l -1.485 1.79E-04 0.026 
    TC1653326 -1.483 6.84E-04 0.042 
    4932442K08Rik -1.483 7.01E-04 0.042 
    Mlstd2 -1.482 2.38E-04 0.029 
    9330132A10Rik -1.476 5.69E-04 0.039 
    Brms1l -1.475 5.12E-04 0.038 
    Olfr450 -1.470 3.53E-04 0.032 
    Wdr44 -1.469 1.03E-04 0.020 
    Chrna6 -1.469 8.87E-04 0.046 
    Elavl2 -1.467 1.68E-04 0.025 
    LOC638058 -1.466 9.14E-04 0.047 
    Ryr1 -1.466 2.27E-04 0.028 
    Arl4a -1.465 3.96E-04 0.034 
    Chgb -1.464 1.07E-03 0.050 
    TC1666853 -1.463 2.93E-04 0.031 
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 Gene Fold Change p-value
Adjusted 
p-value
    NAP000001-064 -1.462 5.33E-04 0.038 
    D86419 -1.462 9.26E-04 0.047 
    Syt16 -1.459 3.47E-04 0.032 
    Nab2 -1.458 2.14E-04 0.028 
    6330439K17Rik -1.457 1.28E-04 0.022 
    1190002N15Rik -1.454 5.16E-04 0.038 
    6720475J19Rik -1.453 3.44E-04 0.032 
    Rufy3 -1.451 8.58E-04 0.045 
    AK086756 -1.451 2.32E-04 0.029 
    Cxcl12 -1.449 1.05E-03 0.050 
    Ywhae -1.446 3.12E-04 0.031 
    Zfp422-rs1 -1.443 8.06E-04 0.044 
    Gamt -1.443 9.12E-04 0.047 
    Gipr -1.442 7.58E-05 0.017 
    Ryr1 -1.442 6.21E-04 0.040 
    Rab6 -1.440 8.06E-04 0.044 
    Prss12 -1.440 6.38E-05 0.017 
    Igsf11 -1.439 4.52E-04 0.036 
    LOC195531 -1.439 7.39E-04 0.043 
    D10Bwg1379e -1.438 3.91E-04 0.033 
    Btbd3 -1.436 9.35E-04 0.047 
    Chd9 -1.434 3.29E-04 0.032 
    TC1709027 -1.432 1.05E-03 0.050 
    2810426N06Rik -1.431 2.79E-04 0.030 
    Gabrg2 -1.431 4.36E-04 0.035 
    Fbxo11 -1.425 1.05E-03 0.050 
    Smad3 -1.425 3.54E-04 0.032 
    Hmgn3 -1.423 2.62E-04 0.030 
    Plcl4 -1.422 3.55E-04 0.032 
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 Gene Fold Change p-value
Adjusted 
p-value
    TC1775183 -1.422 6.90E-04 0.042 
    Mtus1 -1.421 6.48E-04 0.041 
    Fcho2 -1.421 1.69E-04 0.025 
    Plxna4 -1.420 3.19E-04 0.032 
    Pde1c -1.420 3.02E-04 0.031 
    Egr3 -1.419 5.66E-04 0.039 
    Steap1 -1.418 7.28E-04 0.043 
    Zfp85-rs1 -1.417 5.80E-04 0.039 
    Lrrcc1 -1.417 9.74E-05 0.019 
    Tmco3 -1.416 1.06E-03 0.050 
    Plch1 -1.416 3.23E-04 0.032 
    Otud7a -1.416 6.21E-04 0.040 
    Btbd10 -1.416 9.01E-04 0.047 
    Lrrc4c -1.415 8.77E-04 0.046 
    Tasp1 -1.412 8.75E-04 0.046 
    Wdr20a -1.412 7.76E-04 0.044 
    Tspan32 -1.412 1.59E-04 0.024 
    Sypl -1.411 1.03E-03 0.049 
    Kbtbd9 -1.410 2.69E-04 0.030 
    Zcchc2 -1.409 1.05E-03 0.050 
    Plcxd2 -1.409 5.98E-04 0.040 
    Pip5k1c -1.408 6.19E-04 0.040 
    AK133399 -1.408 5.24E-04 0.038 
    Igsf21 -1.408 8.62E-04 0.045 
    Ccdc80 -1.408 3.38E-04 0.032 
    Ptpre -1.406 1.98E-04 0.027 
    BC002059 -1.405 5.08E-04 0.038 
    Zfp95 -1.405 8.18E-04 0.044 
    Srr -1.405 6.10E-04 0.040 
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    Zfp758 -1.403 9.36E-04 0.047 
    Slc7a7 -1.403 3.78E-04 0.033 
    LOC634588 -1.403 9.42E-04 0.047 
    CJ326049 -1.399 2.55E-04 0.029 
    Adamts3 -1.399 3.88E-04 0.033 
    Ghitm -1.397 6.87E-04 0.042 
    Ubox5 -1.397 1.01E-03 0.049 
    TC1635888 -1.395 3.19E-04 0.032 
    Spnb2 -1.395 5.19E-04 0.038 
    Taf1a -1.395 9.94E-04 0.049 
    Map4k3 -1.395 9.15E-04 0.047 
    A130090K04Rik -1.395 3.38E-04 0.032 
    Apc2 -1.392 9.03E-04 0.047 
    NAP102683-1 -1.392 9.74E-04 0.048 
    Pak7 -1.392 5.03E-04 0.038 
    Tmem176b -1.391 5.40E-04 0.038 
    Zfp1 -1.391 8.57E-04 0.045 
    Tns3 -1.391 2.03E-04 0.027 
    1200016B10Rik -1.389 8.19E-04 0.044 
    Spock2 -1.389 7.61E-04 0.043 
    D330050I23Rik -1.388 4.73E-04 0.036 
    NAP048198-1 -1.386 8.30E-04 0.045 
    Trim9 -1.386 8.10E-04 0.044 
    Vps53 -1.384 8.33E-04 0.045 
    Fgf13 -1.381 9.49E-04 0.047 
    Syn2 -1.380 9.64E-04 0.048 
    Dusp14 -1.379 9.22E-04 0.047 
    Kit -1.378 4.04E-04 0.034 
    Prr15 -1.378 1.63E-04 0.024 
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    Wwc1 -1.375 4.32E-04 0.035 
    Spcs3 -1.374 3.70E-04 0.033 
    Ng23 -1.374 7.14E-04 0.043 
    Lrch2 -1.373 6.70E-04 0.041 
    Robo2 -1.373 2.61E-04 0.030 
    Fzd10 -1.372 9.16E-04 0.047 
    4933435A13Rik -1.371 3.37E-04 0.032 
    C130081A10Rik -1.371 9.91E-04 0.049 
    Dscr6 -1.369 6.15E-04 0.040 
    Epha7 -1.368 1.41E-04 0.023 
    Olfr56 -1.368 5.20E-04 0.038 
    4930432O21Rik -1.366 6.27E-04 0.040 
    Pcdhb17 -1.365 9.49E-04 0.047 
    1300010F03Rik -1.365 4.62E-04 0.036 
    LOC433801 -1.364 5.14E-04 0.038 
    Osbpl8 -1.363 8.12E-04 0.044 
    ENSMUST00000036296 -1.362 5.39E-04 0.038 
    Gpr75 -1.362 9.05E-04 0.047 
    BC065397 -1.362 2.32E-04 0.029 
    Wdr37 -1.361 2.70E-04 0.030 
    Edg2 -1.361 8.59E-04 0.045 
    BB456595 -1.360 8.40E-04 0.045 
    A530058N18Rik -1.359 2.22E-04 0.028 
    Cnot8 -1.358 5.44E-04 0.039 
    Prss34 -1.357 8.99E-04 0.047 
    1700047I17Rik -1.355 7.75E-04 0.044 
    Sh3yl1 -1.354 1.06E-03 0.050 
    Bpnt1 -1.350 2.48E-04 0.029 
    8430426H19Rik -1.350 5.87E-04 0.040 
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    Dnajc6 -1.350 8.29E-04 0.045 
    Pro25G -1.347 1.03E-03 0.049 
    3732412D22Rik -1.347 2.96E-04 0.031 
    Tmem163 -1.346 4.08E-04 0.034 
    Sox13 -1.341 7.08E-04 0.043 
    Pigg -1.341 9.74E-04 0.048 
    Pvr -1.340 2.09E-04 0.028 
    1810011O10Rik -1.339 4.55E-04 0.036 
    Plfr -1.337 5.90E-04 0.040 
    Zfp263 -1.336 6.62E-04 0.041 
    Ppp1r3d -1.336 2.20E-04 0.028 
    LOC434179 -1.333 1.05E-03 0.050 
    Tkt -1.330 1.03E-03 0.049 
    Tnik -1.329 5.56E-04 0.039 
    AI452195 -1.328 6.66E-04 0.041 
    Rsu1 -1.326 1.06E-03 0.050 
    4933407L21Rik -1.326 7.08E-04 0.043 
    Hhat -1.325 7.87E-04 0.044 
    Zdhhc8 -1.324 9.48E-04 0.047 
    TC1640689 -1.323 6.92E-04 0.042 
    AK078994 -1.317 5.27E-04 0.038 
    Grrp1 -1.316 1.01E-03 0.049 
    Adcyap1 -1.311 9.92E-04 0.049 
    5730508B09Rik -1.306 6.18E-04 0.040 
    Elovl7 -1.303 9.35E-04 0.047 
    AI585793 -1.301 5.53E-04 0.039 
    Cadps2 -1.298 6.25E-04 0.040 
    BC049806 -1.295 7.35E-04 0.043 
    Zbtb6 -1.294 7.96E-04 0.044 
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    Spats1 -1.292 6.16E-04 0.040 
    2310002A05Rik -1.288 9.15E-04 0.047 
    Arl8b -1.285 9.93E-04 0.049 
    Chl1 -1.282 9.15E-04 0.047 
    Olfr1519 -1.278 9.66E-04 0.048 
    NP431110 -1.276 6.37E-04 0.040 
    9430091E24Rik -1.275 7.52E-04 0.043 
    Srr -1.274 7.71E-04 0.044 
    Spats1 -1.271 9.64E-04 0.048 
    Pfkfb2 -1.270 1.06E-03 0.050 
    3021401N23Rik -1.268 8.85E-04 0.046 
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